apiLogger::2021-10-16 14:44:42,839::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-16 14:44:42,848::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-16 14:44:42,848::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpyc9fhc_c 
apiLogger::2021-10-16 14:44:42,848::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-16 14:44:42,849::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-16 14:44:42,854::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-16 14:44:42,854::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpyc9fhc_c
apiLogger::2021-10-16 14:44:42,869::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-16 14:44:42,869::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-16 14:44:42,870::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-16 14:44:42,870::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-16 14:44:42,874::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-16 14:44:42,874::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-16 14:44:42,874::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-16 14:44:42,874::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh <reshabh.reshabh@rxlogix.com>\nReceived Date : 16-Oct-2021 14:43:50 +0000\nTo : "Medsaf.dev3@regeneron.com" <medsaf.dev3@regeneron.com>\nSubject : <External> send\nEXTERNAL MESSAGE \n \nCase ']
apiLogger::2021-10-16 14:44:42,874::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-16 14:44:42,874::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-16 18:36:42,717::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-16 18:36:42,717::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-16 18:36:42,718::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpceqvol4d 
apiLogger::2021-10-16 18:36:42,718::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-16 18:36:42,718::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-16 18:36:42,723::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-16 18:36:42,723::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpceqvol4d
apiLogger::2021-10-16 18:36:42,735::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-16 18:36:42,735::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-16 18:36:42,735::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-16 18:36:42,735::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-16 18:36:42,740::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-16 18:36:42,740::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-16 18:36:42,740::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-16 18:36:42,740::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Spam Daily Digest <digest@regeneron.com>\nReceived Date : 16-Oct-2021 14:36:20 +0000\nTo : Medsaf.dev3@regeneron.com\nSubject : Spam Daily Digest: 0 New Messages  (1 Valid Emails)\nProofpoint']
apiLogger::2021-10-16 18:36:42,740::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-16 18:36:42,740::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-17 16:26:42,800::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-17 16:26:42,805::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-17 16:26:42,805::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnhmlwh5k 
apiLogger::2021-10-17 16:26:42,805::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-17 16:26:42,806::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-17 16:26:42,881::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-17 16:26:42,881::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnhmlwh5k
apiLogger::2021-10-17 16:26:44,969::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-17 16:26:44,969::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-17 16:26:44,969::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-17 16:26:44,969::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-17 16:26:44,974::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-17 16:26:44,975::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-17 16:26:44,975::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-17 16:26:44,975::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-17 16:26:44,975::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-17 16:26:44,975::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-17 16:26:44,975::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-17 16:26:44,975::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-17 16:26:44,975::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-17 16:26:44,976::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-17 16:26:59,814::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-17 16:26:59,814::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-17 17:50:42,800::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-17 17:50:42,862::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-17 17:50:42,862::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppv1nyw68 
apiLogger::2021-10-17 17:50:42,865::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-17 17:50:42,865::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-17 17:50:43,815::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-17 17:50:43,815::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppv1nyw68
apiLogger::2021-10-17 17:50:47,209::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-17 17:50:47,209::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-17 17:50:47,209::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-17 17:50:47,209::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-17 17:50:47,214::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-17 17:50:47,214::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-17 17:50:47,214::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-17 17:50:47,214::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-17 17:50:47,214::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-17 17:50:47,214::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-17 17:50:47,214::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-17 17:50:47,214::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-17 17:50:47,214::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-17 17:50:47,214::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-17 17:51:10,739::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-17 17:51:10,740::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 04:24:42,693::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 04:24:42,699::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 04:24:42,699::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp4q8fpy56 
apiLogger::2021-10-18 04:24:42,700::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 04:24:42,700::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 04:24:42,850::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 04:24:42,850::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp4q8fpy56
apiLogger::2021-10-18 04:24:44,469::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 04:24:44,469::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 04:24:44,469::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 04:24:44,469::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 04:24:44,474::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 04:24:44,474::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 04:24:44,474::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 04:24:44,474::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 04:24:44,478::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 04:24:44,478::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 04:24:44,478::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-18 04:24:44,478::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-18 04:24:44,482::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 04:24:44,482::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-18 04:24:44,482::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 04:24:44,482::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-18 04:24:44,482::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-18 04:24:44,482::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 04:24:44,482::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 04:24:44,483::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 04:24:44,483::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 04:24:44,483::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 04:24:58,934::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 04:24:58,934::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 04:36:42,713::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 04:36:42,734::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 04:36:42,734::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpvetmq_zp 
apiLogger::2021-10-18 04:36:42,735::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 04:36:42,735::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 04:36:43,008::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 04:36:43,008::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpvetmq_zp
apiLogger::2021-10-18 04:36:45,850::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 04:36:45,850::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 04:36:45,850::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 04:36:45,850::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 04:36:45,855::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-18 04:36:45,855::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 04:36:45,855::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 04:36:45,855::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-18 04:36:45,855::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-18 04:36:45,855::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 04:36:45,855::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-18 04:36:45,855::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 04:36:45,855::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 04:36:45,855::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fcfde3570b8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 04:37:05,569::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 04:37:05,569::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 05:37:50,260::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 05:37:50,261::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 05:37:50,261::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpa63ndm6x 
apiLogger::2021-10-18 05:37:52,630::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 05:37:52,630::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 05:37:52,655::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 05:37:52,655::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpa63ndm6x
apiLogger::2021-10-18 05:37:53,075::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 05:37:53,075::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 05:37:53,075::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 05:37:53,075::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 05:37:53,080::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-18 05:37:53,080::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 05:37:53,080::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 05:37:53,080::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-18 05:37:53,080::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-18 05:37:53,080::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 05:37:53,080::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-18 05:37:53,080::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 05:37:53,080::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 05:37:53,081::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba0c0eeeb8>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 05:38:09,231::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 05:38:09,231::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 05:52:42,717::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 05:52:42,723::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 05:52:42,723::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1ox45jmj 
apiLogger::2021-10-18 05:52:42,724::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 05:52:42,724::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 05:52:42,749::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 05:52:42,749::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1ox45jmj
apiLogger::2021-10-18 05:52:42,780::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 05:52:42,780::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 05:52:42,780::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 05:52:42,780::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 05:52:42,784::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 05:52:42,785::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 05:52:42,785::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 05:52:42,785::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Test Data for PVIT scenario 14 ']
apiLogger::2021-10-18 05:52:42,785::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-18 05:52:42,785::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 05:52:43,063::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 05:52:43,063::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 05:52:43,064::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmph5e1hjnp 
apiLogger::2021-10-18 05:52:43,064::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 05:52:43,064::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 05:52:43,069::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 05:52:43,069::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmph5e1hjnp
apiLogger::2021-10-18 05:52:43,081::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 05:52:43,081::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 05:52:43,081::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 05:52:43,081::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 05:52:43,084::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 05:52:43,084::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 05:52:43,085::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 05:52:43,085::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 18-Oct-2021 05:51:45 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 14\n ']
apiLogger::2021-10-18 05:52:43,085::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-18 05:52:43,085::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 06:08:42,608::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 06:08:42,619::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 06:08:42,619::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpkf_28jgi 
apiLogger::2021-10-18 06:08:42,620::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 06:08:42,620::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 06:08:42,766::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 06:08:42,766::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpkf_28jgi
apiLogger::2021-10-18 06:08:44,377::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 06:08:44,377::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 06:08:44,377::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 06:08:44,377::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 06:08:44,380::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 06:08:44,381::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 06:08:44,381::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 06:08:44,381::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 06:08:44,384::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 06:08:44,385::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 06:08:44,385::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-18 06:08:44,385::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-18 06:08:44,387::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 06:08:44,387::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-18 06:08:44,387::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 06:08:44,387::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-18 06:08:44,387::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-18 06:08:44,388::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 06:08:44,388::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 06:08:44,388::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 06:08:44,388::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 06:08:44,388::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 06:08:59,174::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 06:08:59,174::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 06:12:42,663::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 06:12:42,669::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 06:12:42,670::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpl5eg_ud2 
apiLogger::2021-10-18 06:12:42,670::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 06:12:42,670::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 06:12:42,817::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 06:12:42,817::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpl5eg_ud2
apiLogger::2021-10-18 06:12:44,383::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 06:12:44,383::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 06:12:44,383::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 06:12:44,383::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 06:12:44,386::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 06:12:44,386::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 06:12:44,386::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 06:12:44,386::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 06:12:44,389::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 06:12:44,389::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 06:12:44,389::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-18 06:12:44,389::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-18 06:12:44,392::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 06:12:44,392::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-18 06:12:44,392::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 06:12:44,392::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-18 06:12:44,392::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-18 06:12:44,392::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 06:12:44,392::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 06:12:44,392::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 06:12:44,392::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 06:12:44,392::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 06:12:59,122::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 06:12:59,123::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 06:16:42,763::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 06:16:42,804::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 06:16:42,805::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplai_252r 
apiLogger::2021-10-18 06:16:42,806::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 06:16:42,807::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 06:16:43,982::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 06:16:43,982::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplai_252r
apiLogger::2021-10-18 06:16:48,759::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 06:16:48,759::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 06:16:48,759::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 06:16:48,759::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 06:16:48,762::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-18 06:16:48,762::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 06:16:48,763::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 06:16:48,763::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-18 06:16:48,763::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-18 06:16:48,763::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 06:16:48,763::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-18 06:16:48,763::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 06:16:48,763::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 06:16:48,763::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 06:17:13,956::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 06:17:13,956::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 06:18:42,617::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 06:18:42,622::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 06:18:42,623::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpui3eiw8g 
apiLogger::2021-10-18 06:18:42,623::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 06:18:42,623::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 06:18:42,753::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 06:18:42,754::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpui3eiw8g
apiLogger::2021-10-18 06:18:44,566::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 06:18:44,566::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 06:18:44,566::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 06:18:44,566::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 06:18:44,569::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 06:18:44,569::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 06:18:44,569::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 06:18:44,569::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 06:18:44,572::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 06:18:44,572::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 06:18:44,572::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 06:18:44,572::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-18 06:18:44,572::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-18 06:18:44,572::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 06:18:44,572::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 06:18:44,573::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 06:18:44,573::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 06:18:44,573::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 06:18:59,322::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 06:18:59,322::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 07:04:42,759::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 07:04:42,783::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 07:04:42,783::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwst066mc 
apiLogger::2021-10-18 07:04:42,785::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 07:04:42,785::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 07:04:43,052::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 07:04:43,052::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwst066mc
apiLogger::2021-10-18 07:04:45,861::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 07:04:45,861::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 07:04:45,861::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 07:04:45,861::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 07:04:45,864::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-18 07:04:45,865::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 07:04:45,865::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 07:04:45,865::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-18 07:04:45,865::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-18 07:04:45,865::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 07:04:45,865::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-18 07:04:45,865::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 07:04:45,865::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 07:04:45,865::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 07:05:05,002::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 07:05:05,002::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 07:16:42,693::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 07:16:42,698::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 07:16:42,698::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5z3lvwmx 
apiLogger::2021-10-18 07:16:42,699::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 07:16:42,699::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 07:16:42,830::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 07:16:42,830::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5z3lvwmx
apiLogger::2021-10-18 07:16:44,655::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 07:16:44,655::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 07:16:44,655::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 07:16:44,655::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 07:16:44,658::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 07:16:44,658::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 07:16:44,658::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 07:16:44,658::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 07:16:44,661::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 07:16:44,661::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 07:16:44,661::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 07:16:44,661::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-18 07:16:44,662::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-18 07:16:44,662::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 07:16:44,662::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 07:16:44,662::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 07:16:44,662::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 07:16:44,662::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 07:16:59,204::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 07:16:59,204::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 08:02:42,717::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 08:02:42,724::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 08:02:42,724::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmv8mhe6d 
apiLogger::2021-10-18 08:02:42,724::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 08:02:42,724::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 08:02:42,871::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 08:02:42,871::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmv8mhe6d
apiLogger::2021-10-18 08:02:44,459::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 08:02:44,459::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 08:02:44,459::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 08:02:44,459::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 08:02:44,462::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 08:02:44,462::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 08:02:44,462::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 08:02:44,462::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 08:02:44,465::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 08:02:44,465::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 08:02:44,465::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-18 08:02:44,465::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-18 08:02:44,468::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 08:02:44,468::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-18 08:02:44,468::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 08:02:44,468::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-18 08:02:44,468::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-18 08:02:44,468::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 08:02:44,468::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 08:02:44,468::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 08:02:44,468::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 08:02:44,468::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 08:02:58,979::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 08:02:58,979::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 08:08:42,753::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 08:08:42,775::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 08:08:42,776::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppizr6iue 
apiLogger::2021-10-18 08:08:42,777::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 08:08:42,777::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 08:08:43,044::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 08:08:43,044::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppizr6iue
apiLogger::2021-10-18 08:08:45,829::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 08:08:45,829::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 08:08:45,829::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 08:08:45,829::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 08:08:45,833::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-18 08:08:45,833::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 08:08:45,833::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 08:08:45,833::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-18 08:08:45,833::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-18 08:08:45,833::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 08:08:45,833::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-18 08:08:45,833::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 08:08:45,833::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 08:08:45,833::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 08:09:05,162::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 08:09:05,162::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 08:12:42,777::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 08:12:42,798::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 08:12:42,799::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp02qt7nes 
apiLogger::2021-10-18 08:12:42,800::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 08:12:42,800::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 08:12:43,066::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 08:12:43,067::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp02qt7nes
apiLogger::2021-10-18 08:12:45,852::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 08:12:45,852::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 08:12:45,852::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 08:12:45,852::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 08:12:45,855::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-18 08:12:45,856::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 08:12:45,856::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 08:12:45,856::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-18 08:12:45,856::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-18 08:12:45,856::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 08:12:45,856::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-18 08:12:45,856::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 08:12:45,856::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 08:12:45,856::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 08:13:05,191::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 08:13:05,191::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 10:44:42,964::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 10:44:42,970::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 10:44:42,971::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3osdgx64 
apiLogger::2021-10-18 10:44:42,971::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 10:44:42,971::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 10:44:43,119::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 10:44:43,119::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3osdgx64
apiLogger::2021-10-18 10:44:44,710::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 10:44:44,710::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 10:44:44,710::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 10:44:44,710::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 10:44:44,713::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 10:44:44,713::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 10:44:44,714::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 10:44:44,714::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 10:44:44,717::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 10:44:44,717::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 10:44:44,717::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-18 10:44:44,717::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-18 10:44:44,720::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 10:44:44,720::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-18 10:44:44,720::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 10:44:44,720::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-18 10:44:44,720::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n56,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-18 10:44:44,720::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 10:44:44,720::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 10:44:44,720::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 10:44:44,720::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 10:44:44,720::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 10:44:59,237::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 10:44:59,238::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 10:44:59,297::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 10:44:59,302::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 10:44:59,302::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpp64l_nhh 
apiLogger::2021-10-18 10:44:59,303::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 10:44:59,303::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 10:44:59,433::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 10:44:59,433::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpp64l_nhh
apiLogger::2021-10-18 10:45:01,257::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 10:45:01,257::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 10:45:01,257::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 10:45:01,257::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 10:45:01,260::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 10:45:01,261::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 10:45:01,261::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 10:45:01,261::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 10:45:01,263::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 10:45:01,263::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 10:45:01,263::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 10:45:01,264::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-18 10:45:01,264::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-18 10:45:01,264::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 10:45:01,264::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 10:45:01,264::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 10:45:01,264::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 10:45:01,264::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 10:45:15,799::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 10:45:15,799::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 11:02:42,856::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 11:02:42,891::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 11:02:42,892::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1dfttoql 
apiLogger::2021-10-18 11:02:42,893::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 11:02:42,893::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 11:02:43,798::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 11:02:43,798::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1dfttoql
apiLogger::2021-10-18 11:02:53,690::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 11:02:53,690::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 11:02:53,690::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 11:02:53,690::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 11:02:53,694::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 11:02:53,694::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 11:02:53,694::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 11:02:53,694::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 11:02:53,697::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-18 11:02:53,697::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 11:02:53,697::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 11:02:53,697::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-18 11:02:53,697::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-18 11:02:53,698::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 11:02:53,698::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-18 11:02:53,698::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 11:02:53,698::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 11:02:53,698::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 11:03:29,425::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 11:03:29,425::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 11:04:43,020::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 11:04:43,055::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 11:04:43,056::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp4w3xoiwq 
apiLogger::2021-10-18 11:04:43,057::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 11:04:43,057::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 11:04:43,963::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 11:04:43,963::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp4w3xoiwq
apiLogger::2021-10-18 11:04:53,734::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 11:04:53,734::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 11:04:53,734::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 11:04:53,734::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 11:04:53,738::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 11:04:53,738::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 11:04:53,738::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 11:04:53,738::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 11:04:53,741::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-18 11:04:53,742::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 11:04:53,742::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 11:04:53,742::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-18 11:04:53,742::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-18 11:04:53,742::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 11:04:53,742::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-18 11:04:53,742::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 11:04:53,742::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 11:04:53,742::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 11:05:29,406::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 11:05:29,406::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 11:06:43,025::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 11:06:43,059::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 11:06:43,059::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpaoze4cs3 
apiLogger::2021-10-18 11:06:43,061::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 11:06:43,061::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 11:06:43,963::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 11:06:43,964::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpaoze4cs3
apiLogger::2021-10-18 11:06:53,727::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 11:06:53,727::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 11:06:53,728::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 11:06:53,728::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 11:06:53,731::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 11:06:53,731::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 11:06:53,731::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 11:06:53,732::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 11:06:53,735::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-18 11:06:53,735::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 11:06:53,735::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 11:06:53,735::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-18 11:06:53,735::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Protocol: R1979-ONC-1625\nDay 0: 27-JUL-2020\nCountry: POLAND\nSite # /Investigator: 1625616004/ Knopinska Posluszny, Wanda\nSubject ID: 616004002\nStudy Drug(s): REGN1979\nEvent Term: DEATH\nOnset date: 25-JUL-2020\nSeverity/Grade: Grade 5\nSAE Criteria and/or AESI Criteria: Death/No\nInvestigator Relationship to Study Drug: Not Applicable\nInvestigator Relationship to Study Conduct: Not Related\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2020-00197\n \nKind regards,\n \nAnna\n \nAnna  Ntansah\nSafety & PV Specialist I\nSyneos Health\nUSA\nMobile +1 908-906-0353\nanna.ntansah@syneoshealth.com\nsyneoshealth.com  \n \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No Subject: 616004002\nPage: Adverse Event - ADVERSE EVENTS\nAdverse Event\nCurrently viewing line 2 of 2.\n  Apply to Record\nClick here to return to "Complete View".\nCRF History\nMain Adverse Event Description (Term) DEATH\n616004002 - Adverse\n   \nEvent\nSOC 10018065General disorders and administration site conditions\n616004002 - Adverse\nEvents Yes/No HLGT10053172Fatal outcomes\nHLT 10011907 Death and sudden death\nPT 10011906 Death\nLLT 10011906 Death\nStart date (dd-mon-yyyy)\n25 JUL 2020\nPlease complete only if event onset on Week 1 Day 1 : Did this event start prior to the start of study drug\nadministration?\nIf the event is part of cytokine release syndrome, Infusion Related Reaction or tumor flare, please check the box and\ncomplete the appropriate IRR/CRS/tumor flare CRF.\nSelect if AE is intermittent\nNo\nAE suspected to be caused by REGN1979?\nNot Applicable\nAE suspected to be caused by study conduct?\nNo\nIf yes, specify study conduct\nOutcome of AE Fatal\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 25 JUL 2020\nAE initial severity grade\nGrade 5\nAE most extreme severity grade\nGrade 5\nDate event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 JUL 2020\nDate event became higher than Grade 3 - Not applicable\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nDate event became lesser than Grade 3 - Not applicable\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication please\nenter into concomitant medications eCRF; If procedure or surgery please enter into the Concomitant\nprocedures/surgeries eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nAction taken with REGN1979\nDrug Withdrawn\nDoes this AE qualify as Serious?\nYes\nIs this an AE of Special interest (AESI)?\nNo\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of special\ninterest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may jeopardize\nthe subject, and may require medical or surgical intervention to prevent one of the outcomes listed above).\nONLY FILL OUT IF AE MEETS CRITERIA FOR AESI\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nGrade 3 or higher TLS\nGrade 2 or greater CRS (Lee,2014)\nGrade 3 or greater allergic reactions\nGrade 3 or greater infections\nGrade 2 or greater CNS events\nHepatitis B re-activation\n \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:38:56 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SERIOUS ADVERSE EVENTS/AESI Serious Adverse Event/AESI #1\nSERIOUS ADVERSE\nEVENTS/AESI\nSubject: 616004002\nSerious Adverse Page: Serious Adverse Event/AESI #1 - SERIOUS ADVERSE EVENTS/AESI\nEvent/AESI #1\nAE number\n2\nCRF History\nAdverse Event Description (Term)\n616004002 - Serious DEATH\nAdverse Event/AESI #1\n616004002 - Adverse Start Date (dd-mon-yyyy) 25 JUL 2020\nEvent\nCurrently viewing line 1 of 1.\n616004002 - Adverse   Apply to Record\nClick here to return to "Complete View".\nEvents Yes/No\nDate event became serious (dd-mon-yyyy)\nSAE/AESI Narrative Text\n \nSeverity at the time event became serious\nOther suspected causes\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN1979\nNot applicable\nSpecify the rationale for causality to study conduct\nNot applicable\nSAE/AESI NARRATIVE\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:43:30 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Demography\nSCREENING\nVisit Subject: 616004002\nPage: Demography - SCREENING\nDemography\nEligibility\nYear of Birth (yyyy) (integrated)\n1960\nMedical History Yes/No\nMedical History (including Age (integrated)\n59\nany cancers other than\nlymphoma)\nSex (integrated)\nMale\nComplete Physical\nExamination\nRace (choose only one primary race)\nWhite\nDisease-Specific Cohort\nECOG If Other, specify\n12-Lead\nElectrocardiogram Ethnicity\nNot Hispanic or Latino\nVital Signs\nPrintable Version  View PDF   Icon Key\nHematology - Local Lab Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:44:53 Eastern Daylight Time\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 SCREENING Medical History (including any cancers oth...\nSCREENING\nVisit Subject: 616004002\nPage: Medical History (including any cancers other than lymphoma) - SCREENING\nDemography\nEligibility  Start Date (dd-mon-  Check for unknown start  Ongoing at study  If ongoing specify CTCAE  Date resolved (End date) (dd-mon-  Check for unknown end\n#  Medical History /Finding (Abnormality)\nyyyy) date entry? Grade yyyy) date\nMedical History Yes/No\nDEPRESSION\nMedical History (including    \nany cancers other than\nSOC 10037175Psychiatric disorders\nlymphoma)\n1 HLGT10012375Depressed mood disorders and UN MAY 2018 Ongoing Grade 1\nComplete Physical disturbances\nExamination HLT 10012401Depressive disorders\nDisease-Specific Cohort PT 10012378Depression\nLLT 10012378Depression\nECOG\n2    \n12-Lead\n   \nElectrocardiogram\nPrintable Version  View PDF   Icon Key\nVital Signs Save   Cancel\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:23 Eastern Daylight Time\nHematology - Local Lab\nUrinalysis - Local Lab\nBlood Chemistry - Local\nLab\nCoagulation Test\nBone Marrow Biopsy\nBone Marrow Aspirate\nBone Marrow Examinatio\nLymph node/Tumor Biop\nLymphatic Physical Exam\nBrain CT scan/MRI scan\nSerum Immunoglobulins \nLocal Lab\nViral Infection Status\nLymphoma B Symptoms\nQuestionnaire - EQ5D-3L\nQuestionnaire-EORTC-\nQLQ-C30\nCardiac Ejection Fraction\n(ECHO or MUGA)\nNHL Initial Diagnosis GA\nNHL Molecular GA1\nNHL at study entry for\nDLBCL Cohort\nQuestionnaire - FACT-Ly\nTruCulture - Central Lab\nVisit Continuation\nCRF History\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT\nMEDICATIONS\nSubject: 616004002\nConcomitant Medications Page: Concomitant Medications - CONCOMITANT MEDICATIONS\nYes/No\n Drug Name\nConcomitant Medications  If Prophylaxis Or  Dose  Other,  If Other  If Other,  Unknown  Stop\n# List only one  Indication  MHx Specify  Adverse Event record #  Dose  Frequency  Route  Start date  Ongoing\nOther, specify Unit specify Specify specify Start Date date\nmedication per line\nCRF History Medical 1_DEPRESSION_UN UN MAY\n1 SETALOFT _ _ 25 mg _ QD _ Oral _ _\nHistory MAY 2018 2018\n616004002 - Concomitant\nMedications 2 VENLAFAXINE Adverse _ _ 1_SEVERE DEPRESSIVE 37.5 mg _ QD _ Oral _ 23 JUL _\nEvent EPISODE_23 JUN 2020 2020\n616004002 - Concomitant\n   \nMedications Yes/No\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Medical\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:45:59 Eastern Daylight Time\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 CONCOMITANT PROCEDURES/SURGERIES Concomitant Procedures/Surgeries Yes/No\nCONCOMITANT\nPROCEDURES/SURGE\nSubject: 616004002\nConcomitant Page: Concomitant Procedures/Surgeries Yes/No - CONCOMITANT PROCEDURES/SURGERIES\nProcedures/Surgeries\nYes/No\nDid the subject have any procedures or surgeries after signing the informed consent that were not per-protocol\nmandated interventions?\nCRF History Printable Version  View PDF   Icon Key\nSave   Cancel\n616004002 - Concomitant CRF Version 8302 - Page Generated: 28 Jul 2020 07:46:34 Eastern Daylight Time\nProcedures/Surgeries\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc. REG-2020-00197 GSPV Date of Receipt 27 JUL 2020 AN 13 pages \n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Anna Ntansah Sr Glbl Safety & PV Assistant (Safety)\nR1979-ONC-1625 616004 - Knopinska Posluszny - Poland 616004002 PROTOCOL/ICF TRACKING Informed Consent and Protocol Amendment Tr...\nPROTOCOL/ICF\nTRACKING\nSubject: 616004002\nInformed Consent and Page: Informed Consent and Protocol Amendment Tracking - PROTOCOL/ICF TRACKING\nProtocol Amendment\nTracking  Global Protocol ; Amendment  Were there any local  Amendment  Protocol IRB Approval  ICF  Date Subject Signed Informed  Consent  Informed Consent Approval date  Date subject signed local Informed\n#\nVersion amendments? Version (Local) date (dd-mon-yyyy) VersionConsent (dd-mon-yyyy) Type from EC/IRB (dd-mon-yyyy) Consent (dd-mon-yyyy), if applicable\nR1979-ONC-1625 Amendment 1 Main\nCRF History 1 Global; Amendment 03 EU 10 JUN 2020 consent 04 FEB 2020\n616004002 - Informed    \nConsent and Protocol\nDerived Date Subject Signed Informed Consent (dd-mon-yyyy)\n10 JUN 2020\nAmendment Tracking\n616004002 - Concomitant Printable Version  View PDF   Icon Key\nSave   Cancel\nProcedures/Surgeries\nCRF Version 8302 - Page Generated: 28 Jul 2020 07:46:55 Eastern Daylight Time\nYes/No\n616004002 - Concomitant\nMedications\n616004002 - Concomitant\nMedications Yes/No\n616004002 - Medical\nHistory (including any\ncancers other than\nlymphoma)\n616004002 - Demography\n616004002 - Visit\n616004002 - Serious\nAdverse Event/AESI #1\n616004002 - Adverse\nEvent\n616004002 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.']
apiLogger::2021-10-18 11:06:53,735::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 11:06:53,735::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-18 11:06:53,735::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 11:06:53,735::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 11:06:53,735::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 11:07:29,466::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 11:07:29,466::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 12:08:42,670::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 12:08:42,676::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 12:08:42,676::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpvmjvr20d 
apiLogger::2021-10-18 12:08:42,676::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 12:08:42,676::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 12:08:42,808::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 12:08:42,808::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpvmjvr20d
apiLogger::2021-10-18 12:08:44,634::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 12:08:44,634::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 12:08:44,634::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 12:08:44,634::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 12:08:44,637::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 12:08:44,638::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 12:08:44,638::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 12:08:44,638::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 12:08:44,641::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 12:08:44,641::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 12:08:44,641::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 12:08:44,641::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-18 12:08:44,641::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-18 12:08:44,641::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 12:08:44,641::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 12:08:44,641::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 12:08:44,641::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 12:08:44,641::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 12:08:59,163::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 12:08:59,163::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 15:08:42,700::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 15:08:42,701::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 15:08:42,702::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9wow_2xe 
apiLogger::2021-10-18 15:08:42,702::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 15:08:42,702::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 15:08:42,726::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 15:08:42,726::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9wow_2xe
apiLogger::2021-10-18 15:08:43,033::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 15:08:43,033::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 15:08:43,033::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 15:08:43,034::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 15:08:43,037::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-18 15:08:43,037::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 15:08:43,037::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 15:08:43,037::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-18 15:08:43,037::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-18 15:08:43,037::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 15:08:43,037::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-18 15:08:43,037::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 15:08:43,037::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 15:08:43,037::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 15:08:52,054::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 15:08:52,054::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 16:30:42,763::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 16:30:42,769::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 16:30:42,770::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdg5ukmhs 
apiLogger::2021-10-18 16:30:42,770::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 16:30:42,770::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 16:30:42,919::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 16:30:42,919::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdg5ukmhs
apiLogger::2021-10-18 16:30:44,509::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 16:30:44,509::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 16:30:44,509::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 16:30:44,509::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 16:30:44,513::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 16:30:44,513::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 16:30:44,513::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 16:30:44,513::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 16:30:44,516::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 16:30:44,516::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 16:30:44,516::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-18 16:30:44,516::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-18 16:30:44,519::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 16:30:44,519::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-18 16:30:44,519::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 16:30:44,519::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-18 16:30:44,519::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-18 16:30:44,519::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 16:30:44,519::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 16:30:44,520::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 16:30:44,520::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 16:30:44,520::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 16:30:59,056::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 16:30:59,056::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 17:02:42,720::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 17:02:42,725::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 17:02:42,726::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp7hfdxy0g 
apiLogger::2021-10-18 17:02:42,726::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 17:02:42,726::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 17:02:42,854::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 17:02:42,854::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp7hfdxy0g
apiLogger::2021-10-18 17:02:44,691::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 17:02:44,691::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 17:02:44,691::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 17:02:44,691::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 17:02:44,695::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 17:02:44,695::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 17:02:44,695::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 17:02:44,695::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 17:02:44,698::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 17:02:44,698::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 17:02:44,698::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 17:02:44,698::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-18 17:02:44,698::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-18 17:02:44,698::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 17:02:44,699::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 17:02:44,699::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 17:02:44,699::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 17:02:44,699::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 17:02:59,254::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 17:02:59,254::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 17:36:42,740::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 17:36:42,746::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 17:36:42,746::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwg20q15e 
apiLogger::2021-10-18 17:36:42,747::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 17:36:42,747::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 17:36:42,895::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 17:36:42,895::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwg20q15e
apiLogger::2021-10-18 17:36:44,492::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 17:36:44,492::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 17:36:44,492::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 17:36:44,492::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 17:36:44,496::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 17:36:44,496::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 17:36:44,496::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 17:36:44,496::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 17:36:44,499::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 17:36:44,499::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 17:36:44,499::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-18 17:36:44,499::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-18 17:36:44,502::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 17:36:44,502::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-18 17:36:44,502::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 17:36:44,502::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-18 17:36:44,503::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00335\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-18 17:36:44,503::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 17:36:44,503::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 17:36:44,503::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 17:36:44,503::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 17:36:44,503::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 17:36:59,054::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 17:36:59,054::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 18:08:42,691::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 18:08:42,696::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 18:08:42,697::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpcza13k9q 
apiLogger::2021-10-18 18:08:42,697::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 18:08:42,697::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 18:08:42,825::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 18:08:42,825::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpcza13k9q
apiLogger::2021-10-18 18:08:44,670::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 18:08:44,670::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 18:08:44,670::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 18:08:44,670::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 18:08:44,673::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-18 18:08:44,674::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 18:08:44,674::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-18 18:08:44,674::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-18 18:08:44,677::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-18 18:08:44,677::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-18 18:08:44,677::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 18:08:44,677::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-18 18:08:44,677::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00335\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-18 18:08:44,677::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 18:08:44,677::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-18 18:08:44,677::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 18:08:44,677::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 18:08:44,677::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 18:08:59,214::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 18:08:59,214::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-18 21:12:42,709::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-18 21:12:42,716::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-18 21:12:42,716::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpuwq14m8b 
apiLogger::2021-10-18 21:12:42,717::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-18 21:12:42,717::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-18 21:12:42,797::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-18 21:12:42,797::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpuwq14m8b
apiLogger::2021-10-18 21:12:45,100::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-18 21:12:45,100::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-18 21:12:45,100::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-18 21:12:45,100::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-18 21:12:45,104::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-18 21:12:45,104::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-18 21:12:45,104::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-18 21:12:45,104::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-18 21:12:45,105::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-18 21:12:45,105::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-18 21:12:45,105::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-18 21:12:45,105::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-18 21:12:45,105::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-18 21:12:45,105::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-18 21:12:56,224::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-18 21:12:56,224::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 02:24:42,842::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 02:24:42,869::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 02:24:42,869::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpffl7u53d 
apiLogger::2021-10-19 02:24:42,870::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 02:24:42,870::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 02:24:43,246::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 02:24:43,246::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpffl7u53d
apiLogger::2021-10-19 02:24:46,580::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 02:24:46,580::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 02:24:46,580::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 02:24:46,580::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 02:24:46,584::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-19 02:24:46,584::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 02:24:46,584::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 02:24:46,584::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 02:24:46,584::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-19 02:24:46,584::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 02:24:46,584::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-19 02:24:46,584::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 02:24:46,584::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 02:24:46,585::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 02:25:06,877::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 02:25:06,878::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 03:56:42,667::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 03:56:42,673::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 03:56:42,673::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpyw7m944m 
apiLogger::2021-10-19 03:56:42,673::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 03:56:42,673::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 03:56:42,802::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 03:56:42,802::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpyw7m944m
apiLogger::2021-10-19 03:56:44,635::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 03:56:44,636::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 03:56:44,636::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 03:56:44,636::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 03:56:44,639::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 03:56:44,639::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 03:56:44,639::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 03:56:44,639::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 03:56:44,642::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 03:56:44,642::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 03:56:44,642::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 03:56:44,642::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-19 03:56:44,642::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n56,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-19 03:56:44,643::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 03:56:44,643::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 03:56:44,643::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 03:56:44,643::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 03:56:44,643::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 03:56:59,179::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 03:56:59,179::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 05:48:42,746::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 05:48:42,747::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 05:48:42,748::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9glz61by 
apiLogger::2021-10-19 05:48:42,748::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 05:48:42,748::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 05:48:42,790::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 05:48:42,790::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9glz61by
apiLogger::2021-10-19 05:48:43,086::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 05:48:43,086::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 05:48:43,086::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 05:48:43,086::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 05:48:43,090::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-19 05:48:43,090::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 05:48:43,090::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 05:48:43,090::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 05:48:43,091::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-002418\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-19 05:48:43,091::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 05:48:43,091::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-19 05:48:43,091::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 05:48:43,091::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 05:48:43,091::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 05:48:52,135::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 05:48:52,135::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 06:20:43,837::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 06:20:43,857::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 06:20:43,858::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpib8hxse6 
apiLogger::2021-10-19 06:20:43,858::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 06:20:43,858::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 06:20:44,006::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 06:20:44,006::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpib8hxse6
apiLogger::2021-10-19 06:20:45,595::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 06:20:45,595::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 06:20:45,595::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 06:20:45,595::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 06:20:45,602::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 06:20:45,602::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 06:20:45,602::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 06:20:45,602::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 06:20:45,605::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 06:20:45,606::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 06:20:45,606::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-19 06:20:45,606::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-19 06:20:45,609::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 06:20:45,609::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-19 06:20:45,609::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 06:20:45,609::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-19 06:20:45,609::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-19 06:20:45,609::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 06:20:45,609::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 06:20:45,609::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 06:20:45,609::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 06:20:45,609::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 06:21:00,470::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 06:21:00,470::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 06:39:02,839::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 06:39:02,845::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 06:39:02,846::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbkshcn77 
apiLogger::2021-10-19 06:39:02,846::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 06:39:02,846::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 06:39:02,993::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 06:39:02,993::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbkshcn77
apiLogger::2021-10-19 06:39:04,582::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 06:39:04,582::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 06:39:04,582::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 06:39:04,583::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 06:39:04,586::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 06:39:04,586::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 06:39:04,586::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 06:39:04,586::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 06:39:04,589::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 06:39:04,590::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 06:39:04,590::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-19 06:39:04,590::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-19 06:39:04,593::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 06:39:04,593::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-19 06:39:04,593::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 06:39:04,593::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-19 06:39:04,593::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-19 06:39:04,593::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 06:39:04,593::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 06:39:04,593::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 06:39:04,593::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 06:39:04,593::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 06:39:19,124::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 06:39:19,124::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 06:56:42,706::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 06:56:42,710::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 06:56:42,711::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpi_syxsyl 
apiLogger::2021-10-19 06:56:42,711::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 06:56:42,711::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 06:56:42,786::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 06:56:42,786::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpi_syxsyl
apiLogger::2021-10-19 06:56:44,835::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 06:56:44,835::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 06:56:44,835::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 06:56:44,836::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 06:56:44,839::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 06:56:44,839::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 06:56:44,839::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 06:56:44,839::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 06:56:44,839::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-19 06:56:44,840::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 06:56:44,840::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 06:56:44,840::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 06:56:44,840::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 06:56:44,840::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 06:56:59,404::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 06:56:59,405::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 07:58:42,703::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 07:58:42,708::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 07:58:42,709::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6xh0la0s 
apiLogger::2021-10-19 07:58:42,709::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 07:58:42,709::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 07:58:42,841::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 07:58:42,841::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6xh0la0s
apiLogger::2021-10-19 07:58:44,663::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 07:58:44,664::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 07:58:44,664::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 07:58:44,664::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 07:58:44,667::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 07:58:44,667::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 07:58:44,667::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 07:58:44,667::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 07:58:44,670::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 07:58:44,670::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 07:58:44,670::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 07:58:44,671::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-19 07:58:44,671::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-19 07:58:44,671::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 07:58:44,671::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 07:58:44,671::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 07:58:44,671::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 07:58:44,671::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 07:58:59,198::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 07:58:59,198::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 08:48:42,809::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 08:48:42,814::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 08:48:42,814::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpyrnaw4_l 
apiLogger::2021-10-19 08:48:42,815::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 08:48:42,815::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 08:48:42,943::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 08:48:42,943::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpyrnaw4_l
apiLogger::2021-10-19 08:48:44,773::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 08:48:44,774::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 08:48:44,774::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 08:48:44,774::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 08:48:44,777::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 08:48:44,777::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 08:48:44,777::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 08:48:44,777::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 08:48:44,781::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 08:48:44,781::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 08:48:44,781::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 08:48:44,781::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-19 08:48:44,781::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n56,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-19 08:48:44,781::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 08:48:44,781::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 08:48:44,781::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 08:48:44,781::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 08:48:44,781::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 08:48:59,219::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 08:48:59,219::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 09:04:42,600::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 09:04:42,605::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 09:04:42,605::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5cr1cl0r 
apiLogger::2021-10-19 09:04:42,606::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 09:04:42,606::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 09:04:42,733::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 09:04:42,733::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5cr1cl0r
apiLogger::2021-10-19 09:04:44,566::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 09:04:44,567::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 09:04:44,567::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 09:04:44,567::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 09:04:44,570::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 09:04:44,570::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 09:04:44,570::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 09:04:44,570::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 09:04:44,574::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 09:04:44,574::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 09:04:44,574::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 09:04:44,574::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-19 09:04:44,574::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-19 09:04:44,574::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 09:04:44,574::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 09:04:44,574::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 09:04:44,574::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 09:04:44,574::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 09:04:59,103::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 09:04:59,103::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 09:14:52,657::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 09:14:52,658::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 09:14:52,658::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpzcjcuwkv 
apiLogger::2021-10-19 09:14:52,659::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 09:14:52,659::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 09:14:52,701::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 09:14:52,701::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpzcjcuwkv
apiLogger::2021-10-19 09:14:53,077::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 09:14:53,078::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 09:14:53,078::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 09:14:53,078::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 09:14:53,081::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-19 09:14:53,081::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 09:14:53,081::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 09:14:53,081::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 09:14:53,081::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-002418\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-19 09:14:53,081::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 09:14:53,081::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-19 09:14:53,081::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 09:14:53,081::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 09:14:53,081::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 09:15:03,984::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 09:15:03,984::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 12:12:42,710::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 12:12:42,716::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 12:12:42,716::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp4wfz7sju 
apiLogger::2021-10-19 12:12:42,716::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 12:12:42,716::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 12:12:42,847::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 12:12:42,848::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp4wfz7sju
apiLogger::2021-10-19 12:12:44,675::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 12:12:44,675::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 12:12:44,676::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 12:12:44,676::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 12:12:44,679::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 12:12:44,679::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 12:12:44,679::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 12:12:44,679::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 12:12:44,683::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 12:12:44,683::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 12:12:44,683::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 12:12:44,683::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-19 12:12:44,683::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-19 12:12:44,683::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 12:12:44,683::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 12:12:44,683::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 12:12:44,683::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 12:12:44,683::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 12:12:59,127::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 12:12:59,127::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 13:32:42,824::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 13:32:42,830::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 13:32:42,830::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpvmhq_48f 
apiLogger::2021-10-19 13:32:42,831::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 13:32:42,831::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 13:32:42,978::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 13:32:42,979::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpvmhq_48f
apiLogger::2021-10-19 13:32:44,570::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 13:32:44,570::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 13:32:44,570::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 13:32:44,570::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 13:32:44,574::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 13:32:44,574::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 13:32:44,574::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 13:32:44,574::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 13:32:44,578::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 13:32:44,578::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 13:32:44,578::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-19 13:32:44,578::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-19 13:32:44,581::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 13:32:44,581::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-19 13:32:44,581::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 13:32:44,581::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-19 13:32:44,581::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-19 13:32:44,581::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 13:32:44,581::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 13:32:44,581::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 13:32:44,581::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 13:32:44,581::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 13:32:59,113::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 13:32:59,113::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 13:34:42,721::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 13:34:42,727::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 13:34:42,727::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpoh767408 
apiLogger::2021-10-19 13:34:42,728::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 13:34:42,728::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 13:34:42,876::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 13:34:42,876::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpoh767408
apiLogger::2021-10-19 13:34:44,467::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 13:34:44,467::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 13:34:44,467::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 13:34:44,467::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 13:34:44,471::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 13:34:44,471::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 13:34:44,471::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 13:34:44,471::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 13:34:44,474::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 13:34:44,474::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 13:34:44,474::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-19 13:34:44,474::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-19 13:34:44,477::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 13:34:44,478::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-19 13:34:44,478::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 13:34:44,478::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-19 13:34:44,478::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-19 13:34:44,478::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 13:34:44,478::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 13:34:44,478::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 13:34:44,478::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 13:34:44,478::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 13:34:59,014::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 13:34:59,014::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 13:36:42,678::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 13:36:42,684::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 13:36:42,684::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpki_icqgf 
apiLogger::2021-10-19 13:36:42,685::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 13:36:42,685::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 13:36:42,787::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 13:36:42,788::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpki_icqgf
apiLogger::2021-10-19 13:36:44,394::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 13:36:44,394::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 13:36:44,394::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 13:36:44,394::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 13:36:44,398::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 13:36:44,398::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 13:36:44,398::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 13:36:44,398::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 13:36:44,402::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 13:36:44,402::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 13:36:44,402::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-19 13:36:44,402::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-19 13:36:44,405::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 13:36:44,405::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-19 13:36:44,405::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 13:36:44,405::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-19 13:36:44,405::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-19 13:36:44,405::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 13:36:44,405::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 13:36:44,406::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 13:36:44,406::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 13:36:44,406::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 13:36:58,908::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 13:36:58,908::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 14:05:11,216::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 14:05:11,258::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 14:05:11,258::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6kthaxjw 
apiLogger::2021-10-19 14:05:11,260::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 14:05:11,260::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 14:05:12,447::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 14:05:12,447::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6kthaxjw
apiLogger::2021-10-19 14:05:17,254::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 14:05:17,254::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 14:05:17,254::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 14:05:17,254::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 14:05:17,258::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-19 14:05:17,259::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 14:05:17,259::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 14:05:17,259::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 14:05:17,259::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-19 14:05:17,259::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 14:05:17,259::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-19 14:05:17,259::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 14:05:17,259::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 14:05:17,259::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 14:05:42,270::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 14:05:42,270::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 14:26:42,753::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 14:26:42,759::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 14:26:42,759::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1_iaylh6 
apiLogger::2021-10-19 14:26:42,760::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 14:26:42,760::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 14:26:42,908::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 14:26:42,908::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1_iaylh6
apiLogger::2021-10-19 14:26:44,499::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 14:26:44,500::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 14:26:44,500::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 14:26:44,500::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 14:26:44,504::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 14:26:44,504::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 14:26:44,504::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 14:26:44,504::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 14:26:44,507::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 14:26:44,507::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 14:26:44,507::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-19 14:26:44,507::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-19 14:26:44,510::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 14:26:44,510::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-19 14:26:44,510::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 14:26:44,511::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-19 14:26:44,511::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-19 14:26:44,511::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 14:26:44,511::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 14:26:44,511::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 14:26:44,511::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 14:26:44,511::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 14:26:59,050::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 14:26:59,050::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 14:34:43,041::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 14:34:43,047::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 14:34:43,047::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpu4l_ve7d 
apiLogger::2021-10-19 14:34:43,048::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 14:34:43,048::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 14:34:43,196::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 14:34:43,196::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpu4l_ve7d
apiLogger::2021-10-19 14:34:44,789::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 14:34:44,789::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 14:34:44,789::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 14:34:44,789::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 14:34:44,793::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 14:34:44,793::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 14:34:44,793::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 14:34:44,793::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 14:34:44,797::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 14:34:44,797::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 14:34:44,797::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-19 14:34:44,797::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-19 14:34:44,800::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 14:34:44,800::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-19 14:34:44,800::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 14:34:44,800::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-19 14:34:44,800::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-19 14:34:44,800::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 14:34:44,800::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 14:34:44,800::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 14:34:44,800::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 14:34:44,800::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 14:34:59,548::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 14:34:59,548::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 14:34:59,617::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 14:34:59,623::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 14:34:59,624::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpg6atjavp 
apiLogger::2021-10-19 14:34:59,624::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 14:34:59,624::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 14:34:59,772::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 14:34:59,772::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpg6atjavp
apiLogger::2021-10-19 14:35:01,362::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 14:35:01,363::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 14:35:01,363::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 14:35:01,363::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 14:35:01,367::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 14:35:01,367::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 14:35:01,367::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 14:35:01,367::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 14:35:01,371::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 14:35:01,371::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 14:35:01,371::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-19 14:35:01,371::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-19 14:35:01,374::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 14:35:01,374::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-19 14:35:01,375::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 14:35:01,375::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-19 14:35:01,375::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-19 14:35:01,375::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 14:35:01,375::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 14:35:01,375::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 14:35:01,375::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 14:35:01,375::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 14:35:15,969::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 14:35:15,969::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 14:42:51,080::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 14:42:51,086::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 14:42:51,086::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpi8un1u_w 
apiLogger::2021-10-19 14:42:51,087::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 14:42:51,087::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 14:42:51,214::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 14:42:51,214::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpi8un1u_w
apiLogger::2021-10-19 14:42:52,845::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 14:42:52,845::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 14:42:52,845::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 14:42:52,845::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 14:42:52,849::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 14:42:52,849::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 14:42:52,849::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 14:42:52,849::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 14:42:52,853::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 14:42:52,853::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 14:42:52,853::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-19 14:42:52,853::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-19 14:42:52,856::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 14:42:52,856::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-19 14:42:52,856::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 14:42:52,856::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-19 14:42:52,856::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-19 14:42:52,856::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 14:42:52,856::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 14:42:52,856::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 14:42:52,856::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 14:42:52,856::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 14:43:07,422::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 14:43:07,422::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 15:00:42,710::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 15:00:42,731::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 15:00:42,732::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpw9yswjj7 
apiLogger::2021-10-19 15:00:42,733::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 15:00:42,733::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 15:00:43,001::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 15:00:43,001::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpw9yswjj7
apiLogger::2021-10-19 15:00:45,793::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 15:00:45,793::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 15:00:45,794::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 15:00:45,794::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 15:00:45,798::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-19 15:00:45,798::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 15:00:45,798::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 15:00:45,798::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 15:00:45,798::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-19 15:00:45,798::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 15:00:45,798::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-19 15:00:45,798::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 15:00:45,798::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 15:00:45,798::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 15:01:05,193::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 15:01:05,193::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 15:08:42,760::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 15:08:42,781::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 15:08:42,781::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqtyq1ol4 
apiLogger::2021-10-19 15:08:42,783::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 15:08:42,783::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 15:08:43,024::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 15:08:43,024::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqtyq1ol4
apiLogger::2021-10-19 15:08:45,869::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 15:08:45,869::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 15:08:45,869::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 15:08:45,869::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 15:08:45,873::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-19 15:08:45,873::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 15:08:45,873::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 15:08:45,873::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 15:08:45,874::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-19 15:08:45,874::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 15:08:45,874::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-19 15:08:45,874::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 15:08:45,874::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 15:08:45,874::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 15:09:05,413::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 15:09:05,413::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 15:30:42,677::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 15:30:42,682::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 15:30:42,682::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp7sjjezdl 
apiLogger::2021-10-19 15:30:42,683::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 15:30:42,683::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 15:30:42,811::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 15:30:42,811::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp7sjjezdl
apiLogger::2021-10-19 15:30:44,646::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 15:30:44,646::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 15:30:44,646::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 15:30:44,646::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 15:30:44,650::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 15:30:44,650::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 15:30:44,650::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 15:30:44,650::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 15:30:44,653::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 15:30:44,653::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 15:30:44,653::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 15:30:44,653::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-19 15:30:44,654::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-19 15:30:44,654::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 15:30:44,654::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 15:30:44,654::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 15:30:44,654::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 15:30:44,654::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 15:30:59,203::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 15:30:59,203::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 15:42:45,621::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 15:42:45,627::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 15:42:45,627::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqop2sg8j 
apiLogger::2021-10-19 15:42:45,628::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 15:42:45,628::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 15:42:45,776::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 15:42:45,776::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqop2sg8j
apiLogger::2021-10-19 15:42:47,367::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 15:42:47,368::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 15:42:47,368::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 15:42:47,368::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 15:42:47,372::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 15:42:47,372::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 15:42:47,372::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 15:42:47,372::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 15:42:47,376::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 15:42:47,376::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 15:42:47,376::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-19 15:42:47,376::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-19 15:42:47,379::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 15:42:47,379::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-19 15:42:47,379::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 15:42:47,379::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-19 15:42:47,379::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-19 15:42:47,380::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 15:42:47,380::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 15:42:47,380::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 15:42:47,380::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 15:42:47,380::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 15:43:01,819::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 15:43:01,819::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 15:58:42,842::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 15:58:42,863::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 15:58:42,863::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpkvif80cr 
apiLogger::2021-10-19 15:58:42,864::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 15:58:42,864::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 15:58:43,133::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 15:58:43,133::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpkvif80cr
apiLogger::2021-10-19 15:58:45,925::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 15:58:45,925::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 15:58:45,925::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 15:58:45,925::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 15:58:45,929::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-19 15:58:45,929::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 15:58:45,929::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 15:58:45,929::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 15:58:45,930::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-19 15:58:45,930::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 15:58:45,930::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-19 15:58:45,930::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 15:58:45,930::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 15:58:45,930::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 15:59:05,105::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 15:59:05,105::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 16:08:57,625::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 16:08:57,630::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 16:08:57,631::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpclq4hmym 
apiLogger::2021-10-19 16:08:57,631::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 16:08:57,631::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 16:08:57,762::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 16:08:57,762::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpclq4hmym
apiLogger::2021-10-19 16:08:59,589::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 16:08:59,589::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 16:08:59,589::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 16:08:59,589::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 16:08:59,593::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 16:08:59,593::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 16:08:59,593::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 16:08:59,593::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 16:08:59,597::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 16:08:59,597::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 16:08:59,597::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 16:08:59,597::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-19 16:08:59,597::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-19 16:08:59,597::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 16:08:59,597::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 16:08:59,597::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 16:08:59,597::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 16:08:59,597::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 16:09:14,040::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 16:09:14,040::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 17:20:42,706::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 17:20:42,707::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 17:20:42,707::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2twhk1gs 
apiLogger::2021-10-19 17:20:42,707::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 17:20:42,708::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 17:20:42,731::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 17:20:42,731::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2twhk1gs
apiLogger::2021-10-19 17:20:43,039::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 17:20:43,039::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 17:20:43,040::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 17:20:43,040::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 17:20:43,043::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-19 17:20:43,043::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 17:20:43,043::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 17:20:43,043::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 17:20:43,043::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-19 17:20:43,044::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 17:20:43,044::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-19 17:20:43,044::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 17:20:43,044::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 17:20:43,044::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 17:20:51,591::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 17:20:51,591::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 18:22:42,651::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 18:22:42,656::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 18:22:42,656::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp28y6wbx0 
apiLogger::2021-10-19 18:22:42,657::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 18:22:42,657::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 18:22:42,785::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 18:22:42,785::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp28y6wbx0
apiLogger::2021-10-19 18:22:44,621::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 18:22:44,621::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 18:22:44,621::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 18:22:44,621::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 18:22:44,625::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-19 18:22:44,625::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 18:22:44,625::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-19 18:22:44,625::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-19 18:22:44,629::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 18:22:44,629::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-19 18:22:44,629::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 18:22:44,629::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-19 18:22:44,629::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-19 18:22:44,629::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 18:22:44,629::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 18:22:44,629::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 18:22:44,629::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 18:22:44,629::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 18:22:59,213::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 18:22:59,213::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 21:20:43,091::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 21:20:43,092::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 21:20:43,092::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1e1dloes 
apiLogger::2021-10-19 21:20:43,093::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 21:20:43,093::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 21:20:43,117::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 21:20:43,117::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1e1dloes
apiLogger::2021-10-19 21:20:43,504::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 21:20:43,504::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 21:20:43,504::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 21:20:43,504::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 21:20:43,508::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-19 21:20:43,508::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 21:20:43,508::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 21:20:43,508::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 21:20:43,508::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-19 21:20:43,508::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 21:20:43,508::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-19 21:20:43,508::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 21:20:43,508::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 21:20:43,508::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 21:20:53,610::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 21:20:53,610::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-19 22:52:42,838::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-19 22:52:42,842::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-19 22:52:42,842::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp29s_9kh6 
apiLogger::2021-10-19 22:52:42,843::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-19 22:52:42,843::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-19 22:52:42,917::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-19 22:52:42,917::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp29s_9kh6
apiLogger::2021-10-19 22:52:44,946::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-19 22:52:44,946::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-19 22:52:44,947::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-19 22:52:44,947::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-19 22:52:44,950::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-19 22:52:44,951::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-19 22:52:44,951::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-19 22:52:44,951::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-19 22:52:44,951::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-19 22:52:44,951::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-19 22:52:44,951::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-19 22:52:44,951::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-19 22:52:44,951::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-19 22:52:44,951::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-19 22:52:59,678::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-19 22:52:59,678::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 02:20:43,269::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 02:20:43,271::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 02:20:43,271::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1adyuxx5 
apiLogger::2021-10-20 02:20:43,272::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 02:20:43,272::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 02:20:43,275::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 02:20:43,275::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1adyuxx5
apiLogger::2021-10-20 02:20:44,179::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 02:20:44,179::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 02:20:44,180::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 02:20:44,180::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 02:20:44,184::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-20 02:20:44,184::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 02:20:44,184::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 02:20:44,184::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 02:20:44,184::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(0)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received HOSPITALIZATION\nfrom Spain on 22-Jun-2021, referring to a 81-year old White male subject with     INVOLVED PERSISTENCE OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain. The subject SIGNIFICANT DISABILITY OR\n102-3407-0001, was enrolled in RPL-002-18: A randomized, controlled, Open-Label,  INCAPACITY\nPhase 2 Study of Cemiplimab as Single Agent in Combination with RP1 in Patients \nwith advanced cutaneous squamous cell carcinoma.     LIFE THREATENING\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to     CONGENITAL ANOMALY\n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol \n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral     OTHER MEDICALLY IMPORTANT \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for  CONDITION\nES-RPL-21-00044); subcutaneous Hibor (bemiparin sodium), 7500 international units\nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 15/JUN/2021 20 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00054(0)            \nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n22/JUN/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n30/JUN/2021 X  INITIAL    FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :30/JUN/2021\nReplimune Inc.  Page : 2 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n daily, since 26-May-2021, for auricular fibrillation (taken for ES-RPL-21-00044); oral morphine, 15 mg every \n12 hours, since 26-May-2021 for tumour pain (taken from ES-RPL-21-00044); subcutaneous heparin, 7500 units once\ndaily, since 26-May-2021 for auricular fibrillation; oral MST (morphine sulphate), 30 mg twice daily, since \n15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg twice daily, since 15-Jun-2021, for tumour pain and oral \nNolotil (metamizole), 2 g as needed, since 15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\n \nmg and on 15-Jun-2021, the subject received the last dose of cemiplimab, at a dose of 350 mg prior to the event\nonset.\n \nOn 21-Jun-2021, the subject was admitted to the referral hospital due to tumour pain. Additional information \nhas been requested. \n \nAt the time of this report, the outcome of the event of tumour pain was reported as 'resolving'. The subject \nremained hospitalized. \nAction taken with cemiplimab due to the event was reported as 'dose not changed'.   \nThe Investigator assessed the event of tumour pain as Grade 3 (severe) and not related to cemiplimab, but \nrather related to the primary condition (disease under study).  \n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain is an unexpected adverse event for cemiplimab. Considering the sub ject's \nunderlying malignancy and previous history of tumour pain, the Company assessed the reported event as not \nrelated to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n     \n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A      \n Rechallenge  :  N/A\n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2\n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)\n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n   \n     \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]  Date :30/JUN/2021\nReplimune Inc.  Page : 3 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)   \n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]   \n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n  \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral   \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -          \n Other relevant history (Cont...)\n        \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0] ( Continuing: Yes)\nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n        \n     \n        "]
apiLogger::2021-10-20 02:20:44,184::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 02:20:44,184::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-20 02:20:44,184::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 02:20:44,184::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 02:20:44,184::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 02:20:54,163::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 02:20:54,163::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 03:04:42,870::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 03:04:42,872::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 03:04:42,872::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpahp51uvs 
apiLogger::2021-10-20 03:04:42,873::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 03:04:42,873::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 03:04:42,876::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 03:04:42,876::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpahp51uvs
apiLogger::2021-10-20 03:04:43,936::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 03:04:43,936::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 03:04:43,936::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 03:04:43,936::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 03:04:43,940::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-20 03:04:43,941::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 03:04:43,941::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 03:04:43,941::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 03:04:43,941::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00054(1)            \nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-20 03:04:43,941::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 03:04:43,941::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-20 03:04:43,941::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 03:04:43,941::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 03:04:43,941::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 03:04:54,614::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 03:04:54,614::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 05:12:42,686::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 05:12:42,692::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 05:12:42,692::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbt_ji0ro 
apiLogger::2021-10-20 05:12:42,693::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 05:12:42,693::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 05:12:42,789::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 05:12:42,789::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbt_ji0ro
apiLogger::2021-10-20 05:12:44,770::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 05:12:44,770::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 05:12:44,770::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 05:12:44,771::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 05:12:44,775::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 05:12:44,775::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 05:12:44,775::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 05:12:44,775::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 05:12:44,778::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 05:12:44,778::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 05:12:44,778::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 05:12:44,778::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-20 05:12:44,779::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-20 05:12:44,779::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 05:12:44,779::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 05:12:44,779::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 05:12:44,779::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 05:12:44,779::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 05:12:59,866::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 05:12:59,866::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 06:04:42,820::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 06:04:42,899::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 06:04:42,899::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmvtlzmo_ 
apiLogger::2021-10-20 06:04:42,902::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 06:04:42,902::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 06:04:43,844::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 06:04:43,844::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmvtlzmo_
apiLogger::2021-10-20 06:04:47,164::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 06:04:47,164::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 06:04:47,164::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 06:04:47,164::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 06:04:47,169::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-20 06:04:47,169::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 06:04:47,169::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 06:04:47,169::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 06:04:47,169::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-20 06:04:47,170::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 06:04:47,170::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-20 06:04:47,170::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 06:04:47,170::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 06:04:47,170::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fba40ac92b0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 06:05:10,565::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 06:05:10,565::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 06:20:43,043::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 06:20:43,082::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 06:20:43,082::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0y_23xh4 
apiLogger::2021-10-20 06:20:44,415::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 06:20:44,416::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 06:20:44,685::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 06:20:44,685::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0y_23xh4
apiLogger::2021-10-20 06:20:47,542::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 06:20:47,542::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 06:20:47,542::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 06:20:47,542::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 06:20:47,549::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-20 06:20:47,550::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 06:20:47,550::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 06:20:47,550::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 06:20:47,550::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-20 06:20:47,550::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 06:20:47,550::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-20 06:20:47,550::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 06:20:47,550::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 06:20:47,550::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde4654ffd0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 06:21:06,219::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 06:21:06,219::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 06:21:27,124::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 06:21:27,128::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 06:21:27,128::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpitq0t8ff 
apiLogger::2021-10-20 06:21:27,129::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 06:21:27,129::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 06:21:27,163::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 06:21:27,163::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpitq0t8ff
apiLogger::2021-10-20 06:21:27,586::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 06:21:27,586::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 06:21:27,586::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 06:21:27,586::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 06:21:27,589::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-20 06:21:27,589::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 06:21:27,589::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 06:21:27,589::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 06:21:27,589::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-20 06:21:27,589::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 06:21:27,589::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-20 06:21:27,589::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 06:21:27,589::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 06:21:27,589::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 06:21:55,609::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 06:21:55,609::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 07:02:46,003::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 07:02:46,025::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 07:02:46,025::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpycxmrrb1 
apiLogger::2021-10-20 07:02:46,026::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 07:02:46,026::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 07:02:46,294::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 07:02:46,294::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpycxmrrb1
apiLogger::2021-10-20 07:02:49,121::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 07:02:49,121::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 07:02:49,121::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 07:02:49,121::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 07:02:49,124::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-20 07:02:49,125::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 07:02:49,125::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 07:02:49,125::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 07:02:49,125::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014581\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-20 07:02:49,125::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 07:02:49,125::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-20 07:02:49,125::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 07:02:49,125::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 07:02:49,125::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 07:03:08,305::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 07:03:08,305::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 07:18:42,667::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 07:18:42,669::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 07:18:42,670::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxo27xsur 
apiLogger::2021-10-20 07:18:42,670::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 07:18:42,670::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 07:18:42,703::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 07:18:42,703::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxo27xsur
apiLogger::2021-10-20 07:18:43,612::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 07:18:43,613::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 07:18:43,613::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 07:18:43,613::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 07:18:43,616::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-20 07:18:43,616::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 07:18:43,616::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 07:18:43,616::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 07:18:43,616::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(0)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received HOSPITALIZATION\nfrom Spain on 22-Jun-2021, referring to a 81-year old White male subject with     INVOLVED PERSISTENCE OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain. The subject SIGNIFICANT DISABILITY OR\n102-3407-0001, was enrolled in RPL-002-18: A randomized, controlled, Open-Label,  INCAPACITY\nPhase 2 Study of Cemiplimab as Single Agent in Combination with RP1 in Patients \nwith advanced cutaneous squamous cell carcinoma.     LIFE THREATENING\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to     CONGENITAL ANOMALY\n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol \n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral     OTHER MEDICALLY IMPORTANT \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for  CONDITION\nES-RPL-21-00044); subcutaneous Hibor (bemiparin sodium), 7500 international units\nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 15/JUN/2021 20 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00084(0)\nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n22/JUN/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n30/JUN/2021 X  INITIAL    FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :30/JUN/2021\nReplimune Inc.  Page : 2 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n daily, since 26-May-2021, for auricular fibrillation (taken for ES-RPL-21-00044); oral morphine, 15 mg every \n12 hours, since 26-May-2021 for tumour pain (taken from ES-RPL-21-00044); subcutaneous heparin, 7500 units once\ndaily, since 26-May-2021 for auricular fibrillation; oral MST (morphine sulphate), 30 mg twice daily, since \n15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg twice daily, since 15-Jun-2021, for tumour pain and oral \nNolotil (metamizole), 2 g as needed, since 15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\n \nmg and on 15-Jun-2021, the subject received the last dose of cemiplimab, at a dose of 350 mg prior to the event\nonset.\n \nOn 21-Jun-2021, the subject was admitted to the referral hospital due to tumour pain. Additional information \nhas been requested. \n \nAt the time of this report, the outcome of the event of tumour pain was reported as 'resolving'. The subject \nremained hospitalized. \nAction taken with cemiplimab due to the event was reported as 'dose not changed'.   \nThe Investigator assessed the event of tumour pain as Grade 3 (severe) and not related to cemiplimab, but \nrather related to the primary condition (disease under study).  \n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain is an unexpected adverse event for cemiplimab. Considering the sub ject's \nunderlying malignancy and previous history of tumour pain, the Company assessed the reported event as not \nrelated to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n     \n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A      \n Rechallenge  :  N/A\n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2\n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)\n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n   \n     \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]  Date :30/JUN/2021\nReplimune Inc.  Page : 3 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)   \n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]   \n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n  \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral   \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -          \n Other relevant history (Cont...)\n        \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0] ( Continuing: Yes)\nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n        \n     \n        "]
apiLogger::2021-10-20 07:18:43,616::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 07:18:43,616::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-20 07:18:43,616::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 07:18:43,616::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 07:18:43,617::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 07:18:53,780::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 07:18:53,780::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 08:10:45,858::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 08:10:45,859::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 08:10:45,860::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgb8zbqqj 
apiLogger::2021-10-20 08:10:45,860::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 08:10:45,860::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 08:10:45,884::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 08:10:45,884::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgb8zbqqj
apiLogger::2021-10-20 08:10:46,191::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 08:10:46,191::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 08:10:46,191::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 08:10:46,191::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 08:10:46,194::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-20 08:10:46,194::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 08:10:46,194::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 08:10:46,194::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 08:10:46,194::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-20 08:10:46,194::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 08:10:46,194::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-20 08:10:46,194::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 08:10:46,194::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 08:10:46,194::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 08:10:54,520::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 08:10:54,520::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 08:16:42,698::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 08:16:42,702::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 08:16:42,703::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9ws7rge7 
apiLogger::2021-10-20 08:16:42,703::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 08:16:42,703::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 08:16:42,823::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 08:16:42,823::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9ws7rge7
apiLogger::2021-10-20 08:16:44,891::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 08:16:44,891::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 08:16:44,892::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 08:16:44,892::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 08:16:44,895::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 08:16:44,895::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 08:16:44,895::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 08:16:44,895::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 08:16:44,895::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-20 08:16:44,895::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 08:16:44,895::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 08:16:44,895::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 08:16:44,895::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 08:16:44,895::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 08:16:59,437::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 08:16:59,437::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 08:20:54,982::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 08:20:54,987::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 08:20:54,987::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp8oloa8yl 
apiLogger::2021-10-20 08:20:54,987::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 08:20:54,987::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 08:20:55,124::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 08:20:55,124::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp8oloa8yl
apiLogger::2021-10-20 08:20:57,106::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 08:20:57,106::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 08:20:57,106::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 08:20:57,106::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 08:20:57,110::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 08:20:57,110::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 08:20:57,110::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 08:20:57,110::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 08:20:57,112::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 08:20:57,113::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 08:20:57,113::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 08:20:57,113::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-20 08:20:57,113::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-20 08:20:57,113::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 08:20:57,113::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 08:20:57,113::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 08:20:57,113::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 08:20:57,113::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 08:21:11,852::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 08:21:11,852::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 09:36:42,738::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 09:36:42,740::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 09:36:42,740::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpuei_6zp3 
apiLogger::2021-10-20 09:36:42,741::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 09:36:42,741::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 09:36:42,778::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 09:36:42,778::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpuei_6zp3
apiLogger::2021-10-20 09:36:43,840::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 09:36:43,840::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 09:36:43,840::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 09:36:43,840::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 09:36:43,844::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-20 09:36:43,844::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 09:36:43,844::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 09:36:43,844::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 09:36:43,844::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00084(1)\nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-20 09:36:43,844::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 09:36:43,844::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-20 09:36:43,844::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 09:36:43,844::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 09:36:43,845::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 09:36:54,666::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 09:36:54,666::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 10:40:42,993::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 10:40:43,144::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 10:40:43,145::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdvwxvnss 
apiLogger::2021-10-20 10:40:43,151::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 10:40:43,151::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 10:40:43,785::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 10:40:43,786::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdvwxvnss
apiLogger::2021-10-20 10:40:44,208::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 10:40:44,208::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 10:40:44,208::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 10:40:44,208::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 10:40:44,210::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:44,211::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 10:40:44,211::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 10:40:44,211::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 10:40:44,212::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:44,213::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 10:40:44,213::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-20 10:40:44,213::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-20 10:40:44,214::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:44,214::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-20 10:40:44,214::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-20 10:40:44,214::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-20 10:40:44,216::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:44,216::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-20 10:40:44,216::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-20 10:40:44,216::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-20 10:40:44,218::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:44,218::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-20 10:40:44,218::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-20 10:40:44,218::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-20 10:40:44,220::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:44,220::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-20 10:40:44,220::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-20 10:40:44,220::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-20 10:40:44,221::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:44,221::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-20 10:40:44,221::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-20 10:40:44,222::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-20 10:40:44,223::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:44,223::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-20 10:40:44,223::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-20 10:40:44,223::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-20 10:40:44,225::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:44,225::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-20 10:40:44,225::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-20 10:40:44,225::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-20 10:40:44,227::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:44,227::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-20 10:40:44,227::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-20 10:40:44,227::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-20 10:40:44,227::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-20 10:40:44,227::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 10:40:45,659::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 10:40:45,660::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 10:40:45,660::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpto1h48ey 
apiLogger::2021-10-20 10:40:45,660::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 10:40:45,660::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 10:40:45,665::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 10:40:45,666::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpto1h48ey
apiLogger::2021-10-20 10:40:45,680::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 10:40:45,680::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 10:40:45,680::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 10:40:45,680::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 10:40:45,683::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 10:40:45,683::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 10:40:45,683::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 10:40:45,683::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Nishant Rathour-External <nishant.rathour@regeneron.com>\nReceived Date : 20-Oct-2021 10:39:38 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 11-Follow up Nishant Rathour\nScenario 11 20-Oct-2021 ']
apiLogger::2021-10-20 10:40:45,683::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-20 10:40:45,683::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 11:40:45,515::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 11:40:45,519::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 11:40:45,520::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpepnjmgx4 
apiLogger::2021-10-20 11:40:45,520::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 11:40:45,520::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 11:40:45,595::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 11:40:45,595::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpepnjmgx4
apiLogger::2021-10-20 11:40:47,660::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 11:40:47,660::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 11:40:47,660::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 11:40:47,660::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 11:40:47,663::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 11:40:47,663::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 11:40:47,663::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 11:40:47,663::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 11:40:47,663::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-20 11:40:47,664::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 11:40:47,664::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 11:40:47,664::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 11:40:47,664::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 11:40:47,664::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 11:41:02,280::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 11:41:02,280::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 11:48:47,637::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 11:48:47,723::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 11:48:47,723::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfpn7jxak 
apiLogger::2021-10-20 11:48:47,727::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 11:48:47,727::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 11:48:48,469::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 11:48:48,469::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfpn7jxak
apiLogger::2021-10-20 11:48:52,622::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 11:48:52,622::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 11:48:52,622::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 11:48:52,622::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 11:48:52,626::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-20 11:48:52,626::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 11:48:52,626::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 11:48:52,626::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 11:48:52,626::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 79201200511\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nGrade 2 -\n1 ANEMIA 22 JUL 2020 UNCHECKED Ongoing UNCHECKED\nModerate\nHYPONA Grade 3 -\n2 27 JUL 2020 UNCHECKED Ongoing UNCHECKED\nTREMIA Severe\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nUNCHEC\n1 KYTRIL Pre Med 1 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n2 DEKORT Pre Med 12 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n3 ULCURAN Pre Med 50 mg QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nPOATASSIU UNCHEC\n4 M CHLORIDE Pre Med 0.02 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nMAGNESIUM UNCHEC\n5 SULFATE  Pre Med 1.5 g QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n6 MANNITOL Pre Med 100 mL QD Intravenous 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n7 EMEND Pre Med 125 g QD Oral 27 JUL 2020 27 JUL 2020 KED\nUNCHEC\n8 DODEX Pre Med 1000 mg QD Intramuscular 27 JUL 2020 27 JUL 2020 KED\nCHECKE\n9 OXOPANE Pre Med 5 mg PRN Oral 03 JUL 2020 D\nUNCHEC\n10 KYTRIL Pre Med 1 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n11 DEKORT Pre Med 12 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n12 ULCURAN Pre Med 50 mg QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nPOTASSIUM UNCHEC\n13 CHLORIDE Pre Med 0.02 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nMAGNESIUM UNCHEC\n14 SULPHATE Pre Med 1.5 g QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n15 MANNITOL Pre Med 100 mL QD Intravenous 17 AUG 2020 17 AUG 2020 KED\nUNCHEC\n16 DODEX Pre Med 1000 mcg QD Intramuscular 17 AUG 2020 17 AUG 2020 KED\nCHECKE\n17 LANSOR  Pre Med 30 mg QD Oral 17 AUG 2020 D\nUNCHEC\n18 KYTRIL Pre Med 1 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n19 DEKORT Pre Med 12 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n20 ULCURAN Pre Med 50 mg QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nPOTASSIUM UNCHEC\n21 CHLORIDE Pre Med 0.02 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nMAGNESIUM UNCHEC\n22 SULFATE Pre Med 1.5 g QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n23 MANNITOL Pre Med 100 mL QD Intravenous 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n24 EMEND Pre Med 125 mg QD Oral 07 SEP 2020 07 SEP 2020 KED\nUNCHEC\n25 DODEX Pre Med 1000 mcg QD Intramuscular 07 SEP 2020 07 SEP 2020 KED\nPROPHYL CHECKE\n26 EMETRIL Other AXIS 1 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n27 EMEDUR Other AXIS 200 mg QD Oral 07 SEP 2020 D\nPROPHYL CHECKE\n28 FOLBIOL Other AXIS 5 mg QD Oral 07 SEP 2020 D\nUNCHEC\n29 KYTRIL Pre Med 1 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n30 DEKORT Pre Med 12 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n31 ULCURAN Pre Med 50 mg QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nPOTASSIUM UNCHEC\n32 CHLORIDE Pre Med 0.02 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nMAGNESIUM UNCHEC\n33 SULPHATE Pre Med 1.5 g QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n34 MANNITOL Pre Med 100 mL QD Intravenous 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n35 DODEX Pre Med 1000 mcg QD Intramuscular 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n36 EMEND Pre Med 125 mg QD Oral 30 SEP 2020 30 SEP 2020 KED\nUNCHEC\n37 KYTRIL Pre Med 1 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n38 DEKORT Pre Med 12 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n39 ULCURAN Pre Med 50 mg QD Intravenous 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n40 DODEX Pre Med 1000 mcg QD Intramuscular 21 OCT 2020 21 OCT 2020 KED\nUNCHEC\n41 KYTRIL Pre Med 1 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n42 DEKORT Pre Med 12 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n43 ULCURAN Pre Med 50 mg QD Intravenous 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n44 DODEX Pre Med 1000 mcg QD Intramuscular 11 NOV 2020 11 NOV 2020 KED\nUNCHEC\n45 KYTRIL Pre Med 1 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n46 DEKORT Pre Med 12 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n47 ULCURAN Pre Med 50 mg QD Intravenous 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n48 DODEX Pre Med 1000 mcg QD Intramuscular 02 DEC 2020 02 DEC 2020 KED\nUNCHEC\n49 KYTRIL Pre Med 1 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n50 DEKORT Pre Med 12 mg QD Intravenous 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n51 DODEX Pre Med 1000 mcg QD Intramuscular 23 DEC 2020 23 DEC 2020 KED\nUNCHEC\n52 KYTRIL Pre Med 1 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n53 DEKORT Pre Med 12 mg QD Intravenous 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n54 DODEX Pre Med 1000 mcg QD Intramuscular 13 JAN 2021 13 JAN 2021 KED\nUNCHEC\n55 KYTRIL Pre Med 1 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n56 DEKORT Pre Med 12 mg QD Intravenous 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n57 DODEX Pre Med 1000 mcg QD Intramuscular 05 FEB 2021 05 FEB 2021 KED\nUNCHEC\n58 KYTRIL Pre Med 1 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n59 DEKORT Pre Med 12 mg QD Intravenous 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n60 DODEX Pre Med 1000 mcg QD Intramuscular 26 FEB 2021 26 FEB 2021 KED\nUNCHEC\n61 KYTRIL Pre Med 1 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n62 DEKORT Pre Med 12 mg QD Intravenous 18 MAR 2021 18 MAR 2021 KED\nR2810-ONC-16113_SAE Report_28-JUL-2021 UNCHEC\n63 DODEX Pre Med 1.000 mcg QD Intramuscular 18 MAR 2021 18 MAR 2021 KED\nUNCHEC\n64 KYTRIL Pre Med 1 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n65 DEKORT Pre Med 12 mg QD Intravenous 07 APR 2021 07 APR 2021 KED\nUNCHEC\n66 DODEX Pre Med 1.000 mcg QD Intramuscular 07 APR 2021 07 APR 2021 KED\nUNCHEC\n67 KYTRIL Pre Med 1 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n68 DEKORT Pre Med 12 mg QD Intravenous 29 APR 2021 29 APR 2021 KED\nUNCHEC\n69 DODEX Pre Med 1.000 mcg QD Intramuscular 29 APR 2021 29 APR 2021 KED\nUNCHEC\n70 KYTRIL Pre Med 1 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n71 DEKORT Pre Med 12 mg QD Intravenous 20 MAY 2021 20 MAY 2021 KED\nUNCHEC\n72 DODEX Pre Med 1000 mcg QD Intramuscular 20 MAY 2021 20 MAY 2021 KED\nAdverse UNCHEC\n73 PREDNOL Event 7_IMMUNE PNOMONIA 120 mg QD Oral 10 JUN 2021 16 JUN 2021 KED\nPIPERACILLI\nN\nAdverse UNCHEC\nTAZOBACTA\n74 Event 7_IMMUNE PNOMONIA 4.5 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nM\nLEVOFLOXA Adverse UNCHEC\n75 CIN Event 7_IMMUNE PNOMONIA 500 mg QD Intravenous 10 JUN 2021 16 JUN 2021 KED\nAdverse UNCHEC\n76 PREDNOL Event 7_IMMUNE PNOMONIA 64 mg QD Oral 17 JUN 2021 23 JUN 2021 KED\nAdverse CHECKE\n77 PREDNOL Event 7_IMMUNE PNOMONIA 32 mg QD Oral 24 JUN 2021 D\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_28-JUL-2021"]
apiLogger::2021-10-20 11:48:52,626::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 11:48:52,626::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-20 11:48:52,626::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 11:48:52,626::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 11:48:52,626::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 11:49:25,700::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 11:49:25,700::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 12:24:42,708::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 12:24:42,712::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 12:24:42,712::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnxv17kuc 
apiLogger::2021-10-20 12:24:42,713::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 12:24:42,713::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 12:24:42,833::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 12:24:42,833::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnxv17kuc
apiLogger::2021-10-20 12:24:44,867::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 12:24:44,867::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 12:24:44,867::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 12:24:44,867::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 12:24:44,870::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 12:24:44,870::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 12:24:44,870::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 12:24:44,870::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 12:24:44,870::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-20 12:24:44,870::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 12:24:44,870::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 12:24:44,870::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 12:24:44,870::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 12:24:44,871::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 12:24:59,495::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 12:24:59,495::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 12:26:42,810::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 12:26:42,851::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 12:26:42,851::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpthvonoys 
apiLogger::2021-10-20 12:26:42,853::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 12:26:42,853::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 12:26:43,333::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 12:26:43,333::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpthvonoys
apiLogger::2021-10-20 12:26:46,798::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 12:26:46,798::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 12:26:46,798::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 12:26:46,798::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 12:26:46,801::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-20 12:26:46,801::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 12:26:46,801::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 12:26:46,802::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 12:26:46,802::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-20 12:26:46,802::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 12:26:46,802::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-20 12:26:46,802::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 12:26:46,802::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 12:26:46,802::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 12:27:09,649::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 12:27:09,649::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 12:30:42,760::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 12:30:42,764::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 12:30:42,764::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6570po0k 
apiLogger::2021-10-20 12:30:42,765::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 12:30:42,765::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 12:30:42,885::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 12:30:42,885::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6570po0k
apiLogger::2021-10-20 12:30:44,917::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 12:30:44,917::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 12:30:44,917::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 12:30:44,917::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 12:30:44,921::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 12:30:44,921::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 12:30:44,921::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 12:30:44,921::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 12:30:44,921::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-20 12:30:44,921::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 12:30:44,921::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 12:30:44,921::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 12:30:44,921::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 12:30:44,921::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 12:30:59,451::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 12:30:59,451::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 13:06:42,760::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 13:06:42,761::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 13:06:42,761::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_q9xhxoq 
apiLogger::2021-10-20 13:06:42,762::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 13:06:42,762::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 13:06:42,786::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 13:06:42,786::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_q9xhxoq
apiLogger::2021-10-20 13:06:43,099::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 13:06:43,099::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 13:06:43,099::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 13:06:43,099::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 13:06:43,102::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-20 13:06:43,103::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 13:06:43,103::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 13:06:43,103::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 13:06:43,103::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-20 13:06:43,103::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 13:06:43,103::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-20 13:06:43,103::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 13:06:43,103::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 13:06:43,103::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 13:06:51,537::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 13:06:51,537::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 13:08:42,646::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 13:08:42,647::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 13:08:42,647::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2bj9_n88 
apiLogger::2021-10-20 13:08:42,648::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 13:08:42,648::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 13:08:42,672::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 13:08:42,672::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2bj9_n88
apiLogger::2021-10-20 13:08:43,068::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 13:08:43,068::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 13:08:43,068::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 13:08:43,068::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 13:08:43,071::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-20 13:08:43,071::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 13:08:43,071::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 13:08:43,071::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 13:08:43,071::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-20 13:08:43,072::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 13:08:43,072::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-20 13:08:43,072::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 13:08:43,072::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 13:08:43,072::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 13:08:53,204::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 13:08:53,204::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 13:28:42,773::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 13:28:42,794::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 13:28:42,794::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpzq7ah46g 
apiLogger::2021-10-20 13:28:42,795::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 13:28:42,796::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 13:28:43,065::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 13:28:43,065::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpzq7ah46g
apiLogger::2021-10-20 13:28:45,899::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 13:28:45,899::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 13:28:45,899::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 13:28:45,899::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 13:28:45,902::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-20 13:28:45,903::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 13:28:45,903::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 13:28:45,903::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 13:28:45,903::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014581\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-20 13:28:45,903::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 13:28:45,903::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-20 13:28:45,903::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 13:28:45,903::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 13:28:45,903::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 13:29:05,413::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 13:29:05,413::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 13:30:42,618::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 13:30:42,624::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 13:30:42,624::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2quo2r4q 
apiLogger::2021-10-20 13:30:42,624::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 13:30:42,624::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 13:30:42,754::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 13:30:42,754::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2quo2r4q
apiLogger::2021-10-20 13:30:44,631::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 13:30:44,631::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 13:30:44,631::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 13:30:44,631::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 13:30:44,634::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 13:30:44,634::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 13:30:44,635::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 13:30:44,635::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 13:30:44,637::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 13:30:44,638::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 13:30:44,638::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 13:30:44,638::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-20 13:30:44,638::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-20 13:30:44,638::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 13:30:44,638::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 13:30:44,638::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 13:30:44,638::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 13:30:44,638::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 13:30:59,096::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 13:30:59,096::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 13:32:42,686::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 13:32:42,691::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 13:32:42,692::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgcj70qnc 
apiLogger::2021-10-20 13:32:42,692::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 13:32:42,692::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 13:32:42,821::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 13:32:42,821::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgcj70qnc
apiLogger::2021-10-20 13:32:44,688::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 13:32:44,689::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 13:32:44,689::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 13:32:44,689::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 13:32:44,692::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 13:32:44,692::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 13:32:44,692::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 13:32:44,692::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 13:32:44,695::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 13:32:44,695::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 13:32:44,695::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 13:32:44,695::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-20 13:32:44,695::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-20 13:32:44,695::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 13:32:44,696::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 13:32:44,696::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 13:32:44,696::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 13:32:44,696::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 13:32:59,258::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 13:32:59,258::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 13:44:42,676::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 13:44:42,677::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 13:44:42,678::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0yu15ux3 
apiLogger::2021-10-20 13:44:42,678::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 13:44:42,678::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 13:44:42,711::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 13:44:42,711::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0yu15ux3
apiLogger::2021-10-20 13:44:43,600::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 13:44:43,600::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 13:44:43,600::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 13:44:43,600::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 13:44:43,604::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-20 13:44:43,604::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 13:44:43,604::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 13:44:43,604::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 13:44:43,604::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(0)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received HOSPITALIZATION\nfrom Spain on 22-Jun-2021, referring to a 81-year old White male subject with     INVOLVED PERSISTENCE OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain. The subject SIGNIFICANT DISABILITY OR\n102-3407-0001, was enrolled in RPL-002-18: A randomized, controlled, Open-Label,  INCAPACITY\nPhase 2 Study of Cemiplimab as Single Agent in Combination with RP1 in Patients \nwith advanced cutaneous squamous cell carcinoma.     LIFE THREATENING\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to     CONGENITAL ANOMALY\n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol \n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral     OTHER MEDICALLY IMPORTANT \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for  CONDITION\nES-RPL-21-00044); subcutaneous Hibor (bemiparin sodium), 7500 international units\nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 15/JUN/2021 20 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00084(0)\nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n22/JUN/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n30/JUN/2021 X  INITIAL    FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :30/JUN/2021\nReplimune Inc.  Page : 2 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n daily, since 26-May-2021, for auricular fibrillation (taken for ES-RPL-21-00044); oral morphine, 15 mg every \n12 hours, since 26-May-2021 for tumour pain (taken from ES-RPL-21-00044); subcutaneous heparin, 7500 units once\ndaily, since 26-May-2021 for auricular fibrillation; oral MST (morphine sulphate), 30 mg twice daily, since \n15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg twice daily, since 15-Jun-2021, for tumour pain and oral \nNolotil (metamizole), 2 g as needed, since 15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\n \nmg and on 15-Jun-2021, the subject received the last dose of cemiplimab, at a dose of 350 mg prior to the event\nonset.\n \nOn 21-Jun-2021, the subject was admitted to the referral hospital due to tumour pain. Additional information \nhas been requested. \n \nAt the time of this report, the outcome of the event of tumour pain was reported as 'resolving'. The subject \nremained hospitalized. \nAction taken with cemiplimab due to the event was reported as 'dose not changed'.   \nThe Investigator assessed the event of tumour pain as Grade 3 (severe) and not related to cemiplimab, but \nrather related to the primary condition (disease under study).  \n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain is an unexpected adverse event for cemiplimab. Considering the sub ject's \nunderlying malignancy and previous history of tumour pain, the Company assessed the reported event as not \nrelated to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n     \n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A      \n Rechallenge  :  N/A\n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2\n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)\n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n   \n     \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]  Date :30/JUN/2021\nReplimune Inc.  Page : 3 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)   \n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]   \n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n  \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral   \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -          \n Other relevant history (Cont...)\n        \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0] ( Continuing: Yes)\nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n        \n     \n        "]
apiLogger::2021-10-20 13:44:43,604::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 13:44:43,604::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-20 13:44:43,604::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 13:44:43,604::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 13:44:43,604::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 13:44:53,666::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 13:44:53,666::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 13:46:42,836::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 13:46:42,858::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 13:46:42,858::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsfwdtf7v 
apiLogger::2021-10-20 13:46:42,859::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 13:46:42,859::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 13:46:43,129::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 13:46:43,129::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsfwdtf7v
apiLogger::2021-10-20 13:46:45,963::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 13:46:45,963::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 13:46:45,963::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 13:46:45,963::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 13:46:45,967::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-20 13:46:45,967::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 13:46:45,967::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 13:46:45,967::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 13:46:45,967::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014581\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-20 13:46:45,967::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 13:46:45,967::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-20 13:46:45,967::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 13:46:45,967::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 13:46:45,967::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 13:47:05,476::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 13:47:05,476::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 14:30:42,701::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 14:30:42,706::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 14:30:42,706::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp54qy0l4r 
apiLogger::2021-10-20 14:30:42,707::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 14:30:42,707::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 14:30:42,805::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 14:30:42,805::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp54qy0l4r
apiLogger::2021-10-20 14:30:44,827::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 14:30:44,827::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 14:30:44,827::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 14:30:44,827::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 14:30:44,830::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 14:30:44,831::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 14:30:44,831::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 14:30:44,831::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 14:30:44,834::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 14:30:44,834::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 14:30:44,834::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 14:30:44,834::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-20 14:30:44,834::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-20 14:30:44,834::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 14:30:44,834::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 14:30:44,834::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 14:30:44,834::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 14:30:44,834::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 14:30:59,972::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 14:30:59,972::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 14:33:07,195::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 14:33:07,201::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 14:33:07,201::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdqpzsb4x 
apiLogger::2021-10-20 14:33:07,201::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 14:33:07,201::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 14:33:07,351::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 14:33:07,351::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdqpzsb4x
apiLogger::2021-10-20 14:33:08,973::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 14:33:08,973::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 14:33:08,973::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 14:33:08,973::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 14:33:08,976::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 14:33:08,977::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 14:33:08,977::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 14:33:08,977::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 14:33:08,980::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 14:33:08,980::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 14:33:08,980::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-20 14:33:08,980::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-20 14:33:08,983::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 14:33:08,983::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-20 14:33:08,983::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 14:33:08,983::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-20 14:33:08,983::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-20 14:33:08,983::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 14:33:08,983::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 14:33:08,983::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 14:33:08,983::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 14:33:08,983::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 14:33:23,533::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 14:33:23,533::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 15:00:42,706::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 15:00:42,707::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 15:00:42,708::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpx79b1sx5 
apiLogger::2021-10-20 15:00:42,708::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 15:00:42,708::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 15:00:42,732::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 15:00:42,732::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpx79b1sx5
apiLogger::2021-10-20 15:00:43,045::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 15:00:43,045::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 15:00:43,045::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 15:00:43,046::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 15:00:43,049::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-20 15:00:43,049::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 15:00:43,049::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 15:00:43,049::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 15:00:43,049::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-20 15:00:43,049::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 15:00:43,049::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-20 15:00:43,049::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 15:00:43,049::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 15:00:43,049::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 15:00:51,493::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 15:00:51,494::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 15:22:42,795::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 15:22:42,816::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 15:22:42,816::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmproq_0t48 
apiLogger::2021-10-20 15:22:42,817::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 15:22:42,817::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 15:22:43,087::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 15:22:43,088::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmproq_0t48
apiLogger::2021-10-20 15:22:45,935::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 15:22:45,935::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 15:22:45,935::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 15:22:45,935::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 15:22:45,939::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-20 15:22:45,939::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 15:22:45,939::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 15:22:45,939::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 15:22:45,939::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014581\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-20 15:22:45,939::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 15:22:45,939::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-20 15:22:45,939::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 15:22:45,939::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 15:22:45,939::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 15:23:05,376::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 15:23:05,376::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 15:24:43,027::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 15:24:43,048::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 15:24:43,048::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxhd3pz5d 
apiLogger::2021-10-20 15:24:43,049::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 15:24:43,049::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 15:24:43,320::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 15:24:43,320::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxhd3pz5d
apiLogger::2021-10-20 15:24:46,164::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 15:24:46,164::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 15:24:46,164::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 15:24:46,164::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 15:24:46,168::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-20 15:24:46,168::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 15:24:46,168::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 15:24:46,168::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 15:24:46,168::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014581\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-20 15:24:46,168::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 15:24:46,169::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-20 15:24:46,169::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 15:24:46,169::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 15:24:46,169::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 15:25:05,776::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 15:25:05,776::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 15:25:05,851::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 15:25:05,873::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 15:25:05,873::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmmk1lylq 
apiLogger::2021-10-20 15:25:05,875::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 15:25:05,875::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 15:25:06,118::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 15:25:06,118::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmmk1lylq
apiLogger::2021-10-20 15:25:09,015::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 15:25:09,015::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 15:25:09,015::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 15:25:09,015::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 15:25:09,019::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-20 15:25:09,019::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 15:25:09,019::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 15:25:09,019::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 15:25:09,020::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014581\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-20 15:25:09,020::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 15:25:09,020::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-20 15:25:09,020::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 15:25:09,020::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 15:25:09,020::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 15:25:28,372::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 15:25:28,372::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 15:32:42,708::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 15:32:42,728::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 15:32:42,729::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpj8zo5o3n 
apiLogger::2021-10-20 15:32:42,730::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 15:32:42,730::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 15:32:43,000::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 15:32:43,000::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpj8zo5o3n
apiLogger::2021-10-20 15:32:45,839::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 15:32:45,839::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 15:32:45,839::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 15:32:45,839::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 15:32:45,843::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-20 15:32:45,843::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 15:32:45,843::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 15:32:45,843::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 15:32:45,843::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 41000501411\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-20 15:32:45,844::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 15:32:45,844::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-20 15:32:45,844::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 15:32:45,844::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 15:32:45,844::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 15:33:05,553::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 15:33:05,553::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 16:45:08,353::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 16:45:08,358::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 16:45:08,358::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpt0j3uhx7 
apiLogger::2021-10-20 16:45:08,359::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 16:45:08,359::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 16:45:08,487::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 16:45:08,488::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpt0j3uhx7
apiLogger::2021-10-20 16:45:10,359::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 16:45:10,359::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 16:45:10,359::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 16:45:10,359::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 16:45:10,363::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 16:45:10,363::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 16:45:10,363::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 16:45:10,363::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 16:45:10,366::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 16:45:10,366::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 16:45:10,367::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 16:45:10,367::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-20 16:45:10,367::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-20 16:45:10,367::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 16:45:10,367::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 16:45:10,367::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 16:45:10,367::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 16:45:10,367::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 16:45:24,935::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 16:45:24,935::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 16:55:08,832::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 16:55:08,838::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 16:55:08,838::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqzyuguot 
apiLogger::2021-10-20 16:55:08,839::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 16:55:08,839::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 16:55:08,976::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 16:55:08,976::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqzyuguot
apiLogger::2021-10-20 16:55:10,974::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 16:55:10,974::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 16:55:10,974::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 16:55:10,974::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 16:55:10,978::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 16:55:10,978::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 16:55:10,978::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 16:55:10,978::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 16:55:10,981::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 16:55:10,982::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 16:55:10,982::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 16:55:10,982::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-20 16:55:10,982::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-20 16:55:10,982::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 16:55:10,982::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 16:55:10,982::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 16:55:10,982::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 16:55:10,982::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 16:55:26,061::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 16:55:26,061::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 16:57:08,988::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 16:57:09,009::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 16:57:09,009::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplxbwg_ec 
apiLogger::2021-10-20 16:57:09,010::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 16:57:09,011::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 16:57:09,280::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 16:57:09,280::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplxbwg_ec
apiLogger::2021-10-20 16:57:12,117::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 16:57:12,117::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 16:57:12,117::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 16:57:12,117::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 16:57:12,121::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-20 16:57:12,121::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 16:57:12,121::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 16:57:12,121::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 16:57:12,122::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014581\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-20 16:57:12,122::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 16:57:12,122::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-20 16:57:12,122::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 16:57:12,122::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 16:57:12,122::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 16:57:31,620::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 16:57:31,620::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 17:16:42,679::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 17:16:42,681::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 17:16:42,681::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdjfebrln 
apiLogger::2021-10-20 17:16:42,681::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 17:16:42,681::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 17:16:42,718::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 17:16:42,718::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdjfebrln
apiLogger::2021-10-20 17:16:43,790::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 17:16:43,790::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 17:16:43,790::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 17:16:43,790::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 17:16:43,794::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-20 17:16:43,794::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 17:16:43,794::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 17:16:43,794::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 17:16:43,794::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00084(1)\nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-20 17:16:43,795::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 17:16:43,795::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-20 17:16:43,795::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 17:16:43,795::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 17:16:43,795::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 17:16:54,699::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 17:16:54,699::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 17:18:42,705::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 17:18:42,710::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 17:18:42,710::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpvvu5synh 
apiLogger::2021-10-20 17:18:42,711::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 17:18:42,711::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 17:18:42,839::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 17:18:42,839::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpvvu5synh
apiLogger::2021-10-20 17:18:44,708::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 17:18:44,708::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 17:18:44,708::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 17:18:44,708::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 17:18:44,712::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 17:18:44,712::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 17:18:44,712::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 17:18:44,712::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 17:18:44,715::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 17:18:44,715::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 17:18:44,715::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 17:18:44,715::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-20 17:18:44,715::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-20 17:18:44,716::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 17:18:44,716::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 17:18:44,716::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 17:18:44,716::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 17:18:44,716::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 17:18:59,346::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 17:18:59,346::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 20:17:04,725::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 20:17:04,730::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 20:17:04,730::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp8vofc_in 
apiLogger::2021-10-20 20:17:04,730::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 20:17:04,731::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 20:17:04,867::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 20:17:04,867::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp8vofc_in
apiLogger::2021-10-20 20:17:06,853::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 20:17:06,853::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 20:17:06,853::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 20:17:06,853::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 20:17:06,857::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 20:17:06,857::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 20:17:06,857::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 20:17:06,857::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 20:17:06,860::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 20:17:06,860::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 20:17:06,860::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 20:17:06,860::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-20 20:17:06,860::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-20 20:17:06,860::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 20:17:06,861::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 20:17:06,861::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 20:17:06,861::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 20:17:06,861::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 20:17:21,760::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 20:17:21,760::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 21:00:42,884::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 21:00:42,924::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 21:00:42,924::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjkw46bjk 
apiLogger::2021-10-20 21:00:42,926::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 21:00:42,927::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 21:00:43,406::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 21:00:43,406::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjkw46bjk
apiLogger::2021-10-20 21:00:46,794::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 21:00:46,794::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 21:00:46,794::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 21:00:46,794::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 21:00:46,798::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-20 21:00:46,798::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 21:00:46,798::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 21:00:46,798::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-20 21:00:46,799::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-20 21:00:46,799::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 21:00:46,799::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-20 21:00:46,799::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 21:00:46,799::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 21:00:46,799::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 21:01:09,718::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 21:01:09,718::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-20 23:14:51,081::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-20 23:14:51,087::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-20 23:14:51,088::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5499854e 
apiLogger::2021-10-20 23:14:51,088::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-20 23:14:51,088::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-20 23:14:51,237::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-20 23:14:51,237::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5499854e
apiLogger::2021-10-20 23:14:52,851::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-20 23:14:52,851::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-20 23:14:52,851::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-20 23:14:52,851::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-20 23:14:52,855::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 23:14:52,855::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-20 23:14:52,855::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-20 23:14:52,855::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-20 23:14:52,858::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-20 23:14:52,858::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-20 23:14:52,859::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-20 23:14:52,859::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-20 23:14:52,862::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-20 23:14:52,862::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-20 23:14:52,862::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-20 23:14:52,862::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-20 23:14:52,862::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-20 23:14:52,862::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-20 23:14:52,862::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-20 23:14:52,862::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-20 23:14:52,862::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-20 23:14:52,862::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-20 23:15:07,292::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-20 23:15:07,292::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 01:38:42,777::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 01:38:42,818::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 01:38:42,819::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0wzj4qte 
apiLogger::2021-10-21 01:38:42,821::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 01:38:42,821::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 01:38:43,301::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 01:38:43,301::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0wzj4qte
apiLogger::2021-10-21 01:38:46,685::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 01:38:46,685::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 01:38:46,685::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 01:38:46,685::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 01:38:46,689::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-21 01:38:46,689::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 01:38:46,689::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 01:38:46,689::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 01:38:46,689::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-21 01:38:46,689::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 01:38:46,689::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-21 01:38:46,690::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 01:38:46,690::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 01:38:46,690::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 01:39:09,706::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 01:39:09,707::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 02:04:43,097::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 02:04:43,241::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 02:04:43,241::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp7x89ijk6 
apiLogger::2021-10-21 02:04:43,247::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 02:04:43,247::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 02:04:43,879::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 02:04:43,879::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp7x89ijk6
apiLogger::2021-10-21 02:04:44,303::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 02:04:44,303::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 02:04:44,303::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 02:04:44,303::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 02:04:44,306::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:44,306::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 02:04:44,306::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 02:04:44,306::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 02:04:44,308::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:44,308::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 02:04:44,308::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-21 02:04:44,308::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-21 02:04:44,311::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:44,311::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-21 02:04:44,311::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-21 02:04:44,311::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-21 02:04:44,313::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:44,313::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-21 02:04:44,313::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-21 02:04:44,313::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-21 02:04:44,315::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:44,315::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-21 02:04:44,315::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-21 02:04:44,315::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-21 02:04:44,318::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:44,318::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-21 02:04:44,318::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-21 02:04:44,318::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-21 02:04:44,320::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:44,320::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-21 02:04:44,320::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-21 02:04:44,320::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-21 02:04:44,322::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:44,322::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-21 02:04:44,322::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-21 02:04:44,322::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-21 02:04:44,324::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:44,324::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-21 02:04:44,325::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-21 02:04:44,325::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-21 02:04:44,327::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:44,327::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-21 02:04:44,327::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-21 02:04:44,327::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-21 02:04:44,327::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-21 02:04:44,327::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 02:04:45,849::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 02:04:45,850::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 02:04:45,850::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpplja2tsu 
apiLogger::2021-10-21 02:04:45,850::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 02:04:45,850::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 02:04:45,857::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 02:04:45,857::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpplja2tsu
apiLogger::2021-10-21 02:04:45,877::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 02:04:45,877::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 02:04:45,877::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 02:04:45,877::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 02:04:45,880::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 02:04:45,880::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 02:04:45,881::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 02:04:45,881::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 21-Oct-2021 02:04:03 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 11 Follow Up - MWL\nScenario 11 Follow Up – 20-Oct-2021 \n \nMarc Lamberti \n617.515.6030 \nUpcoming PTO: 22-Oct \n ']
apiLogger::2021-10-21 02:04:45,881::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-21 02:04:45,881::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 02:38:42,616::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 02:38:42,622::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 02:38:42,622::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpco6hxm2_ 
apiLogger::2021-10-21 02:38:42,623::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 02:38:42,623::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 02:38:42,749::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 02:38:42,750::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpco6hxm2_
apiLogger::2021-10-21 02:38:45,029::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 02:38:45,029::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 02:38:45,029::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 02:38:45,029::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 02:38:45,033::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-21 02:38:45,033::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 02:38:45,033::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 02:38:45,033::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 02:38:45,033::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-21 02:38:45,034::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 02:38:45,034::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-21 02:38:45,034::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 02:38:45,034::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 02:38:45,034::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 02:38:55,963::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 02:38:55,963::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 05:17:00,096::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 05:17:00,103::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 05:17:00,106::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5csfzzja 
apiLogger::2021-10-21 05:17:00,107::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 05:17:00,107::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 05:17:00,234::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 05:17:00,234::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5csfzzja
apiLogger::2021-10-21 05:17:02,512::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 05:17:02,512::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 05:17:02,512::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 05:17:02,512::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 05:17:02,516::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-21 05:17:02,516::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 05:17:02,516::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 05:17:02,516::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 05:17:02,517::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-21 05:17:02,517::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 05:17:02,517::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-21 05:17:02,517::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 05:17:02,517::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 05:17:02,517::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 05:17:13,690::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 05:17:13,691::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 07:56:43,161::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 07:56:43,308::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 07:56:43,309::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpb0h9tewx 
apiLogger::2021-10-21 07:56:43,315::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 07:56:43,316::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 07:56:43,950::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 07:56:43,950::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpb0h9tewx
apiLogger::2021-10-21 07:56:44,372::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 07:56:44,372::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 07:56:44,372::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 07:56:44,372::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 07:56:44,375::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:44,376::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 07:56:44,376::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 07:56:44,376::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 07:56:44,378::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:44,378::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 07:56:44,378::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-21 07:56:44,378::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-21 07:56:44,380::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:44,380::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-21 07:56:44,381::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-21 07:56:44,381::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-21 07:56:44,383::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:44,383::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-21 07:56:44,383::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-21 07:56:44,383::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-21 07:56:44,385::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:44,385::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-21 07:56:44,385::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-21 07:56:44,385::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-21 07:56:44,387::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:44,387::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-21 07:56:44,388::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-21 07:56:44,388::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-21 07:56:44,390::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:44,390::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-21 07:56:44,390::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-21 07:56:44,390::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-21 07:56:44,392::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:44,392::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-21 07:56:44,392::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-21 07:56:44,392::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-21 07:56:44,394::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:44,394::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-21 07:56:44,394::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-21 07:56:44,394::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-21 07:56:44,397::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:44,397::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-21 07:56:44,397::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-21 07:56:44,397::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-21 07:56:44,397::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-21 07:56:44,397::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 07:56:45,915::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 07:56:45,916::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 07:56:45,916::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwabf9tbh 
apiLogger::2021-10-21 07:56:45,916::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 07:56:45,916::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 07:56:45,922::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 07:56:45,922::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwabf9tbh
apiLogger::2021-10-21 07:56:45,938::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 07:56:45,938::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 07:56:45,939::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 07:56:45,939::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 07:56:45,942::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 07:56:45,942::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 07:56:45,942::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 07:56:45,942::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Priyanka Gupta-External <priyanka.gupta@regeneron.com>\nReceived Date : 21-Oct-2021 07:56:01 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 11- Follow Up <<<Priyanka Gupta\nScenario 11 Follow Up <<<21-Oct-2021 \n \nThanks and Regards \nPriyanka Gupta \n ']
apiLogger::2021-10-21 07:56:45,942::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-21 07:56:45,943::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 08:51:04,377::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 08:51:04,399::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 08:51:04,399::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfgaq6thc 
apiLogger::2021-10-21 08:51:04,400::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 08:51:04,400::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 08:51:04,668::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 08:51:04,668::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfgaq6thc
apiLogger::2021-10-21 08:51:07,490::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 08:51:07,490::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 08:51:07,490::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 08:51:07,490::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 08:51:07,494::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-21 08:51:07,494::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 08:51:07,494::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 08:51:07,494::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 08:51:07,494::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014581\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-21 08:51:07,494::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 08:51:07,494::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-21 08:51:07,495::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 08:51:07,495::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 08:51:07,495::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 08:51:26,774::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 08:51:26,774::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 13:04:42,830::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 13:04:42,859::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 13:04:42,860::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpntb4dtb0 
apiLogger::2021-10-21 13:04:42,861::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 13:04:42,861::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 13:04:43,303::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 13:04:43,303::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpntb4dtb0
apiLogger::2021-10-21 13:04:46,694::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 13:04:46,694::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 13:04:46,694::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 13:04:46,694::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 13:04:46,698::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-21 13:04:46,698::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 13:04:46,698::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 13:04:46,698::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 13:04:46,698::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 84002700273\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-21 13:04:46,699::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 13:04:46,699::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-21 13:04:46,699::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 13:04:46,699::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 13:04:46,699::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 13:05:07,222::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 13:05:07,222::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 13:15:11,971::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 13:15:12,032::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 13:15:12,032::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3qoo2omp 
apiLogger::2021-10-21 13:15:12,034::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 13:15:12,034::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 13:15:13,302::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 13:15:13,303::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3qoo2omp
apiLogger::2021-10-21 13:15:18,210::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 13:15:18,210::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 13:15:18,210::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 13:15:18,210::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 13:15:18,214::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-21 13:15:18,214::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 13:15:18,214::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 13:15:18,214::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 13:15:18,214::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 84002700273\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-21 13:15:18,215::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 13:15:18,215::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-21 13:15:18,215::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 13:15:18,215::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 13:15:18,215::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 13:15:43,529::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 13:15:43,529::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 13:23:06,052::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 13:23:06,057::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 13:23:06,057::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphnaahf2_ 
apiLogger::2021-10-21 13:23:06,058::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 13:23:06,058::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 13:23:06,186::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 13:23:06,186::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphnaahf2_
apiLogger::2021-10-21 13:23:08,050::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 13:23:08,050::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 13:23:08,050::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 13:23:08,050::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 13:23:08,054::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 13:23:08,054::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 13:23:08,054::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 13:23:08,054::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 13:23:08,057::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-21 13:23:08,057::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 13:23:08,058::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 13:23:08,058::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-21 13:23:08,058::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-21 13:23:08,058::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 13:23:08,058::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-21 13:23:08,058::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 13:23:08,058::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 13:23:08,058::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 13:23:22,623::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 13:23:22,623::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 13:29:06,411::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 13:29:06,413::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 13:29:06,413::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpq9no5h_3 
apiLogger::2021-10-21 13:29:06,414::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 13:29:06,414::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 13:29:06,417::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 13:29:06,417::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpq9no5h_3
apiLogger::2021-10-21 13:29:07,308::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 13:29:07,309::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 13:29:07,309::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 13:29:07,309::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 13:29:07,313::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-21 13:29:07,313::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 13:29:07,313::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 13:29:07,313::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 13:29:07,313::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(0)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received HOSPITALIZATION\nfrom Spain on 22-Jun-2021, referring to a 81-year old White male subject with     INVOLVED PERSISTENCE OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain. The subject SIGNIFICANT DISABILITY OR\n102-3407-0001, was enrolled in RPL-002-18: A randomized, controlled, Open-Label,  INCAPACITY\nPhase 2 Study of Cemiplimab as Single Agent in Combination with RP1 in Patients \nwith advanced cutaneous squamous cell carcinoma.     LIFE THREATENING\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to     CONGENITAL ANOMALY\n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol \n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral     OTHER MEDICALLY IMPORTANT \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for  CONDITION\nES-RPL-21-00044); subcutaneous Hibor (bemiparin sodium), 7500 international units\nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 15/JUN/2021 20 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00054(0)            \nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n22/JUN/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n30/JUN/2021 X  INITIAL    FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :30/JUN/2021\nReplimune Inc.  Page : 2 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n daily, since 26-May-2021, for auricular fibrillation (taken for ES-RPL-21-00044); oral morphine, 15 mg every \n12 hours, since 26-May-2021 for tumour pain (taken from ES-RPL-21-00044); subcutaneous heparin, 7500 units once\ndaily, since 26-May-2021 for auricular fibrillation; oral MST (morphine sulphate), 30 mg twice daily, since \n15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg twice daily, since 15-Jun-2021, for tumour pain and oral \nNolotil (metamizole), 2 g as needed, since 15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\n \nmg and on 15-Jun-2021, the subject received the last dose of cemiplimab, at a dose of 350 mg prior to the event\nonset.\n \nOn 21-Jun-2021, the subject was admitted to the referral hospital due to tumour pain. Additional information \nhas been requested. \n \nAt the time of this report, the outcome of the event of tumour pain was reported as 'resolving'. The subject \nremained hospitalized. \nAction taken with cemiplimab due to the event was reported as 'dose not changed'.   \nThe Investigator assessed the event of tumour pain as Grade 3 (severe) and not related to cemiplimab, but \nrather related to the primary condition (disease under study).  \n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain is an unexpected adverse event for cemiplimab. Considering the sub ject's \nunderlying malignancy and previous history of tumour pain, the Company assessed the reported event as not \nrelated to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n     \n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A      \n Rechallenge  :  N/A\n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2\n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)\n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n   \n     \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]  Date :30/JUN/2021\nReplimune Inc.  Page : 3 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)   \n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]   \n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n  \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral   \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -          \n Other relevant history (Cont...)\n        \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0] ( Continuing: Yes)\nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n        \n     \n        "]
apiLogger::2021-10-21 13:29:07,313::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 13:29:07,313::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-21 13:29:07,313::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 13:29:07,313::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 13:29:07,314::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 13:29:17,588::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 13:29:17,588::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 14:03:08,541::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 14:03:08,582::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 14:03:08,582::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpm1d_ebh1 
apiLogger::2021-10-21 14:03:08,584::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 14:03:08,584::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 14:03:09,063::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 14:03:09,064::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpm1d_ebh1
apiLogger::2021-10-21 14:03:12,447::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 14:03:12,447::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 14:03:12,447::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 14:03:12,447::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 14:03:12,451::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-21 14:03:12,451::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 14:03:12,451::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 14:03:12,451::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 14:03:12,451::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-21 14:03:12,451::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 14:03:12,451::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-21 14:03:12,451::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 14:03:12,451::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 14:03:12,452::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 14:03:35,494::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 14:03:35,494::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 14:28:43,275::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 14:28:43,420::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 14:28:43,420::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9q38hr0c 
apiLogger::2021-10-21 14:28:43,426::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 14:28:43,426::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 14:28:43,431::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 14:28:43,431::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9q38hr0c
apiLogger::2021-10-21 14:28:43,855::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 14:28:43,855::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 14:28:43,855::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 14:28:43,855::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 14:28:43,858::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:43,858::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 14:28:43,858::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 14:28:43,858::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 14:28:43,860::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:43,860::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 14:28:43,860::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-21 14:28:43,860::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-21 14:28:43,863::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:43,863::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-21 14:28:43,863::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-21 14:28:43,863::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-21 14:28:43,865::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:43,865::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-21 14:28:43,865::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-21 14:28:43,865::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-21 14:28:43,868::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:43,868::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-21 14:28:43,868::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-21 14:28:43,868::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-21 14:28:43,870::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:43,870::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-21 14:28:43,870::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-21 14:28:43,870::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-21 14:28:43,872::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:43,873::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-21 14:28:43,873::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-21 14:28:43,873::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-21 14:28:43,875::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:43,875::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-21 14:28:43,875::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-21 14:28:43,875::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-21 14:28:43,877::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:43,877::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-21 14:28:43,877::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-21 14:28:43,878::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-21 14:28:43,880::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:43,880::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-21 14:28:43,880::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-21 14:28:43,880::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-21 14:28:43,880::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-21 14:28:43,880::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 14:28:45,448::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 14:28:45,449::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 14:28:45,449::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbv9gigqo 
apiLogger::2021-10-21 14:28:45,450::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 14:28:45,450::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 14:28:45,455::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 14:28:45,455::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbv9gigqo
apiLogger::2021-10-21 14:28:45,481::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 14:28:45,481::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 14:28:45,481::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 14:28:45,481::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 14:28:45,485::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:28:45,485::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 14:28:45,485::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 14:28:45,485::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Justin Staley <justin.staley@regeneron.com>\nReceived Date : 21-Oct-2021 14:26:34 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 11 Follow Up Justin Staley\nScenario 11 Follow Up 21 Oct 2021 \n \nBest Regards \n \nJustin Staley, MBS \nAssociate Specialist, GPS Case Evaluation and Reporting Management\nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \njustin.staley@regeneron.com \n ']
apiLogger::2021-10-21 14:28:45,485::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-21 14:28:45,485::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 14:32:42,849::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 14:32:42,879::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 14:32:42,879::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6_fqy6qh 
apiLogger::2021-10-21 14:32:42,881::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 14:32:42,881::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 14:32:43,321::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 14:32:43,321::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6_fqy6qh
apiLogger::2021-10-21 14:32:46,692::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 14:32:46,692::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 14:32:46,692::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 14:32:46,692::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 14:32:46,696::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-21 14:32:46,697::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 14:32:46,697::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 14:32:46,697::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 14:32:46,697::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 84002700273\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-10-21 14:32:46,697::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 14:32:46,697::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-21 14:32:46,697::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 14:32:46,697::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 14:32:46,697::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 14:33:07,071::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 14:33:07,071::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 14:42:42,800::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 14:42:42,841::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 14:42:42,841::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpiqmn5bqd 
apiLogger::2021-10-21 14:42:42,843::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 14:42:42,843::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 14:42:44,046::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 14:42:44,046::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpiqmn5bqd
apiLogger::2021-10-21 14:42:48,867::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 14:42:48,868::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 14:42:48,868::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 14:42:48,868::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 14:42:48,872::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-21 14:42:48,872::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 14:42:48,872::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 14:42:48,872::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 14:42:48,872::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-21 14:42:48,872::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 14:42:48,872::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-21 14:42:48,872::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 14:42:48,872::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 14:42:48,872::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 14:43:13,738::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 14:43:13,738::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 14:50:43,212::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 14:50:43,218::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 14:50:43,218::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxpwx889z 
apiLogger::2021-10-21 14:50:43,219::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 14:50:43,219::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 14:50:43,358::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 14:50:43,358::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxpwx889z
apiLogger::2021-10-21 14:50:46,330::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 14:50:46,330::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 14:50:46,330::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 14:50:46,330::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 14:50:46,335::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 14:50:46,335::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 14:50:46,335::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 14:50:46,335::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 14:50:46,338::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-21 14:50:46,338::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 14:50:46,338::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 14:50:46,338::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-21 14:50:46,338::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-21 14:50:46,339::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 14:50:46,339::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-21 14:50:46,339::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 14:50:46,339::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 14:50:46,339::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 14:51:05,613::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 14:51:05,613::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 15:20:42,775::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 15:20:42,780::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 15:20:42,781::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp4og_hyn1 
apiLogger::2021-10-21 15:20:42,781::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 15:20:42,781::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 15:20:42,908::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 15:20:42,908::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp4og_hyn1
apiLogger::2021-10-21 15:20:45,180::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 15:20:45,180::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 15:20:45,180::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 15:20:45,180::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 15:20:45,185::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-21 15:20:45,185::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 15:20:45,185::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 15:20:45,185::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 15:20:45,185::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-21 15:20:45,185::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 15:20:45,185::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-21 15:20:45,185::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 15:20:45,185::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 15:20:45,185::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 15:20:56,277::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 15:20:56,277::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 15:40:52,326::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 15:40:52,471::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 15:40:52,472::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp90q4plhk 
apiLogger::2021-10-21 15:40:52,478::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 15:40:52,478::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 15:40:52,482::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 15:40:52,482::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp90q4plhk
apiLogger::2021-10-21 15:40:52,911::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 15:40:52,911::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 15:40:52,911::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 15:40:52,911::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 15:40:52,914::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:52,914::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 15:40:52,914::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 15:40:52,914::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 15:40:52,916::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:52,917::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 15:40:52,917::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-21 15:40:52,917::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-21 15:40:52,919::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:52,919::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-21 15:40:52,919::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-21 15:40:52,919::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-21 15:40:52,922::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:52,922::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-21 15:40:52,922::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-21 15:40:52,922::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-21 15:40:52,924::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:52,924::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-21 15:40:52,924::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-21 15:40:52,924::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-21 15:40:52,927::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:52,927::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-21 15:40:52,927::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-21 15:40:52,927::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-21 15:40:52,929::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:52,929::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-21 15:40:52,929::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-21 15:40:52,929::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-21 15:40:52,932::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:52,932::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-21 15:40:52,932::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-21 15:40:52,932::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-21 15:40:52,934::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:52,934::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-21 15:40:52,934::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-21 15:40:52,935::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-21 15:40:52,937::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:52,937::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-21 15:40:52,937::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-21 15:40:52,937::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-21 15:40:52,937::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-21 15:40:52,937::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 15:40:54,562::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 15:40:54,562::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 15:40:54,563::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0jxug55q 
apiLogger::2021-10-21 15:40:54,563::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 15:40:54,563::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 15:40:54,568::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 15:40:54,568::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0jxug55q
apiLogger::2021-10-21 15:40:54,593::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 15:40:54,593::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 15:40:54,593::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 15:40:54,593::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 15:40:54,597::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 15:40:54,597::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 15:40:54,597::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 15:40:54,597::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Justin Staley <justin.staley@regeneron.com>\nReceived Date : 21-Oct-2021 15:39:53 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 11 Justin Staley\nScenario 11 21 Oct 2021 \n \nBest Regards \n \nJustin Staley, MBS \nAssociate Specialist, GPS Case Evaluation and Reporting Management\nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \njustin.staley@regeneron.com \n ']
apiLogger::2021-10-21 15:40:54,597::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-21 15:40:54,597::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 16:26:43,104::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 16:26:43,251::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 16:26:43,251::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0asapp0o 
apiLogger::2021-10-21 16:26:43,257::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 16:26:43,257::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 16:26:43,890::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 16:26:43,891::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0asapp0o
apiLogger::2021-10-21 16:26:44,316::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 16:26:44,316::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 16:26:44,316::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 16:26:44,316::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 16:26:44,319::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:44,319::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 16:26:44,319::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 16:26:44,319::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 16:26:44,322::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:44,322::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 16:26:44,322::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-21 16:26:44,322::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-21 16:26:44,324::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:44,324::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-21 16:26:44,324::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-21 16:26:44,324::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-21 16:26:44,327::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:44,327::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-21 16:26:44,327::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-21 16:26:44,327::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-21 16:26:44,329::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:44,329::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-21 16:26:44,329::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-21 16:26:44,329::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-21 16:26:44,332::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:44,332::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-21 16:26:44,332::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-21 16:26:44,332::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-21 16:26:44,334::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:44,334::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-21 16:26:44,335::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-21 16:26:44,335::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-21 16:26:44,337::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:44,337::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-21 16:26:44,337::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-21 16:26:44,337::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-21 16:26:44,339::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:44,340::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-21 16:26:44,340::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-21 16:26:44,340::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-21 16:26:44,342::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:44,342::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-21 16:26:44,342::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-21 16:26:44,342::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-21 16:26:44,342::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-21 16:26:44,342::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 16:26:45,819::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 16:26:45,819::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 16:26:45,820::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdes_o3tj 
apiLogger::2021-10-21 16:26:45,820::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 16:26:45,820::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 16:26:45,825::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 16:26:45,825::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdes_o3tj
apiLogger::2021-10-21 16:26:45,839::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 16:26:45,840::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 16:26:45,840::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 16:26:45,840::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 16:26:45,844::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:26:45,844::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 16:26:45,844::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 16:26:45,844::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Sahil Bansal-External <sahil.bansal@regeneron.com>\nReceived Date : 21-Oct-2021 16:25:47 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 11 - Follow Up Sahil Bansal\n \nScenario 11 Follow Up 21-Oct-2021 \n ']
apiLogger::2021-10-21 16:26:45,844::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-21 16:26:45,844::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 16:46:51,422::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 16:46:51,423::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 16:46:51,423::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpvsxl7afb 
apiLogger::2021-10-21 16:46:51,423::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 16:46:51,423::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 16:46:51,428::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 16:46:51,429::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpvsxl7afb
apiLogger::2021-10-21 16:46:51,441::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 16:46:51,442::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 16:46:51,442::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 16:46:51,442::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 16:46:51,445::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 16:46:51,446::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 16:46:51,446::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 16:46:51,446::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Roohila Banu-External <roohila.banu@regeneron.com>\nReceived Date : 21-Oct-2021 16:44:43 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 8 - Roohila Banu\nScenario 8 21-OCT-2021 ']
apiLogger::2021-10-21 16:46:51,446::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-21 16:46:51,446::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 16:52:54,614::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 16:52:54,615::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 16:52:54,615::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpy0iy08me 
apiLogger::2021-10-21 16:52:54,616::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 16:52:54,616::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 16:52:54,640::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 16:52:54,640::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpy0iy08me
apiLogger::2021-10-21 16:52:55,036::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 16:52:55,036::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 16:52:55,036::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 16:52:55,036::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 16:52:55,040::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-21 16:52:55,040::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 16:52:55,040::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 16:52:55,040::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 16:52:55,040::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-21 16:52:55,040::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 16:52:55,040::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-21 16:52:55,040::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 16:52:55,041::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 16:52:55,041::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 16:53:05,224::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 16:53:05,224::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 17:48:53,527::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 17:48:53,548::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 17:48:53,548::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplknv1x5u 
apiLogger::2021-10-21 17:48:53,549::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 17:48:53,549::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 17:48:53,820::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 17:48:53,820::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplknv1x5u
apiLogger::2021-10-21 17:48:56,653::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 17:48:56,653::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 17:48:56,653::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 17:48:56,653::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 17:48:56,658::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-21 17:48:56,658::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 17:48:56,658::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 17:48:56,658::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-21 17:48:56,658::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014581\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\nCHLORPHENIRAMI\n13 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n14 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n15 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n16 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n17 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n18 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n19 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n20 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n21 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n22 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n23 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n24 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\nPremedication for\n25 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n26 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n27 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -\nQD - Oral - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Intravenous - 19 AUG 2020 - 19 AUG 2020 -\nQD - Oral - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 26 AUG 2020 - 26 AUG 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Intravenous - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 02 SEP 2020 - 02 SEP 2020 -\nQD - Oral - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Intravenous - 09 SEP 2020 - 09 SEP 2020 -\nQD - Oral - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nPremedication for\n28 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\n2_PNEUMONIA_09\n29 ACETAMINOPHEN Adverse Event - - 1 g - QD\nOCT 2020\n2_PNEUMONIA_09\n30 TAZOFERAN Adverse Event - - 4.5 g - Qid\nOCT 2020\n2_PNEUMONIA_09\n31 LEVOFLOXACIN Adverse Event - - 750 mg - QD\nOCT 2020\nSULFAMETHOXAZO 2_PNEUMONIA_09\n32 Adverse Event - - 1 Tablet - QD\nLE /TRIMETHOPRIM OCT 2020\nMETHYLPREDNISO 2_PNEUMONIA_09\n33 Adverse Event - - 60 mg - QD\nLONE OCT 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nQD - Intravenous - 16 SEP 2020 - 16 SEP 2020 -\nQD - Intravenous - 09 OCT 2020 - -  \nQid - Intravenous - 09 OCT 2020 - -  \nQD - Intravenous - 09 OCT 2020 - -  \nQD - Oral - 10 OCT 2020 - -  \nQD - Intravenous - 10 OCT 2020 - -   REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nBlood Chemistry - Local Lab\nIf at dosing visit,\nGlucose\nWas a Sample Date of Collection was the sample\nInstance Name Reason Not Done Other, Specify Sodium Potassium Chloride Calcium (Non-\nCollected? (dd-mon-yyyy) collected prior to\nFasting)\ndosing?\nSCREENING Yes - - 29 JUL 2020 Not Applicable 140_mmol/L 4.2_mmol/L 101_mmol/L 9.6_mg/dL 103_mg/dL\nTreatment Week 1\nYes - - 05 AUG 2020 Yes 139_mmol/L 4_mmol/L 100_mmol/L 9.5_mg/dL 132_mg/dL\nDay 1 (1)\nTreatment Week 1\nYes - - 06 AUG 2020 Yes 139_mmol/L 4_mmol/L 99_mmol/L 10_mg/dL 103_mg/dL\nDay 2 (1)\nTreatment Week 1\nYes - - 07 AUG 2020 Not Applicable 141_mmol/L 3.9_mmol/L 104_mmol/L 9.3_mg/dL 87_mg/dL\nDay 3 (1)\nTreatment Week 2\nYes - - 12 AUG 2020 Yes 135_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 141_mg/dL\nDay 1 (1)\nTreatment Week 2\nYes - - 13 AUG 2020 Yes 134_mmol/L 4.4_mmol/L 95_mmol/L 9.7_mg/dL 128_mg/dL\nDay 2 (1)\nTreatment Week 2\nYes - - 14 AUG 2020 Not Applicable 139_mmol/L 4.6_mmol/L 101_mmol/L 9.5_mg/dL 112_mg/dL\nDay 3 (1)\nTreatment Week 3\nYes - - 19 AUG 2020 Yes 138_mmol/L 4.1_mmol/L 101_mmol/L 9_mg/dL 104_mg/dL\nDay 1 (1)\nTreatment Week 3\nYes - - 20 AUG 2020 Not Applicable 136_mmol/L 4.2_mmol/L 101_mmol/L 9.1_mg/dL 118_mg/dL\nDay 3 (1)\nTreatment Week 4\nYes - - 26 AUG 2020 Yes 139_mmol/L 4.5_mmol/L 105_mmol/L 9.2_mg/dL 87_mg/dL\nDay 1 (1)\nTreatment Week 4\nYes - - 27 AUG 2020 Not Applicable 137_mmol/L 4.4_mmol/L 101_mmol/L 9.2_mg/dL 120_mg/dL\nDay 2 (1)\nTreatment Week 5\nYes - - 02 SEP 2020 Yes 139_mmol/L 3.9_mmol/L 103_mmol/L 9.2_mg/dL 99_mg/dL\nDay 1 (1)\nTreatment Week 6\nYes - - 09 SEP 2020 Yes 140_mmol/L 4.1_mmol/L 105_mmol/L 9.2_mg/dL 96_mg/dL\nDay 1 (1)\nTreatment Week 7\nYes - - 16 SEP 2020 Yes 138_mmol/L 4.1_mmol/L 103_mmol/L 8.8_mg/dL 97_mg/dL\nDay 1 (1)']
apiLogger::2021-10-21 17:48:56,658::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 17:48:56,658::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-21 17:48:56,658::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 17:48:56,658::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 17:48:56,658::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 17:49:15,853::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 17:49:15,853::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 19:38:59,212::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 19:38:59,217::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 19:38:59,217::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmprty5id0m 
apiLogger::2021-10-21 19:38:59,217::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 19:38:59,217::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 19:38:59,354::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 19:38:59,354::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmprty5id0m
apiLogger::2021-10-21 19:39:01,330::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 19:39:01,331::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 19:39:01,331::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 19:39:01,331::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 19:39:01,335::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:39:01,335::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 19:39:01,335::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 19:39:01,335::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 19:39:01,338::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-21 19:39:01,338::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 19:39:01,338::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 19:39:01,338::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-21 19:39:01,339::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-21 19:39:01,339::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 19:39:01,339::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-21 19:39:01,339::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 19:39:01,339::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 19:39:01,339::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 19:39:16,113::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 19:39:16,113::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 19:47:00,435::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 19:47:00,582::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 19:47:00,582::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_vgvsar0 
apiLogger::2021-10-21 19:47:00,588::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 19:47:00,588::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 19:47:01,224::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 19:47:01,224::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_vgvsar0
apiLogger::2021-10-21 19:47:01,647::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 19:47:01,647::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 19:47:01,647::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 19:47:01,647::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 19:47:01,650::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:01,650::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 19:47:01,650::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 19:47:01,650::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 19:47:01,653::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:01,653::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 19:47:01,653::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-21 19:47:01,653::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-21 19:47:01,655::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:01,655::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-21 19:47:01,655::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-21 19:47:01,655::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-21 19:47:01,658::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:01,658::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-21 19:47:01,658::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-21 19:47:01,658::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-21 19:47:01,660::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:01,660::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-21 19:47:01,660::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-21 19:47:01,660::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-21 19:47:01,663::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:01,663::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-21 19:47:01,663::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-21 19:47:01,663::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-21 19:47:01,665::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:01,665::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-21 19:47:01,666::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-21 19:47:01,666::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-21 19:47:01,668::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:01,668::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-21 19:47:01,668::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-21 19:47:01,668::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-21 19:47:01,671::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:01,671::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-21 19:47:01,671::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-21 19:47:01,671::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-21 19:47:01,673::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:01,673::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-21 19:47:01,673::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-21 19:47:01,673::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-21 19:47:01,673::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-21 19:47:01,673::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 19:47:03,341::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 19:47:03,342::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 19:47:03,342::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpm76kw14v 
apiLogger::2021-10-21 19:47:03,342::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 19:47:03,342::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 19:47:03,347::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 19:47:03,347::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpm76kw14v
apiLogger::2021-10-21 19:47:03,362::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 19:47:03,362::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 19:47:03,362::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 19:47:03,362::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 19:47:03,366::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 19:47:03,366::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 19:47:03,366::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 19:47:03,366::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Yuvraj Singh-External <yuvraj.singh@regeneron.com>\nReceived Date : 21-Oct-2021 19:44:59 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : P11\n \n \nKind regards, \nYuvraj Singh \n \n \n ']
apiLogger::2021-10-21 19:47:03,366::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-21 19:47:03,367::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 20:22:42,710::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 20:22:42,717::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 20:22:42,717::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpvoddplpm 
apiLogger::2021-10-21 20:22:42,718::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 20:22:42,718::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 20:22:42,819::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 20:22:42,819::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpvoddplpm
apiLogger::2021-10-21 20:22:45,806::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 20:22:45,806::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 20:22:45,806::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 20:22:45,806::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 20:22:45,810::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 20:22:45,810::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 20:22:45,810::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 20:22:45,810::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 20:22:45,814::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-21 20:22:45,814::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 20:22:45,814::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-21 20:22:45,814::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-21 20:22:45,814::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-21 20:22:45,814::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-21 20:22:45,814::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-21 20:22:45,814::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-21 20:22:45,814::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-21 20:22:45,814::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-21 20:23:05,076::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-21 20:23:05,076::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 21:32:43,055::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 21:32:43,201::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 21:32:43,201::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpkjm1xpcw 
apiLogger::2021-10-21 21:32:43,207::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 21:32:43,207::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 21:32:43,842::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 21:32:43,842::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpkjm1xpcw
apiLogger::2021-10-21 21:32:44,266::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 21:32:44,266::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 21:32:44,266::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 21:32:44,266::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 21:32:44,269::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:44,269::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 21:32:44,269::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 21:32:44,269::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-21 21:32:44,272::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:44,272::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-21 21:32:44,272::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-21 21:32:44,272::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-21 21:32:44,274::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:44,275::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-21 21:32:44,275::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-21 21:32:44,275::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-21 21:32:44,277::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:44,277::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-21 21:32:44,277::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-21 21:32:44,277::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-21 21:32:44,280::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:44,280::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-21 21:32:44,280::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-21 21:32:44,280::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-21 21:32:44,282::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:44,282::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-21 21:32:44,282::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-21 21:32:44,282::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-21 21:32:44,285::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:44,285::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-21 21:32:44,285::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-21 21:32:44,285::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-21 21:32:44,287::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:44,288::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-21 21:32:44,288::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-21 21:32:44,288::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-21 21:32:44,290::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:44,290::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-21 21:32:44,290::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-21 21:32:44,290::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-21 21:32:44,293::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:44,293::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-21 21:32:44,293::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-21 21:32:44,293::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-21 21:32:44,293::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-21 21:32:44,293::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-21 21:32:45,621::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-21 21:32:45,622::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-21 21:32:45,622::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnqd37xv3 
apiLogger::2021-10-21 21:32:45,623::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-21 21:32:45,623::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-21 21:32:45,629::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-21 21:32:45,629::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnqd37xv3
apiLogger::2021-10-21 21:32:45,666::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-21 21:32:45,667::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-21 21:32:45,667::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-21 21:32:45,667::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-21 21:32:45,671::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-21 21:32:45,671::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-21 21:32:45,671::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-21 21:32:45,671::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Katarzyna Przezdziecki <katarzy.przezdziecki@regeneron.com>\nReceived Date : 21-Oct-2021 17:31:12 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 11- Follow Up  Katie Przezdziecki\nScenario 11 Follow Up  21-Oct-2021 \n \nKind regards, \n \nKatie Przezdziecki, RN \nAssociate Manager - GPS- Case Evaluation and Reporting Management  \nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \nTel: 914-479-8571 \nEmail: katarzy.przezdziecki@regeneron.com    \nUpcoming Out-Of-Office Dates: 15-Oct-2021, 18-Oct-2021 \nUpcoming Regeneron Holidays: 05Jul2021, 06Sep2021, 25-26Nov2021, 27-31Dec2021 \n \n \n ']
apiLogger::2021-10-21 21:32:45,671::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-21 21:32:45,671::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 05:20:42,696::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 05:20:42,701::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 05:20:42,702::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpr_6llzhp 
apiLogger::2021-10-22 05:20:42,702::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 05:20:42,702::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 05:20:42,838::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 05:20:42,838::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpr_6llzhp
apiLogger::2021-10-22 05:20:44,818::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 05:20:44,818::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 05:20:44,818::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 05:20:44,818::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 05:20:44,822::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 05:20:44,822::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 05:20:44,822::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 05:20:44,822::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-22 05:20:44,826::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-22 05:20:44,826::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-22 05:20:44,826::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 05:20:44,826::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-22 05:20:44,826::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-22 05:20:44,826::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 05:20:44,826::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-22 05:20:44,826::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 05:20:44,826::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 05:20:44,826::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 05:21:00,009::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 05:21:00,009::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 05:42:44,695::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 05:42:44,705::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 05:42:44,705::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwo_bc8f3 
apiLogger::2021-10-22 05:42:44,718::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 05:42:44,718::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 05:42:44,855::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 05:42:44,855::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwo_bc8f3
apiLogger::2021-10-22 05:42:46,840::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 05:42:46,841::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 05:42:46,841::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 05:42:46,841::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 05:42:46,845::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 05:42:46,845::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 05:42:46,845::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 05:42:46,845::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-22 05:42:46,849::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-22 05:42:46,849::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-22 05:42:46,849::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 05:42:46,849::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-22 05:42:46,849::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-22 05:42:46,849::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 05:42:46,849::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-22 05:42:46,849::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 05:42:46,849::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 05:42:46,849::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 05:43:02,163::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 05:43:02,163::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 06:00:42,721::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 06:00:42,726::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 06:00:42,726::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpp6raepg3 
apiLogger::2021-10-22 06:00:42,727::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 06:00:42,727::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 06:00:42,863::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 06:00:42,863::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpp6raepg3
apiLogger::2021-10-22 06:00:44,849::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 06:00:44,850::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 06:00:44,850::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 06:00:44,850::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 06:00:44,854::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 06:00:44,854::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 06:00:44,854::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 06:00:44,854::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-22 06:00:44,857::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-22 06:00:44,858::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-22 06:00:44,858::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 06:00:44,858::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-22 06:00:44,858::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-22 06:00:44,858::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 06:00:44,858::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-22 06:00:44,858::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 06:00:44,858::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 06:00:44,858::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 06:01:00,151::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 06:01:00,151::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 06:06:42,756::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 06:06:42,762::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 06:06:42,762::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppm_znt7t 
apiLogger::2021-10-22 06:06:42,762::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 06:06:42,762::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 06:06:42,899::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 06:06:42,899::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppm_znt7t
apiLogger::2021-10-22 06:06:44,881::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 06:06:44,881::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 06:06:44,881::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 06:06:44,881::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 06:06:44,885::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 06:06:44,885::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 06:06:44,885::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 06:06:44,885::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-22 06:06:44,889::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-22 06:06:44,889::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-22 06:06:44,889::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 06:06:44,889::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-22 06:06:44,889::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-22 06:06:44,889::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 06:06:44,889::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-22 06:06:44,889::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 06:06:44,889::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 06:06:44,889::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 06:06:59,936::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 06:06:59,936::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 08:01:06,816::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 08:01:06,823::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 08:01:06,852::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp7d1giv6y 
apiLogger::2021-10-22 08:01:06,853::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 08:01:06,853::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 08:01:06,973::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 08:01:06,973::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp7d1giv6y
apiLogger::2021-10-22 08:01:09,005::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 08:01:09,005::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 08:01:09,005::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 08:01:09,006::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 08:01:09,010::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-22 08:01:09,010::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 08:01:09,010::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 08:01:09,010::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-22 08:01:09,010::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-22 08:01:09,010::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 08:01:09,010::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-22 08:01:09,010::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 08:01:09,010::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 08:01:09,010::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 08:01:23,647::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 08:01:23,647::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 08:14:42,745::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 08:14:42,751::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 08:14:42,751::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpw1i3guiu 
apiLogger::2021-10-22 08:14:42,752::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 08:14:42,752::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 08:14:42,878::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 08:14:42,878::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpw1i3guiu
apiLogger::2021-10-22 08:14:45,146::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 08:14:45,146::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 08:14:45,146::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 08:14:45,146::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 08:14:45,150::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-22 08:14:45,150::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 08:14:45,150::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 08:14:45,150::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-22 08:14:45,150::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-22 08:14:45,151::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 08:14:45,151::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-22 08:14:45,151::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 08:14:45,151::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 08:14:45,151::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 08:14:56,102::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 08:14:56,102::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 11:26:47,737::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 11:26:47,778::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 11:26:47,779::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2esmo1v3 
apiLogger::2021-10-22 11:26:47,781::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 11:26:47,781::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 11:26:48,260::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 11:26:48,260::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2esmo1v3
apiLogger::2021-10-22 11:26:51,626::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 11:26:51,626::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 11:26:51,626::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 11:26:51,627::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 11:26:51,631::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-22 11:26:51,631::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 11:26:51,631::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 11:26:51,631::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-22 11:26:51,631::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-22 11:26:51,631::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 11:26:51,631::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-22 11:26:51,631::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 11:26:51,631::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 11:26:51,631::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 11:27:14,546::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 11:27:14,546::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 13:45:10,949::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 13:45:10,950::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 13:45:10,950::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1j2xugmh 
apiLogger::2021-10-22 13:45:10,950::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 13:45:10,950::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 13:45:10,955::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 13:45:10,956::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1j2xugmh
apiLogger::2021-10-22 13:45:10,969::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 13:45:10,969::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 13:45:10,969::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 13:45:10,969::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 13:45:10,973::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 13:45:10,973::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 13:45:10,973::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 13:45:10,973::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Neha Sharma-External <neha.sharma@regeneron.com>\nReceived Date : 22-Oct-2021 13:44:26 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 06 - Neha Sharma\nScenario 06 21 Oct 2021 \n ']
apiLogger::2021-10-22 13:45:10,973::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-22 13:45:10,973::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 13:54:42,796::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 13:54:42,799::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 13:54:42,799::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_2h3qq27 
apiLogger::2021-10-22 13:54:43,842::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 13:54:43,843::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 13:54:43,843::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsjqvdro6 
apiLogger::2021-10-22 13:54:43,844::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 13:54:43,844::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 13:54:43,849::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 13:54:43,849::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsjqvdro6
apiLogger::2021-10-22 13:54:43,862::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 13:54:43,862::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 13:54:43,862::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 13:54:43,862::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 13:54:43,866::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 13:54:43,866::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 13:54:43,866::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 13:54:43,866::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Neha Sharma-External <neha.sharma@regeneron.com>\nReceived Date : 22-Oct-2021 13:53:08 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 06 - Neha Sharma\nScenario 06 21 Oct 2021 \n ']
apiLogger::2021-10-22 13:54:43,866::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-22 13:54:43,866::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 14:00:42,672::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 14:00:42,674::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 14:00:42,674::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp7ifme7u8 
apiLogger::2021-10-22 14:00:42,674::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 14:00:42,674::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 14:00:42,711::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 14:00:42,711::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp7ifme7u8
apiLogger::2021-10-22 14:00:43,778::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 14:00:43,778::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 14:00:43,778::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 14:00:43,778::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 14:00:43,783::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-22 14:00:43,783::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 14:00:43,783::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 14:00:43,783::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-22 14:00:43,783::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00084(1)\nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-22 14:00:43,783::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 14:00:43,783::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-22 14:00:43,783::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 14:00:43,783::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 14:00:43,783::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 14:00:54,967::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 14:00:54,967::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 14:08:42,965::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 14:08:42,970::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 14:08:42,970::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2t7d9ti5 
apiLogger::2021-10-22 14:08:42,971::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 14:08:42,971::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 14:08:43,102::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 14:08:43,102::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2t7d9ti5
apiLogger::2021-10-22 14:08:44,955::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 14:08:44,955::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 14:08:44,955::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 14:08:44,956::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 14:08:44,960::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 14:08:44,960::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 14:08:44,960::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 14:08:44,960::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-22 14:08:44,963::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-22 14:08:44,963::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-22 14:08:44,964::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 14:08:44,964::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-22 14:08:44,964::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 46,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-10-22 14:08:44,964::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 14:08:44,964::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-22 14:08:44,964::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 14:08:44,964::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 14:08:44,964::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 14:08:59,512::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 14:08:59,512::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 14:08:59,583::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 14:08:59,585::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 14:08:59,585::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpm5ax_ymv 
apiLogger::2021-10-22 14:08:59,585::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 14:08:59,585::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 14:08:59,622::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 14:08:59,622::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpm5ax_ymv
apiLogger::2021-10-22 14:09:00,691::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 14:09:00,691::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 14:09:00,691::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 14:09:00,691::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 14:09:00,695::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-22 14:09:00,696::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 14:09:00,696::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 14:09:00,696::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-22 14:09:00,696::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00084(1)\nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-22 14:09:00,696::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 14:09:00,696::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-22 14:09:00,696::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 14:09:00,696::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 14:09:00,696::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 14:09:11,614::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 14:09:11,614::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 14:12:47,765::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 14:12:47,807::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 14:12:47,807::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9xclcjth 
apiLogger::2021-10-22 14:12:47,809::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 14:12:47,809::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 14:12:49,014::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 14:12:49,014::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9xclcjth
apiLogger::2021-10-22 14:12:53,831::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 14:12:53,831::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 14:12:53,831::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 14:12:53,831::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 14:12:53,835::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-22 14:12:53,835::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 14:12:53,836::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 14:12:53,836::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-22 14:12:53,836::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-22 14:12:53,836::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 14:12:53,836::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-22 14:12:53,836::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 14:12:53,836::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 14:12:53,836::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 14:13:18,569::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 14:13:18,569::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 14:15:04,879::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 14:15:04,881::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 14:15:04,882::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp41fxkmj4 
apiLogger::2021-10-22 14:15:04,882::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 14:15:04,882::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 14:15:04,919::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 14:15:04,919::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp41fxkmj4
apiLogger::2021-10-22 14:15:05,987::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 14:15:05,988::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 14:15:05,988::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 14:15:05,988::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 14:15:05,992::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-22 14:15:05,992::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 14:15:05,992::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 14:15:05,992::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-22 14:15:05,992::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00084(1)\nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-22 14:15:05,993::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 14:15:05,993::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-22 14:15:05,993::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 14:15:05,993::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 14:15:05,993::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 14:15:16,822::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 14:15:16,822::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 14:42:42,705::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 14:42:42,707::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 14:42:42,707::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpweeb04vg 
apiLogger::2021-10-22 14:42:42,708::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 14:42:42,708::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 14:42:42,744::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 14:42:42,744::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpweeb04vg
apiLogger::2021-10-22 14:42:43,806::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 14:42:43,806::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 14:42:43,806::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 14:42:43,806::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 14:42:43,811::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-22 14:42:43,811::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 14:42:43,811::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 14:42:43,811::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-22 14:42:43,811::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00084(1)\nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-22 14:42:43,811::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 14:42:43,811::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-22 14:42:43,811::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 14:42:43,811::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 14:42:43,811::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 14:42:54,662::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 14:42:54,662::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 15:32:54,444::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 15:32:54,449::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 15:32:54,449::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp556asjtq 
apiLogger::2021-10-22 15:32:54,450::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 15:32:54,450::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 15:32:54,586::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 15:32:54,586::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp556asjtq
apiLogger::2021-10-22 15:32:56,567::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 15:32:56,567::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 15:32:56,567::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 15:32:56,567::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 15:32:56,572::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 15:32:56,572::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 15:32:56,572::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 15:32:56,572::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-22 15:32:56,576::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-22 15:32:56,576::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-22 15:32:56,576::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-22 15:32:56,576::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-22 15:32:56,576::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,00274\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-22 15:32:56,576::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-22 15:32:56,576::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-22 15:32:56,577::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-22 15:32:56,577::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-22 15:32:56,577::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fde7b98f240>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-22 15:33:11,471::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-22 15:33:11,471::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 17:06:43,088::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 17:06:43,236::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 17:06:43,236::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpt3mfxfia 
apiLogger::2021-10-22 17:06:43,242::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 17:06:43,243::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 17:06:43,876::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 17:06:43,876::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpt3mfxfia
apiLogger::2021-10-22 17:06:44,300::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 17:06:44,301::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 17:06:44,301::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 17:06:44,301::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 17:06:44,304::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:44,304::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 17:06:44,304::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 17:06:44,304::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-22 17:06:44,307::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:44,307::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-22 17:06:44,307::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-22 17:06:44,307::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-22 17:06:44,310::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:44,310::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-22 17:06:44,310::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-22 17:06:44,310::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-22 17:06:44,313::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:44,313::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-22 17:06:44,313::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-22 17:06:44,313::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-22 17:06:44,316::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:44,316::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-22 17:06:44,316::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-22 17:06:44,316::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-22 17:06:44,318::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:44,319::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-22 17:06:44,319::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-22 17:06:44,319::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-22 17:06:44,321::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:44,321::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-22 17:06:44,321::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-22 17:06:44,321::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-22 17:06:44,324::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:44,324::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-22 17:06:44,324::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-22 17:06:44,324::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-22 17:06:44,327::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:44,327::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-22 17:06:44,327::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-22 17:06:44,327::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-22 17:06:44,330::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:44,330::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-22 17:06:44,330::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-22 17:06:44,330::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-22 17:06:44,330::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-22 17:06:44,330::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 17:06:45,898::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 17:06:45,898::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 17:06:45,899::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6rh32ukc 
apiLogger::2021-10-22 17:06:45,899::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 17:06:45,899::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 17:06:45,904::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 17:06:45,904::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6rh32ukc
apiLogger::2021-10-22 17:06:45,918::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 17:06:45,918::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 17:06:45,918::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 17:06:45,918::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 17:06:45,922::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:06:45,923::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 17:06:45,923::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 17:06:45,923::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Neha Sharma-External <neha.sharma@regeneron.com>\nReceived Date : 22-Oct-2021 17:05:37 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 11- Followp Neh S harma\n \nscenario 11 Follow Up 22 Oct 2021 \n ']
apiLogger::2021-10-22 17:06:45,923::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-22 17:06:45,923::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 17:32:43,086::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 17:32:43,235::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 17:32:43,235::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjlo0ydc1 
apiLogger::2021-10-22 17:32:43,241::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 17:32:43,242::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 17:32:43,879::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 17:32:43,879::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjlo0ydc1
apiLogger::2021-10-22 17:32:44,305::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 17:32:44,305::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 17:32:44,305::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 17:32:44,305::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 17:32:44,308::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:44,308::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 17:32:44,309::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 17:32:44,309::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-22 17:32:44,311::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:44,311::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-22 17:32:44,312::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-22 17:32:44,312::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-22 17:32:44,314::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:44,314::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-22 17:32:44,314::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-22 17:32:44,314::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-22 17:32:44,317::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:44,317::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-22 17:32:44,317::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-22 17:32:44,317::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-22 17:32:44,320::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:44,320::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-22 17:32:44,320::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-22 17:32:44,320::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-22 17:32:44,323::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:44,323::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-22 17:32:44,323::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-22 17:32:44,323::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-22 17:32:44,326::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:44,326::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-22 17:32:44,326::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-22 17:32:44,326::content_type.py::(line:131)::find_content_type()::DEBUG : i is 7
apiLogger::2021-10-22 17:32:44,328::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:44,329::content_type.py::(line:134)::find_content_type()::DEBUG : main: 7
apiLogger::2021-10-22 17:32:44,329::content_type.py::(line:178)::find_content_type()::DEBUG : outside:8
apiLogger::2021-10-22 17:32:44,329::content_type.py::(line:131)::find_content_type()::DEBUG : i is 8
apiLogger::2021-10-22 17:32:44,331::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:44,331::content_type.py::(line:134)::find_content_type()::DEBUG : main: 8
apiLogger::2021-10-22 17:32:44,331::content_type.py::(line:178)::find_content_type()::DEBUG : outside:9
apiLogger::2021-10-22 17:32:44,332::content_type.py::(line:131)::find_content_type()::DEBUG : i is 9
apiLogger::2021-10-22 17:32:44,334::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:44,334::content_type.py::(line:134)::find_content_type()::DEBUG : main: 9
apiLogger::2021-10-22 17:32:44,334::content_type.py::(line:178)::find_content_type()::DEBUG : outside:10
apiLogger::2021-10-22 17:32:44,334::content_type.py::(line:190)::find_content_type()::INFO : inside scan code
apiLogger::2021-10-22 17:32:44,334::pvi_api.py::(line:221)::main_function()::DEBUG : {'code': 1, 'message': 'This is scanned pdf, only digital pdf supported'}
apiLogger::2021-10-22 17:32:44,334::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-22 17:32:45,824::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-22 17:32:45,825::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-22 17:32:45,825::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbzp9qyu7 
apiLogger::2021-10-22 17:32:45,825::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-22 17:32:45,825::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-22 17:32:45,830::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-22 17:32:45,830::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbzp9qyu7
apiLogger::2021-10-22 17:32:45,844::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-22 17:32:45,844::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-22 17:32:45,844::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-22 17:32:45,845::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-22 17:32:45,849::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-22 17:32:45,849::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-22 17:32:45,849::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-22 17:32:45,849::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Neha Sharma-External <neha.sharma@regeneron.com>\nReceived Date : 22-Oct-2021 17:31:10 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : FW: Scenario 11- Followp Neh Sharma\n \nscenario 11 Follow Up 22 Oct 2021 \n ']
apiLogger::2021-10-22 17:32:45,849::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-22 17:32:45,849::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 06:56:24,161::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 06:56:24,192::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 06:56:24,193::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp51jljriy 
apiLogger::2021-10-25 06:56:24,722::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 06:56:24,722::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 06:56:24,746::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 06:56:24,746::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp51jljriy
apiLogger::2021-10-25 06:56:25,167::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 06:56:25,167::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 06:56:25,167::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 06:56:25,168::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 06:56:25,173::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-25 06:56:25,173::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 06:56:25,173::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 06:56:25,173::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-25 06:56:25,173::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-25 06:56:25,173::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 06:56:25,173::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-25 06:56:25,173::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 06:56:25,173::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 06:56:25,174::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d5896ffd0>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 06:56:51,433::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 06:56:51,433::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 06:56:53,057::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 07:03:34,625::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 07:03:34,631::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 07:03:34,632::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpeesm3a9s 
apiLogger::2021-10-25 07:03:34,632::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 07:03:34,632::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 07:03:34,744::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 07:03:34,744::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpeesm3a9s
apiLogger::2021-10-25 07:03:36,391::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 07:03:36,391::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 07:03:36,391::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 07:03:36,391::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 07:03:36,396::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 07:03:36,396::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 07:03:36,397::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 07:03:36,397::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 07:03:36,399::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 07:03:36,399::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 07:03:36,399::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-25 07:03:36,399::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-25 07:03:36,402::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-25 07:03:36,402::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-25 07:03:36,402::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 07:03:36,402::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-25 07:03:36,402::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study?\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-25 07:03:36,402::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 07:03:36,402::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-25 07:03:36,402::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 07:03:36,402::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 07:03:36,402::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 07:03:50,911::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 07:03:50,911::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 07:05:34,619::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 07:05:34,624::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 07:05:34,625::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpix4r6usf 
apiLogger::2021-10-25 07:05:34,625::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 07:05:34,626::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 07:05:34,750::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 07:05:34,750::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpix4r6usf
apiLogger::2021-10-25 07:05:37,020::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 07:05:37,020::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 07:05:37,020::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 07:05:37,020::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 07:05:37,024::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-25 07:05:37,024::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 07:05:37,024::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 07:05:37,024::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-25 07:05:37,024::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', "Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse 'Other' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_15-SEP-2021"]
apiLogger::2021-10-25 07:05:37,024::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 07:05:37,025::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-25 07:05:37,025::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 07:05:37,025::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 07:05:37,025::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 07:05:47,974::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 07:05:47,974::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 08:07:34,655::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 08:07:34,663::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 08:07:34,664::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqfub_wcn 
apiLogger::2021-10-25 08:07:34,664::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 08:07:34,664::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 08:07:34,803::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 08:07:34,803::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqfub_wcn
apiLogger::2021-10-25 08:07:37,762::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 08:07:37,762::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 08:07:37,763::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 08:07:37,763::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 08:07:37,766::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 08:07:37,766::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 08:07:37,766::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 08:07:37,766::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 08:07:37,769::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-25 08:07:37,769::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 08:07:37,769::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 08:07:37,769::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-25 08:07:37,769::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-25 08:07:37,769::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 08:07:37,769::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-25 08:07:37,769::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 08:07:37,769::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 08:07:37,769::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 08:07:56,494::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 08:07:56,494::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 09:13:34,632::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 09:13:34,637::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 09:13:34,638::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpu606nstq 
apiLogger::2021-10-25 09:13:34,638::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 09:13:34,638::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 09:13:34,776::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 09:13:34,776::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpu606nstq
apiLogger::2021-10-25 09:13:37,663::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 09:13:37,663::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 09:13:37,663::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 09:13:37,663::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 09:13:37,666::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 09:13:37,666::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 09:13:37,666::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 09:13:37,667::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 09:13:37,669::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-25 09:13:37,669::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 09:13:37,669::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 09:13:37,669::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-25 09:13:37,669::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-25 09:13:37,669::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 09:13:37,669::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-25 09:13:37,670::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 09:13:37,670::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 09:13:37,670::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 09:13:56,394::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 09:13:56,394::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 10:59:34,721::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 10:59:34,735::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 10:59:34,748::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpp03u2n5r 
apiLogger::2021-10-25 10:59:34,749::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 10:59:34,749::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 10:59:34,892::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 10:59:34,892::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpp03u2n5r
apiLogger::2021-10-25 10:59:35,390::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 10:59:35,391::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 10:59:35,391::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 10:59:35,391::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 10:59:35,394::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 10:59:35,394::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 10:59:35,394::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 10:59:35,395::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Ju0l8 2 02115 :3V4i:Fa1a 2x   ->  151086Ce8li4tc5 19  Pag0e0O 1f 0 01 \nCelStpieccP ihaalartcAmyyd  veEvres&neP t r odCumocptl aFironmt  \nRepoIrntfeorr mCaetlSitpoiencc P hiaarlmtayc y 150 CausewBoasyt oS0nt2 r1Me1Ae4 t  \nAE Rec ID: \n.37743184 \nPhone:\nReporter: 1o 1,a s12021 \nDave Cowens 617-624-1000\nPatient Information: \nInitials:  l  DOB:  Gender: \nI \n[_12J:l_ ____  [p_L�4/!?�s[l_. ___s___-_1�  \nI Patient \nI \nPerswohnor  epotrhtAeeE d/ comtpolH auim11aStnP a:  \nConsgeinvtbe yrn e potroct oenrt faofcrot l low•up: \nDrug Details: \nType of ADE or product complaint reported:  I Side Effects \nDrug, Dose:  r·······EYLEA···2MG. . 0.05ML.SDV ----···· ····-· ·· ···-··········-· ················· -· ·········· ·· ·· ·· ·· ··  \nADE Severity:  l�M_li_d  __________�    Onset Date:  �_u_kn_In_o_w_n  _________�  I\n· \nFrequency:  INJECT 2MG INTRAVITREAll.Y INTO  Date ofTherapy: I unk \n····-··· ... .......  ....... \nBOTH EYES EVERY 4 WEEKS  J \nIndication:  c.l _El_l_3. _3_1.._ 3___________,   \nsample Available: \n........................................ ....................\n,  ·······························• \nAdveDrrsuEegx  per(iAceson mcpeal d eetsec roispp otsisoinPb rloevD iidoeg nossyimsp taonmds ): \npt reports redness and bleeding in eye after an injection of eyle,i \n�I _eR_la_t_de_t_o_M_e_d_  ________,  I ADE  c. l _N_to_A_P_P_il_ca·_lb_e ________� \nCausality:  Resolved: \nCurrent Medications: \nAMLODIPINE B TAB 10MG,ATORVASTATIN TAB 40MG,EZETIMIBE TAB 10MG.FUROSEMIDE TAB 40MG,l.OSARTAN POT TAB \n2SMG,lRESIBA FLEX SOP 200UNll/,TYltNOL TAB 3Z5MG,Vll\'AMIN O TAB 25 MCG(lOOO \nLot # [jil48200359 \nExpiration:\nPhysician Information:\nName:   Alex Robson Phone: 617-232-3216\nAddress:  50-60 Longwood, Brookline, MA 02446\n8y//J t1bmtlhftfotl,rIn11,m g :, e trhttathtAfi"dys 11  eErw,nR�te· pewo arI,tn:,: i tbiaytte iJdlm el lHvaitdaeubdaoa lvml eI W ta n$o $tO f/bcymf ei1 an\'n emyda  nner, ']
apiLogger::2021-10-25 10:59:35,395::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 10:59:35,395::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 10:59:35,652::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 10:59:35,665::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 10:59:35,666::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpj8_fh9wd 
apiLogger::2021-10-25 10:59:35,667::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 10:59:35,667::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 10:59:36,972::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 10:59:36,972::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpj8_fh9wd
apiLogger::2021-10-25 10:59:38,289::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 10:59:38,290::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 10:59:38,290::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 10:59:38,290::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 10:59:38,293::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 10:59:38,293::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 10:59:38,293::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 10:59:38,294::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 10:59:38,296::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 10:59:38,296::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 10:59:38,296::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-25 10:59:38,296::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88291 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88291 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Glenn Rivers, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Dave Cowens Reporter Type: Other Health Professional \nTitle:\nAddress: Celtic Specialty Pharmacy  Phone: 617-624-1000\n150 Causeway Street Other Phone:\nBoston, MA 02114  Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Celtic Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88291 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-25 10:59:38,296::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 10:59:38,297::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 10:59:38,779::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 10:59:38,780::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 10:59:38,780::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpht8a5w7y 
apiLogger::2021-10-25 10:59:38,781::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 10:59:38,781::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 10:59:38,786::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 10:59:38,786::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpht8a5w7y
apiLogger::2021-10-25 10:59:38,803::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 10:59:38,803::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 10:59:38,803::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 10:59:38,803::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 10:59:38,806::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 10:59:38,806::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 10:59:38,806::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 10:59:38,806::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Priyanka Gupta-External <priyanka.gupta@regeneron.com>\nReceived Date : 25-Oct-2021 10:58:50 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 Initial - <<<Priyanka Gupta>\nScenario 1 <<<25-Oct-2021>>> \n \nThanks and Regards \nPriyanka Gupta \n ']
apiLogger::2021-10-25 10:59:38,806::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 10:59:38,806::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 11:03:34,603::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 11:03:34,605::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 11:03:34,606::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmprzl3l2qh 
apiLogger::2021-10-25 11:03:34,606::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 11:03:34,606::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 11:03:34,642::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 11:03:34,642::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmprzl3l2qh
apiLogger::2021-10-25 11:03:35,710::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 11:03:35,710::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 11:03:35,710::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 11:03:35,710::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 11:03:35,714::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-25 11:03:35,714::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 11:03:35,714::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 11:03:35,714::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-25 11:03:35,714::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00084(1)\nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-25 11:03:35,714::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 11:03:35,714::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-25 11:03:35,714::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 11:03:35,714::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 11:03:35,714::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 11:03:46,610::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 11:03:46,610::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 11:05:34,757::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 11:05:34,797::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 11:05:34,797::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpu9zii5k5 
apiLogger::2021-10-25 11:05:34,799::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 11:05:34,799::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 11:05:35,984::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 11:05:35,984::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpu9zii5k5
apiLogger::2021-10-25 11:05:40,792::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 11:05:40,792::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 11:05:40,792::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 11:05:40,793::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 11:05:40,796::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-25 11:05:40,796::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 11:05:40,796::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 11:05:40,796::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-25 11:05:40,796::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke 20 AUG\n30 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d 2021 unchecked\nHYPOKALE\nPOTASSIUM Medical 8_INTERMI Intraveno 08 SEP unchecke\n31 CHLORIDE History - TTENT - 20 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nFUROSEMID Medical 12_INTERM Intraveno 30 AUG unchecke 30 AUG\n32 E History - ITTENT - 40 mEq - Other ONCE us - 2021 d 2021 unchecked\nFLUID\nACETAMINO Adverse 2_CYTOKIN 25 AUG unchecke 25 AUG\n33 PHEN Event - - E RELEASE 650 mg - PRN - Oral - 2021 d 2021 unchecked\nSYNDROM\nACETAMINO Medical 18_FEVER_ 15 AUG unchecke\n34 PHEN History - 15 AUG - 650 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke 23 AUG\n35 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPENTAMIDI PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n36 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nIMMUNE PROPHYLA Intraveno 23 AUG unchecke 23 AUG\n37 GLOBULIN Prophylaxis XIS - - 30 g - Other ONCE us - 2021 d 2021 unchecked\nINFECTION\nDIPHENHYD PRE-MED 23 AUG unchecke 23 AUG\n38 RAMINE Other IMMUNE - - 25 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nACETAMINO PRE-MED 23 AUG unchecke 23 AUG\n39 PHEN Other IMMUNE - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nGLOBULIN\nALLOPURIN PROPHYLA 23 AUG unchecke 27 AUG\n40 Prophylaxis - - 300 mg - QD - Oral - unchecked\nOL XIS TLS 2021 d 2021\nOMEPRAZO PROPHYLA 30 MAR unchecke\n41 LE Prophylaxis XIS - - 20 mg - QD - Oral - 2020 d - checked\nGASTRITIS\nDEXAMETH PROPHYLA Intraveno 24 AUG unchecke 25 AUG\n42 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 24 AUG unchecke 26 AUG\n43 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nCIPROFLOX Medical 18_FEVER_ 24 AUG unchecke 27 AUG\n44 ACIN History - 15 AUG - 500 mg - BID - Oral - 2021 d 2021 unchecked\n2021\nCIPROFLOX PROPHYLA 04 SEP unchecke 06 SEP\n45 ACIN Prophylaxis XIS - - 500 mg - BID - Oral - 2021 d 2021 unchecked\nINFECTION\nMedical 21_SEASO 24 AUG unchecke\n46 CETIRIZINE History - NAL - 10 mg - QD - Oral - 2021 d - checked\nALLERGIES\nDIPHENHYD Premedicatio Intraveno 25 AUG unchecke 26 AUG\n47 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 31 AUG unchecke 02 SEP\n48 RAMINE n for - - - 25 mg - PRN - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 10 SEP unchecke 11 SEP\n49 RAMINE n for - - - 25 mg - QD - us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 16 SEP unchecke 16 SEP\n50 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nDIPHENHYD Premedicatio Intraveno 21 SEP unchecke 21 SEP\n51 RAMINE n for - - - 25 mg - Other ONCE us - 2021 d 2021 unchecked\nREGN1979\nMULTIVITA SUPPLEME 31 AUG unchecke 17 SEP\n52 Other - - 1 Tablet - PRN - Oral - unchecked\nMIN NT 2021 d 2021\nACETAMINO Premedicatio 25 AUG unchecke 26 AUG\n53 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 31 AUG unchecke 02 SEP\n54 PHEN n for - - - 650 mg - PRN - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 10 SEP unchecke 11 SEP\n55 PHEN n for - - - 650 mg - QD - Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 16 SEP unchecke 16 SEP\n56 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979\nACETAMINO Premedicatio 21 SEP unchecke 21 SEP\n57 PHEN n for - - - 650 mg - Other ONCE Oral - 2021 d 2021 unchecked\nREGN1979 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nDEXAMETH PROPHYLA 30 AUG unchecke 03 SEP\n58 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 31 AUG unchecke 02 SEP\n59 ASONE Prophylaxis XIS - - 20 mg - QOD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 10 SEP unchecke 11 SEP\n60 ASONE Prophylaxis XIS - - 20 mg - QD - us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 09 SEP unchecke 12 SEP\n61 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 16 SEP unchecke 16 SEP\n62 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA 15 SEP unchecke 17 SEP\n63 ASONE Prophylaxis XIS - - 10 mg - PRN - Oral - 2021 d 2021 unchecked\nODRONEXT\nDEXAMETH PROPHYLA Intraveno 21 SEP unchecke 21 SEP\n64 ASONE Prophylaxis XIS - - 20 mg - Other ONCE us - 2021 d 2021 unchecked\nODRONEXT\nPENTAMIDI PROPHYLA Intraveno 22 SEP unchecke 22 SEP\n65 NE Prophylaxis XIS - - 250 mg - Other ONCE us - 2021 d 2021 unchecked\nINFECTION REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L']
apiLogger::2021-10-25 11:05:40,796::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 11:05:40,797::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-25 11:05:40,797::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 11:05:40,797::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 11:05:40,797::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 11:06:05,307::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 11:06:05,307::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 11:13:34,673::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 11:13:34,679::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 11:13:34,679::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmprmeclpv_ 
apiLogger::2021-10-25 11:13:34,680::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 11:13:34,680::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 11:13:34,817::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 11:13:34,818::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmprmeclpv_
apiLogger::2021-10-25 11:13:37,707::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 11:13:37,708::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 11:13:37,708::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 11:13:37,708::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 11:13:37,711::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 11:13:37,711::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 11:13:37,711::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 11:13:37,711::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 11:13:37,714::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-25 11:13:37,714::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 11:13:37,714::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 11:13:37,714::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-25 11:13:37,714::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-25 11:13:37,715::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 11:13:37,715::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-25 11:13:37,715::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 11:13:37,715::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 11:13:37,715::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 11:13:56,665::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 11:13:56,665::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 11:23:34,660::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 11:23:34,666::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 11:23:34,666::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfw55824q 
apiLogger::2021-10-25 11:23:34,667::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 11:23:34,667::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 11:23:34,804::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 11:23:34,804::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfw55824q
apiLogger::2021-10-25 11:23:37,686::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 11:23:37,686::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 11:23:37,686::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 11:23:37,686::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 11:23:37,689::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 11:23:37,689::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 11:23:37,689::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 11:23:37,689::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 11:23:37,692::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-25 11:23:37,692::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 11:23:37,692::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 11:23:37,692::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-25 11:23:37,692::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-25 11:23:37,693::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 11:23:37,693::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-25 11:23:37,693::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 11:23:37,693::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 11:23:37,693::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 11:23:56,739::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 11:23:56,739::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 11:45:34,661::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 11:45:34,663::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 11:45:34,663::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsxiuhof8 
apiLogger::2021-10-25 11:45:34,663::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 11:45:34,663::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 11:45:34,666::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 11:45:34,667::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsxiuhof8
apiLogger::2021-10-25 11:45:35,704::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 11:45:35,704::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 11:45:35,704::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 11:45:35,704::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 11:45:35,708::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-25 11:45:35,708::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 11:45:35,708::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 11:45:35,708::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-25 11:45:35,708::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(1)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nEDEMA (Oedema) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nHOSPITALIZATION\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received    INVOLVED PERSISTENCE OR\nfrom Spain on 22-Jun-2021, referring to an 81-year old White male subject with  SIGNIFICANT DISABILITY OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain *and  INCAPACITY\noedema*. The subject 102-3407-0001, was enrolled in RPL-002-18: A randomized, \ncontrolled, Open-Label, Phase 2 Study of Cemiplimab as Single Agent in     LIFE THREATENING\nCombination with RP1 in Patients with advanced cutaneous squamous cell carcinoma.\n   CONGENITAL ANOMALY\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to \n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \n   OTHER MEDICALLY IMPORTANT \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol  CONDITION\n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral \nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 06/JUL/2021 41 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00054(1)            \nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n03/SEP/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n10/SEP/2021    INITIAL X  FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :10/SEP/2021\nReplimune Inc.  Page : 2 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Reaction Information ( Cont...)\nSeq. No. : 1\nReaction : TUMOR PAIN (Tumour pain) [v.24.0]\nStart Date : 21/Jun/2021\nSeq. No. : 2\nReaction : EDEMA (Oedema) [v.24.0]\nStart Date : 21/Jun/2021\n \n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for ES-RPL-21-00044); subcutaneous Hibor \n(bemiparin sodium), 7500 international units daily, since 26-May-2021, for atrial   fibrillation (taken for \n \nES-RPL-21-00044); oral morphine, 15 mg every 12 hours, since 26-May-2021 for tumour pain (taken from \nES-RPL-21-00044); subcutaneous heparin, 7500 units once daily, since 26-May-2021 for auricular fibrillation; \noral MST (morphine sulphate), 30 mg twice daily, since 15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg \ntwice daily, since 15-Jun-2021, for tumour pain and oral Nolotil (metamizole), 2 g as needed, since \n \n15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\nmg and on 15-Jun--2021, the   subject received the last dose of cemiplimab , at a dose of 350 m g prior to   the\nevent onset.\nOn 21-Jun-2021, the subject was admitted to the referral   hospital due to tumour pain *and oedema in eft upper\nlimb as a consequence of laterocervical and supraclavicular adenopathy volume increase. The sub ject was treated\nmorphine  , which controlled the pain while in supine position but did not have any effect when the  subject \ntried to stand up. The subject remained hospitalized for  medication adjustment*.\n*On 06-Jul-2021, the subject was transferred to the study site to receive the third dose of study drug and a \nsignificant increase of left upper limb oedema was confirmed. On the same date, there was significant \nimprovement in cutaneous metastases of the right lower limb. The site reported a worsening in right upper limb \noedema, but clinically, the subject did not show a clear worsening during following days until 20 July 2021*.\n*On 20-Jul-2021, the subject showed an abrupt deterioration, presumably due to blood vessel rupture from the \nneck. On the same day, the subject died due to disease progression. Autopsy was not performed*. At  the ti me   \ndeath, the events of tumour pain *and oedema* were considered as *not resolved*.\nAction taken with cemiplimab due to the *events* of tumour pain *and oedema* was reported as 'dose not \nchanged'. \nThe Investigator assessed the *events* of tumour pain *and oedema* as Grade 3 (severe) and not related to \ncemiplimab, but rather related to the primary condition (disease under study).      \nAll follow-up information is blended into case narrative above, with the latest information presented between \nasterisks (*).\nFollow-up information received from the study site on 03-Sep-2021:\nSAE of oedema added. The subject's symptoms provided, course of hospitalization updated. Date of death \nprovided. Outcome for both events at the time of death provided as 'not resolved'.\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain and oedema are unexpected adverse events for cemiplimab. Considering the subject's\nunderlying malignancy and previous history of tumour pain, and oedema as a consequence of laterocervical and \nsupraclavicular adenopathy volume increase, the Company assessed both events as not related to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A\n Rechallenge  :  N/A\n2)EDEMA (Oedema) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Dru g/Vaccine)    :  Not R elated\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge    :  N /A\n Rechallenge  :  N/A\n     \n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)  Date :10/SEP/2021\nReplimune Inc.  Page : 3 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2  \n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)  \n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -   \n \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)  \n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 -   \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral      \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n     \n Other relevant history (Cont...)\n   \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0 ] ( Continuin g: Yes)  \nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)  Date :10/SEP/2021\nReplimune Inc.  Page : 4 /  4\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(1)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n  \n  \n  \n  \n  \n  \n        \n        \n        \n     \n        "]
apiLogger::2021-10-25 11:45:35,708::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 11:45:35,708::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-25 11:45:35,708::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 11:45:35,708::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 11:45:35,708::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 11:45:46,118::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 11:45:46,118::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 12:09:34,700::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 12:09:34,706::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 12:09:34,706::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpryqo6ttj 
apiLogger::2021-10-25 12:09:34,706::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 12:09:34,707::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 12:09:34,844::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 12:09:34,844::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpryqo6ttj
apiLogger::2021-10-25 12:09:37,730::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 12:09:37,730::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 12:09:37,730::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 12:09:37,731::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 12:09:37,734::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:09:37,734::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 12:09:37,734::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 12:09:37,734::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 12:09:37,737::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-25 12:09:37,737::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 12:09:37,737::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 12:09:37,737::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-25 12:09:37,737::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-25 12:09:37,738::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 12:09:37,738::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-25 12:09:37,738::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 12:09:37,738::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 12:09:37,738::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 12:09:56,795::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 12:09:56,795::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 12:11:34,692::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 12:11:34,710::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 12:11:34,710::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxm8x8zlx 
apiLogger::2021-10-25 12:11:34,711::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 12:11:34,711::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 12:11:34,859::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 12:11:34,859::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxm8x8zlx
apiLogger::2021-10-25 12:11:36,515::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 12:11:36,515::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 12:11:36,515::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 12:11:36,515::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 12:11:36,519::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:11:36,519::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 12:11:36,519::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 12:11:36,519::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 12:11:36,522::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:11:36,522::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 12:11:36,522::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-25 12:11:36,522::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-25 12:11:36,525::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:11:36,525::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-25 12:11:36,525::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-25 12:11:36,525::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-25 12:11:36,528::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:11:36,528::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-25 12:11:36,528::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-25 12:11:36,528::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-25 12:11:36,531::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:11:36,531::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-25 12:11:36,531::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-25 12:11:36,531::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-25 12:11:36,534::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:11:36,534::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-25 12:11:36,534::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-25 12:11:36,534::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-25 12:11:36,537::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:11:36,537::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-25 12:11:36,537::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-25 12:11:36,537::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Message Subject : External Regeneron Adverse Event Report for Eylea Vial:\nREGEMC-101358 Version 1\nReceived Time : Wed Sep 22 16:07:21 EDT 2021\nSender Address : regeneronmc@eversana.com\nTo Address :  [katherine.blocher@regeneron.com]; [robert.lewis@regeneron.com];\n[medical.safety@regeneron.com]; [product.complaints@regeneron.com];\nCc Address :\nNo. of Attachments : 2\nRegeneron Adverse Event Form REGEMC-101358 AE Version 1.pdf\nExternal 14632 ADE 2021922134-REGEMC-101358-22-Sep-2021 200500.msg\nMessage content follows :\nEXTERNAL MESSAGE\nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received\nby EVERSANA™ Life Science Services. \n \nThe reference number for this report is REGEMC-101358, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nJennifer Chen, PharmD\nEVERSANA™ Life Science Services\n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this\n#[[#AE469C15-17B3-42CB-B5F8-FA5CD00A83D0#]]#\nIMPORTANT NOTICE:  The information contained in this\ncommunication is for the sole use of the intended\nrecipient(s) and may contain confidential information. If you are not an intended recipient , you are hereby\nnotified that any use, disclosure, copying or\ndistribution of this communication or its contents is\nstrictly prohibited. If you have received this\ncommunication in error, please contact the sender\nimmediately and delete the original message and any\ncopies from your computer system. Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-101358 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-101358 Report Version: 1\nEVERSANA Received Date: 22-Sep-2021 11:38, Version 1 Source: Email\nEVERSANA Staff: Jennifer Chen, PharmD Attachments Included:\nReference ID #: Per Source Doc: 39253966\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Ms. Gina Sharpe Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 800-486-2668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 22-Sep-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to \nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 22-Sep-2021, Regeneron Medical Information received an event report via email from Humana Specialty Pharmacy.\nPlease use the following login credentials to access the source documents in its original form:\nEmail: VISITOR+Medical.Information@regeneron.com\nPassword: RegHumana2021!\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report. \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-101358 (v.1)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nES\nInitials: patient for HCP info?\nAddress: Phone:\nDOB 01-Apr-1941 Fax:\nAge: Gender: Female\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-101358 (v.1)\nVersion 16Nov2020 Message Subject : External Secure attachment for RCT0406324 - REGEMC-101358 Version 1\nReceived Time : Thu Sep 23 10:00:15 EDT 2021\nSender Address : RegeneronSafety.SM@ppd.com\nTo Address :  [medical.safety@regeneron.com];\nCc Address :\nNo. of Attachments : 1\nREGEMC-101358_version1.pdf\nMessage content follows :\nEXTERNAL MESSAGE\n \n \n5\nRegards, 9\n6\n8\nVamsi Krishna Pala, M.Pharm\n8\n-\n1\nSr. Safety Specialist, Pharmacovigilance\n2\nvamsikrishna.pala@ppd.com 0\nEmail:\n2\nMobile: +91 9704077344\n  8-2-293/82/A, Plot No. 226, Andhra Bank Building,\n www.ppdi.com\nRoad no 17, Jubilee Hills, Hyderabad - 500033\n         \nEarly Development | Clinical Development | Laboratories | Post-Approval | Consulting\n \nThis email transmission and any documents, files or previous email messages attached to it may\ncontain information that is confidential or legally privileged. If you are not the intended recipient\nor a person responsible for delivering this transmission to the intended recipient, you are hereby\nnotified that you must not read this transmission and that any disclosure, copying, printing,\ndistribution or use of this transmission is strictly prohibited. If you have received this\ntransmission in error, please immediately notify the sender by telephone or return email and\ndelete the original transmission and its attachments without reading or saving in any manner.  \nHumana Specialty Pharmacy Adverse Event & Product Complaint Form \n       \n  Reporter Information Humana Specialty Pharmacy  111 Merchant St. Springdale, OH 45246   \n \n        AE Rec ID:   39253966   \n             \n    Pharmacy   \nReporter/ \nGINA SHARPE  Phone:  18004862668  Awareness      09/22/2021   \nHumana SP: \n    Date of AE:   \n \nPatient Information: \n \nInitials:  ES  DOB:  04/01/1941  Gender:  F   \n \nPerson who reported the AE/complaint to Humana SP:  Patient   \n     \nConsent given by reporter to contact for follow-up:  No   \n \nDrug Details: \n \n  Type of ADE or product complaint reported:  Adverse Event   \n \n  Drug, Dose:    EYLEA  2MG 0.05ML SDV   \n5\n  9\n  ADE Severity:  Mild  Onset Date:  Unknown   \n6\n \n  Frequency:  Never Filled  8 Date of Therapy:  unknown   \n8\n   \n  - Indication:  H33.103   \n    1      \n      Sample Available:    2      \nAdverse Drug Experience (As complete a de0scription as possible – Provide Diagnosis and symptoms): \n  2\n  Per note -  BXW5478 - Mbr had side effect questions about the eylea -  mbr would like a callback -  unable to transfer to RPH -    \nwas OB and using five9 and had mbr and mdo on the same call \n \n  Causality:  Unknown  ADE Resolved:  No   \n \nRelevant Medical History: \n \nAde related macular \n   \n \nCurrent Medications: \n \n \n   \n   \n   \n \nLot #    Expiration:     \n \nPhysician Information: \n \n  Name:  ABDALLAH JEROUDI  Phone:  3862585777   \n \n  Address:  564 HEALTH BLVD DAYTONA BEACH FL 32114   \n   \n \nBy submitting this form, I certify that this Adverse Event Report was initiated by the individual stated above and it was not solicited by me in any manner. ']
apiLogger::2021-10-25 12:11:36,537::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 12:11:36,537::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 12:11:36,948::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 12:11:36,949::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 12:11:36,949::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbsoxn8_n 
apiLogger::2021-10-25 12:11:36,950::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 12:11:36,950::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 12:11:36,955::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 12:11:36,955::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbsoxn8_n
apiLogger::2021-10-25 12:11:36,970::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 12:11:36,970::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 12:11:36,970::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 12:11:36,970::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 12:11:36,973::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:11:36,974::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 12:11:36,974::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 12:11:36,974::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Priyanka Gupta-External <priyanka.gupta@regeneron.com>\nReceived Date : 25-Oct-2021 12:10:23 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 13 - <<<Priyanka Gupta>\nScenario 13<<<25-Oct-2021>>> \n \nThanks and Regards \nPriyanka Gupta \n ']
apiLogger::2021-10-25 12:11:36,974::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 12:11:36,974::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 12:15:34,690::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 12:15:34,707::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 12:15:34,708::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpl4h03rx5 
apiLogger::2021-10-25 12:15:34,709::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 12:15:34,709::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 12:15:34,858::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 12:15:34,858::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpl4h03rx5
apiLogger::2021-10-25 12:15:36,462::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 12:15:36,462::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 12:15:36,462::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 12:15:36,462::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 12:15:36,465::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:15:36,466::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 12:15:36,466::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 12:15:36,466::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 12:15:36,469::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:15:36,469::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 12:15:36,469::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-25 12:15:36,469::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-25 12:15:36,472::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:15:36,472::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-25 12:15:36,472::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-25 12:15:36,472::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-25 12:15:36,475::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:15:36,475::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-25 12:15:36,475::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-25 12:15:36,475::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-25 12:15:36,478::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:15:36,478::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-25 12:15:36,478::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-25 12:15:36,478::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-25 12:15:36,481::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:15:36,481::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-25 12:15:36,481::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-25 12:15:36,481::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-25 12:15:36,484::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:15:36,485::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-25 12:15:36,485::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-25 12:15:36,485::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Message Subject : External Regeneron Adverse Event Report for Eylea Vial:\nREGEMC-101358 Version 1\nReceived Time : Wed Sep 22 16:07:21 EDT 2021\nSender Address : regeneronmc@eversana.com\nTo Address :  [katherine.blocher@regeneron.com]; [robert.lewis@regeneron.com];\n[medical.safety@regeneron.com]; [product.complaints@regeneron.com];\nCc Address :\nNo. of Attachments : 2\nRegeneron Adverse Event Form REGEMC-101358 AE Version 1.pdf\nExternal 14632 ADE 2021922134-REGEMC-101358-22-Sep-2021 200500.msg\nMessage content follows :\nEXTERNAL MESSAGE\nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received\nby EVERSANA™ Life Science Services. \n \nThe reference number for this report is REGEMC-101358, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nJennifer Chen, PharmD\nEVERSANA™ Life Science Services\n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this\n#[[#AE469C15-17B3-42CB-B5F8-FA5CD00A83D0#]]#\nIMPORTANT NOTICE:  The information contained in this\ncommunication is for the sole use of the intended\nrecipient(s) and may contain confidential information. If you are not an intended recipient , you are hereby\nnotified that any use, disclosure, copying or\ndistribution of this communication or its contents is\nstrictly prohibited. If you have received this\ncommunication in error, please contact the sender\nimmediately and delete the original message and any\ncopies from your computer system. Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-101358 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-101358 Report Version: 1\nEVERSANA Received Date: 22-Sep-2021 11:38, Version 1 Source: Email\nEVERSANA Staff: Jennifer Chen, PharmD Attachments Included:\nReference ID #: Per Source Doc: 39253966\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Ms. Gina Sharpe Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 800-486-2668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 22-Sep-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to \nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 22-Sep-2021, Regeneron Medical Information received an event report via email from Humana Specialty Pharmacy.\nPlease use the following login credentials to access the source documents in its original form:\nEmail: VISITOR+Medical.Information@regeneron.com\nPassword: RegHumana2021!\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report. \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-101358 (v.1)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nES\nInitials: patient for HCP info?\nAddress: Phone:\nDOB 01-Apr-1941 Fax:\nAge: Gender: Female\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-101358 (v.1)\nVersion 16Nov2020 Message Subject : External Secure attachment for RCT0406324 - REGEMC-101358 Version 1\nReceived Time : Thu Sep 23 10:00:15 EDT 2021\nSender Address : RegeneronSafety.SM@ppd.com\nTo Address :  [medical.safety@regeneron.com];\nCc Address :\nNo. of Attachments : 1\nREGEMC-101358_version1.pdf\nMessage content follows :\nEXTERNAL MESSAGE\n \n \n5\nRegards, 9\n6\n8\nVamsi Krishna Pala, M.Pharm\n8\n-\n1\nSr. Safety Specialist, Pharmacovigilance\n2\nvamsikrishna.pala@ppd.com 0\nEmail:\n2\nMobile: +91 9704077344\n  8-2-293/82/A, Plot No. 226, Andhra Bank Building,\n www.ppdi.com\nRoad no 17, Jubilee Hills, Hyderabad - 500033\n         \nEarly Development | Clinical Development | Laboratories | Post-Approval | Consulting\n \nThis email transmission and any documents, files or previous email messages attached to it may\ncontain information that is confidential or legally privileged. If you are not the intended recipient\nor a person responsible for delivering this transmission to the intended recipient, you are hereby\nnotified that you must not read this transmission and that any disclosure, copying, printing,\ndistribution or use of this transmission is strictly prohibited. If you have received this\ntransmission in error, please immediately notify the sender by telephone or return email and\ndelete the original transmission and its attachments without reading or saving in any manner.  \nHumana Specialty Pharmacy Adverse Event & Product Complaint Form \n       \n  Reporter Information Humana Specialty Pharmacy  111 Merchant St. Springdale, OH 45246   \n \n        AE Rec ID:   39253966   \n             \n    Pharmacy   \nReporter/ \nGINA SHARPE  Phone:  18004862668  Awareness      09/22/2021   \nHumana SP: \n    Date of AE:   \n \nPatient Information: \n \nInitials:  ES  DOB:  04/01/1941  Gender:  F   \n \nPerson who reported the AE/complaint to Humana SP:  Patient   \n     \nConsent given by reporter to contact for follow-up:  No   \n \nDrug Details: \n \n  Type of ADE or product complaint reported:  Adverse Event   \n \n  Drug, Dose:    EYLEA  2MG 0.05ML SDV   \n5\n  9\n  ADE Severity:  Mild  Onset Date:  Unknown   \n6\n \n  Frequency:  Never Filled  8 Date of Therapy:  unknown   \n8\n   \n  - Indication:  H33.103   \n    1      \n      Sample Available:    2      \nAdverse Drug Experience (As complete a de0scription as possible – Provide Diagnosis and symptoms): \n  2\n  Per note -  BXW5478 - Mbr had side effect questions about the eylea -  mbr would like a callback -  unable to transfer to RPH -    \nwas OB and using five9 and had mbr and mdo on the same call \n \n  Causality:  Unknown  ADE Resolved:  No   \n \nRelevant Medical History: \n \nAde related macular \n   \n \nCurrent Medications: \n \n \n   \n   \n   \n \nLot #    Expiration:     \n \nPhysician Information: \n \n  Name:  ABDALLAH JEROUDI  Phone:  3862585777   \n \n  Address:  564 HEALTH BLVD DAYTONA BEACH FL 32114   \n   \n \nBy submitting this form, I certify that this Adverse Event Report was initiated by the individual stated above and it was not solicited by me in any manner. ']
apiLogger::2021-10-25 12:15:36,485::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 12:15:36,485::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 12:15:36,933::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 12:15:36,934::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 12:15:36,934::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp6t3kz2l6 
apiLogger::2021-10-25 12:15:36,934::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 12:15:36,934::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 12:15:36,939::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 12:15:36,939::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp6t3kz2l6
apiLogger::2021-10-25 12:15:36,952::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 12:15:36,952::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 12:15:36,952::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 12:15:36,953::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 12:15:36,956::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:15:36,956::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 12:15:36,956::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 12:15:36,956::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Prashant Kapoor-External <prashant.kapoor@regeneron.com>\nReceived Date : 25-Oct-2021 12:14:35 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 13 - Prashant Kapoor\nScenario 13 25-Oct-2021 ']
apiLogger::2021-10-25 12:15:36,956::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 12:15:36,956::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 12:19:34,631::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 12:19:34,637::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 12:19:34,637::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdx1pn50e 
apiLogger::2021-10-25 12:19:34,638::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 12:19:34,638::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 12:19:34,777::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 12:19:34,777::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdx1pn50e
apiLogger::2021-10-25 12:19:37,663::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 12:19:37,663::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 12:19:37,663::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 12:19:37,663::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 12:19:37,667::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:19:37,667::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 12:19:37,667::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 12:19:37,667::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 12:19:37,670::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-25 12:19:37,670::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 12:19:37,670::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 12:19:37,670::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-25 12:19:37,670::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-25 12:19:37,670::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 12:19:37,670::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-25 12:19:37,670::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 12:19:37,670::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 12:19:37,670::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 12:19:56,628::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 12:19:56,628::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 12:43:34,664::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 12:43:34,670::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 12:43:34,671::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfsvy_wnc 
apiLogger::2021-10-25 12:43:34,671::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 12:43:34,671::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 12:43:34,808::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 12:43:34,809::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfsvy_wnc
apiLogger::2021-10-25 12:43:37,696::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 12:43:37,697::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 12:43:37,697::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 12:43:37,697::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 12:43:37,700::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:43:37,700::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 12:43:37,700::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 12:43:37,700::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 12:43:37,703::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-25 12:43:37,703::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 12:43:37,703::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 12:43:37,703::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-25 12:43:37,703::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-25 12:43:37,704::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 12:43:37,704::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-25 12:43:37,704::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 12:43:37,704::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 12:43:37,704::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 12:43:56,772::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 12:43:56,772::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 12:47:34,687::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 12:47:34,705::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 12:47:34,705::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpzrm18zk9 
apiLogger::2021-10-25 12:47:34,706::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 12:47:34,706::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 12:47:34,854::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 12:47:34,854::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpzrm18zk9
apiLogger::2021-10-25 12:47:36,457::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 12:47:36,457::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 12:47:36,457::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 12:47:36,457::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 12:47:36,461::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:47:36,461::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 12:47:36,461::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 12:47:36,461::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 12:47:36,464::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:47:36,464::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 12:47:36,464::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-25 12:47:36,464::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-25 12:47:36,467::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:47:36,467::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-25 12:47:36,467::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-25 12:47:36,467::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-25 12:47:36,470::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:47:36,470::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-25 12:47:36,470::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-25 12:47:36,470::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-25 12:47:36,473::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:47:36,473::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-25 12:47:36,473::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-25 12:47:36,473::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-25 12:47:36,476::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:47:36,476::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-25 12:47:36,476::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-25 12:47:36,476::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-25 12:47:36,480::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:47:36,480::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-25 12:47:36,480::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-25 12:47:36,480::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Message Subject : External Regeneron Adverse Event Report for Eylea Vial:\nREGEMC-101358 Version 1\nReceived Time : Wed Sep 22 16:07:21 EDT 2021\nSender Address : regeneronmc@eversana.com\nTo Address :  [katherine.blocher@regeneron.com]; [robert.lewis@regeneron.com];\n[medical.safety@regeneron.com]; [product.complaints@regeneron.com];\nCc Address :\nNo. of Attachments : 2\nRegeneron Adverse Event Form REGEMC-101358 AE Version 1.pdf\nExternal 14632 ADE 2021922134-REGEMC-101358-22-Sep-2021 200500.msg\nMessage content follows :\nEXTERNAL MESSAGE\nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received\nby EVERSANA™ Life Science Services. \n \nThe reference number for this report is REGEMC-101358, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nJennifer Chen, PharmD\nEVERSANA™ Life Science Services\n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this\n#[[#AE469C15-17B3-42CB-B5F8-FA5CD00A83D0#]]#\nIMPORTANT NOTICE:  The information contained in this\ncommunication is for the sole use of the intended\nrecipient(s) and may contain confidential information. If you are not an intended recipient , you are hereby\nnotified that any use, disclosure, copying or\ndistribution of this communication or its contents is\nstrictly prohibited. If you have received this\ncommunication in error, please contact the sender\nimmediately and delete the original message and any\ncopies from your computer system. Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-101358 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-101358 Report Version: 1\nEVERSANA Received Date: 22-Sep-2021 11:38, Version 1 Source: Email\nEVERSANA Staff: Jennifer Chen, PharmD Attachments Included:\nReference ID #: Per Source Doc: 39253966\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Ms. Gina Sharpe Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 800-486-2668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 22-Sep-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to \nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 22-Sep-2021, Regeneron Medical Information received an event report via email from Humana Specialty Pharmacy.\nPlease use the following login credentials to access the source documents in its original form:\nEmail: VISITOR+Medical.Information@regeneron.com\nPassword: RegHumana2021!\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report. \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-101358 (v.1)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nES\nInitials: patient for HCP info?\nAddress: Phone:\nDOB 01-Apr-1941 Fax:\nAge: Gender: Female\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-101358 (v.1)\nVersion 16Nov2020 Message Subject : External Secure attachment for RCT0406324 - REGEMC-101358 Version 1\nReceived Time : Thu Sep 23 10:00:15 EDT 2021\nSender Address : RegeneronSafety.SM@ppd.com\nTo Address :  [medical.safety@regeneron.com];\nCc Address :\nNo. of Attachments : 1\nREGEMC-101358_version1.pdf\nMessage content follows :\nEXTERNAL MESSAGE\n \n \n5\nRegards, 9\n6\n8\nVamsi Krishna Pala, M.Pharm\n8\n-\n1\nSr. Safety Specialist, Pharmacovigilance\n2\nvamsikrishna.pala@ppd.com 0\nEmail:\n2\nMobile: +91 9704077344\n  8-2-293/82/A, Plot No. 226, Andhra Bank Building,\n www.ppdi.com\nRoad no 17, Jubilee Hills, Hyderabad - 500033\n         \nEarly Development | Clinical Development | Laboratories | Post-Approval | Consulting\n \nThis email transmission and any documents, files or previous email messages attached to it may\ncontain information that is confidential or legally privileged. If you are not the intended recipient\nor a person responsible for delivering this transmission to the intended recipient, you are hereby\nnotified that you must not read this transmission and that any disclosure, copying, printing,\ndistribution or use of this transmission is strictly prohibited. If you have received this\ntransmission in error, please immediately notify the sender by telephone or return email and\ndelete the original transmission and its attachments without reading or saving in any manner.  \nHumana Specialty Pharmacy Adverse Event & Product Complaint Form \n       \n  Reporter Information Humana Specialty Pharmacy  111 Merchant St. Springdale, OH 45246   \n \n        AE Rec ID:   39253966   \n             \n    Pharmacy   \nReporter/ \nGINA SHARPE  Phone:  18004862668  Awareness      09/22/2021   \nHumana SP: \n    Date of AE:   \n \nPatient Information: \n \nInitials:  ES  DOB:  04/01/1941  Gender:  F   \n \nPerson who reported the AE/complaint to Humana SP:  Patient   \n     \nConsent given by reporter to contact for follow-up:  No   \n \nDrug Details: \n \n  Type of ADE or product complaint reported:  Adverse Event   \n \n  Drug, Dose:    EYLEA  2MG 0.05ML SDV   \n5\n  9\n  ADE Severity:  Mild  Onset Date:  Unknown   \n6\n \n  Frequency:  Never Filled  8 Date of Therapy:  unknown   \n8\n   \n  - Indication:  H33.103   \n    1      \n      Sample Available:    2      \nAdverse Drug Experience (As complete a de0scription as possible – Provide Diagnosis and symptoms): \n  2\n  Per note -  BXW5478 - Mbr had side effect questions about the eylea -  mbr would like a callback -  unable to transfer to RPH -    \nwas OB and using five9 and had mbr and mdo on the same call \n \n  Causality:  Unknown  ADE Resolved:  No   \n \nRelevant Medical History: \n \nAde related macular \n   \n \nCurrent Medications: \n \n \n   \n   \n   \n \nLot #    Expiration:     \n \nPhysician Information: \n \n  Name:  ABDALLAH JEROUDI  Phone:  3862585777   \n \n  Address:  564 HEALTH BLVD DAYTONA BEACH FL 32114   \n   \n \nBy submitting this form, I certify that this Adverse Event Report was initiated by the individual stated above and it was not solicited by me in any manner. ']
apiLogger::2021-10-25 12:47:36,480::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 12:47:36,480::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 12:47:36,907::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 12:47:36,907::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 12:47:36,907::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_q1jtniz 
apiLogger::2021-10-25 12:47:36,908::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 12:47:36,908::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 12:47:36,913::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 12:47:36,913::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_q1jtniz
apiLogger::2021-10-25 12:47:36,926::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 12:47:36,926::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 12:47:36,926::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 12:47:36,926::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 12:47:36,929::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 12:47:36,929::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 12:47:36,929::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 12:47:36,930::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Sahil Bansal-External <sahil.bansal@regeneron.com>\nReceived Date : 25-Oct-2021 12:45:35 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 13 - Sahil Bansal\nScenario 13 25-Oct-2021 \n ']
apiLogger::2021-10-25 12:47:36,930::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 12:47:36,930::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 14:12:40,984::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 14:12:41,033::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 14:12:41,033::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp8ihjrywn 
apiLogger::2021-10-25 14:12:41,035::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 14:12:41,035::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 14:12:41,511::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 14:12:41,511::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp8ihjrywn
apiLogger::2021-10-25 14:12:44,849::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 14:12:44,849::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 14:12:44,849::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 14:12:44,849::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 14:12:44,853::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-25 14:12:44,853::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 14:12:44,853::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 14:12:44,853::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-25 14:12:44,853::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616009134\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries\nDate of Concomitant\nRecord Reason for Surgery/ Procedure/Surgery  (dd-\nPosition Procedure / Surgery Procedure If Other, specify mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Related Surgery\nReason for Surgery/Procedure\nRecord If Surgery Location is Date of Surgery\nProcedure Surgery Location Check for Unknown Date\nPosition Other, specify (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Systemic Cancer Therapy\nLine Number\nTherapy setting\nIf Other, specify\nLine of therapy\nIf Other, specify\nStart date (dd-mon-yyyy)\nStart Date Unknown\nStop date (dd-mon-yyyy)\nStop Date Unknown\nSubject’s Best Response\nIf best response is CR or PR, enter Date of\nBest Response (dd-mon-yyyy)\nDate of Best Response Unknown\nIf subject  recurred/relapsed/progressed after\nthis therapy, please enter Date of Recurrence/\nRelapse/Progression (dd-mon-yyyy)\nIf Date of Recurrence/ Relapse/Progression\nDate of Progressive Disease Unknown\nNumber of cycles\nNumber of cycles unknown/NA\nIf Immunotherapy, Specify\nIf Other, specify\nRegimen Name or Single Therapy\nRecord\nName of Drug (Generic Name)\nPosition\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nPrior Cancer Radiotherapy\nStart Date (dd- Check for Start End Date (dd- Check for End Total Dose\nRecordPosition Type of Radiation Therapy Site of Radiation If Other, specify Intent of treatment mon-yyyy) Date Unknown mon-yyyy) Date Unknown cGY Comments\nUNCHECKED UNCHECKED\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nAdverse Event\nRecord Position 2\nAE number\nMain Adverse Event Description (Term) INFUSION REACTION\nStart date (dd-mon-yyyy) 17 OCT 2019\nIf event occurred on study day 1, did the\nevent occur prior to first study drug Not Applicable\nadministration\nIf the event is part of an Infusion Related\nReaction, please check the box and IRR\ncomplete IRR CRF\nIs this AE immune related? No\nSelect if AE is intermittent No\nAE suspected to be caused by blinded\nNo\nstudy drug?\nAction taken with blinded study drug Dose Not Changed\nCarboplatin NOT CHECKED\nAction taken with Carboplatin Dose Not Changed\nPaclitaxel CHECKED\nAction taken with Paclitaxel Drug Interrupted\nPemetrexed NOT CHECKED\nAction taken with Pemetrexed Not Applicable\nCisplatin NOT CHECKED\nAction taken with Cisplatin Not Applicable\nOther Causality NOT CHECKED\nIf Other Causality, Specify\nIf the Event is not study drug related but\nbelongs to the sponsor list of immune\nrelated event, please provide the\netiology\nIf Other, specify\nAE suspected to be caused by study\nNo\nconduct?\n---If Yes, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with\nSequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy) 17 OCT 2019\nAE initial severity CTCAE grade Grade 2\nAE most extreme severity CTCAE grade Grade 2\nDate Event Became Grade 3 or higher -\nif applicable (dd-mon-yyyy)\nDate Event Became Less than Grade 3 -\nif applicable (dd-mon-yyyy)\nNone NOT CHECKED\nDrug therapy/ Medication CHECKED\nConcomitant Procedure/surgery NOT CHECKED\nOther NOT CHECKED\nIf Other, specify\nDoes this AE qualify as Serious?  (If\nNo\nYES, complete SAE/AESI Form)\nIt resulted in death NOT CHECKED\nIt was life-threatening NOT CHECKED\nIt required or prolonged inpatient\nNOT CHECKED\nhospitalization\nPersistent or significant disability /\nNOT CHECKED\nincapacity\nIt is a congenital anomaly/birth defect in\nNOT CHECKED\noffspring of study subject\nOther medically serious important event\n(It does not meet any of the above\nserious criteria, but may jeopardize the\nNOT CHECKED\nsubject, and may require medical or\nsurgical intervention to prevent one of\nthe outcomes listed above).\nIf Other, specify\nIs this an AE of Special interest (AESI)?\nYes\n(If YES, complete SAE/AESI Form)\nGrade 2 or greater infusion-related\nNOT CHECKED\nreactions\nGrade 2 or greater allergic/\nCHECKED\nhypersensitivity reactions\nGrade 3 or greater irAE.Note: An irAE\ncan occur shortly after the first dose or\nseveral months after the last dose of\ntreatment. All AEs of unknown etiology\nassociated with drug exposure should\nbe evaluated to determine possible\nNOT CHECKED\nimmune etiology. If an irAE is\nsuspected, efforts should be made to\nrule out neoplastic, infectious,\nmetabolic, toxin or other etiologic\ncauses prior to labeling an AE as an\nirAE.\nTreatment Details\nMedications\n4_HYDROCORTISONE\nProcedures or Surgeries\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-25 14:12:44,853::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 14:12:44,853::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-25 14:12:44,853::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 14:12:44,853::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 14:12:44,853::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 14:13:07,507::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 14:13:07,507::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 14:14:27,327::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 14:14:27,333::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 14:14:27,333::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpomox40na 
apiLogger::2021-10-25 14:14:27,334::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 14:14:27,334::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 14:14:27,407::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 14:14:27,407::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpomox40na
apiLogger::2021-10-25 14:14:29,435::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 14:14:29,435::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 14:14:29,435::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 14:14:29,435::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 14:14:29,438::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-25 14:14:29,439::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 14:14:29,439::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 14:14:29,439::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-25 14:14:29,439::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nCLINDAMYCI Medical 1_TOOTH 18 JUN\n1 N History PAIN_UNKNOWN 14 JUN 2021 No 2021 150 mg Q6H Oral\n4_RASH\nHYDROCORT Adverse URTICARIAL_02 SEP 02 SEP Intraven\n2 ISONE Event 2021 02 SEP 2021 No 2021 100 mg PRN ous\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nDENTAL PAINFUL, LOOSE\n1 EXTRACTION Other TOOTH 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TOOTH PAIN CHECKED No 14 JUN 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 01 MAR 2021\nStage Based on Surgical Pathology Stage IV\nT TX\nN N3\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nOther Non-CSCC/Non-BCC Cancer Diagnosis and History details\nDoes the patient have prior history of cancer,\nother than CSCC or BCC? Yes\nOngoing at study Stage at time of\nRecordPosition entry? Stop Date Tumor Type Histologic Grade Date of Diagnosis diagnosis\nINTRAEPIDERMAL\nSQUAMOUS CELL\n1 No 11 MAR 2021 CARCINOMA Unknown 11 MAR 2021 Unknown\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-25 14:14:29,439::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 14:14:29,439::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-25 14:14:29,439::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 14:14:29,439::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 14:14:29,439::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 14:14:43,928::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 14:14:43,928::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 14:27:44,127::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 14:27:44,133::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 14:27:44,133::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpv7q3cvtw 
apiLogger::2021-10-25 14:27:44,134::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 14:27:44,134::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 14:27:44,272::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 14:27:44,273::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpv7q3cvtw
apiLogger::2021-10-25 14:27:47,159::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 14:27:47,159::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 14:27:47,160::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 14:27:47,160::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 14:27:47,163::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 14:27:47,163::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 14:27:47,163::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 14:27:47,163::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 14:27:47,166::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-25 14:27:47,166::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 14:27:47,166::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-25 14:27:47,166::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-25 14:27:47,166::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-10-25 14:27:47,166::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-25 14:27:47,166::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-25 14:27:47,166::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-25 14:27:47,167::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-25 14:27:47,167::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-25 14:28:06,118::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-25 14:28:06,118::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 17:05:34,728::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 17:05:34,745::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 17:05:34,746::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1x15enhi 
apiLogger::2021-10-25 17:05:34,747::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 17:05:34,747::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 17:05:34,896::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 17:05:34,896::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1x15enhi
apiLogger::2021-10-25 17:05:36,499::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 17:05:36,499::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 17:05:36,500::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 17:05:36,500::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 17:05:36,503::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 17:05:36,504::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 17:05:36,504::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 17:05:36,504::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-25 17:05:36,507::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 17:05:36,507::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-25 17:05:36,507::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-25 17:05:36,507::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-25 17:05:36,511::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 17:05:36,511::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-25 17:05:36,511::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-25 17:05:36,511::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-25 17:05:36,514::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 17:05:36,514::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-25 17:05:36,514::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-25 17:05:36,514::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-25 17:05:36,517::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 17:05:36,517::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-25 17:05:36,517::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-25 17:05:36,517::content_type.py::(line:131)::find_content_type()::DEBUG : i is 5
apiLogger::2021-10-25 17:05:36,520::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 17:05:36,520::content_type.py::(line:134)::find_content_type()::DEBUG : main: 5
apiLogger::2021-10-25 17:05:36,521::content_type.py::(line:178)::find_content_type()::DEBUG : outside:6
apiLogger::2021-10-25 17:05:36,521::content_type.py::(line:131)::find_content_type()::DEBUG : i is 6
apiLogger::2021-10-25 17:05:36,524::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 17:05:36,524::content_type.py::(line:134)::find_content_type()::DEBUG : main: 6
apiLogger::2021-10-25 17:05:36,524::content_type.py::(line:178)::find_content_type()::DEBUG : outside:7
apiLogger::2021-10-25 17:05:36,524::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Message Subject : External Regeneron Adverse Event Report for Eylea Vial:\nREGEMC-101358 Version 1\nReceived Time : Wed Sep 22 16:07:21 EDT 2021\nSender Address : regeneronmc@eversana.com\nTo Address :  [katherine.blocher@regeneron.com]; [robert.lewis@regeneron.com];\n[medical.safety@regeneron.com]; [product.complaints@regeneron.com];\nCc Address :\nNo. of Attachments : 2\nRegeneron Adverse Event Form REGEMC-101358 AE Version 1.pdf\nExternal 14632 ADE 2021922134-REGEMC-101358-22-Sep-2021 200500.msg\nMessage content follows :\nEXTERNAL MESSAGE\nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received\nby EVERSANA™ Life Science Services. \n \nThe reference number for this report is REGEMC-101358, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nJennifer Chen, PharmD\nEVERSANA™ Life Science Services\n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this\n#[[#AE469C15-17B3-42CB-B5F8-FA5CD00A83D0#]]#\nIMPORTANT NOTICE:  The information contained in this\ncommunication is for the sole use of the intended\nrecipient(s) and may contain confidential information. If you are not an intended recipient , you are hereby\nnotified that any use, disclosure, copying or\ndistribution of this communication or its contents is\nstrictly prohibited. If you have received this\ncommunication in error, please contact the sender\nimmediately and delete the original message and any\ncopies from your computer system. Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-101358 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-101358 Report Version: 1\nEVERSANA Received Date: 22-Sep-2021 11:38, Version 1 Source: Email\nEVERSANA Staff: Jennifer Chen, PharmD Attachments Included:\nReference ID #: Per Source Doc: 39253966\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Ms. Gina Sharpe Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 800-486-2668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 22-Sep-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to \nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 22-Sep-2021, Regeneron Medical Information received an event report via email from Humana Specialty Pharmacy.\nPlease use the following login credentials to access the source documents in its original form:\nEmail: VISITOR+Medical.Information@regeneron.com\nPassword: RegHumana2021!\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report. \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-101358 (v.1)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nES\nInitials: patient for HCP info?\nAddress: Phone:\nDOB 01-Apr-1941 Fax:\nAge: Gender: Female\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-101358 (v.1)\nVersion 16Nov2020 Message Subject : External Secure attachment for RCT0406324 - REGEMC-101358 Version 1\nReceived Time : Thu Sep 23 10:00:15 EDT 2021\nSender Address : RegeneronSafety.SM@ppd.com\nTo Address :  [medical.safety@regeneron.com];\nCc Address :\nNo. of Attachments : 1\nREGEMC-101358_version1.pdf\nMessage content follows :\nEXTERNAL MESSAGE\n \n \n5\nRegards, 9\n6\n8\nVamsi Krishna Pala, M.Pharm\n8\n-\n1\nSr. Safety Specialist, Pharmacovigilance\n2\nvamsikrishna.pala@ppd.com 0\nEmail:\n2\nMobile: +91 9704077344\n  8-2-293/82/A, Plot No. 226, Andhra Bank Building,\n www.ppdi.com\nRoad no 17, Jubilee Hills, Hyderabad - 500033\n         \nEarly Development | Clinical Development | Laboratories | Post-Approval | Consulting\n \nThis email transmission and any documents, files or previous email messages attached to it may\ncontain information that is confidential or legally privileged. If you are not the intended recipient\nor a person responsible for delivering this transmission to the intended recipient, you are hereby\nnotified that you must not read this transmission and that any disclosure, copying, printing,\ndistribution or use of this transmission is strictly prohibited. If you have received this\ntransmission in error, please immediately notify the sender by telephone or return email and\ndelete the original transmission and its attachments without reading or saving in any manner.  \nHumana Specialty Pharmacy Adverse Event & Product Complaint Form \n       \n  Reporter Information Humana Specialty Pharmacy  111 Merchant St. Springdale, OH 45246   \n \n        AE Rec ID:   39253966   \n             \n    Pharmacy   \nReporter/ \nGINA SHARPE  Phone:  18004862668  Awareness      09/22/2021   \nHumana SP: \n    Date of AE:   \n \nPatient Information: \n \nInitials:  ES  DOB:  04/01/1941  Gender:  F   \n \nPerson who reported the AE/complaint to Humana SP:  Patient   \n     \nConsent given by reporter to contact for follow-up:  No   \n \nDrug Details: \n \n  Type of ADE or product complaint reported:  Adverse Event   \n \n  Drug, Dose:    EYLEA  2MG 0.05ML SDV   \n5\n  9\n  ADE Severity:  Mild  Onset Date:  Unknown   \n6\n \n  Frequency:  Never Filled  8 Date of Therapy:  unknown   \n8\n   \n  - Indication:  H33.103   \n    1      \n      Sample Available:    2      \nAdverse Drug Experience (As complete a de0scription as possible – Provide Diagnosis and symptoms): \n  2\n  Per note -  BXW5478 - Mbr had side effect questions about the eylea -  mbr would like a callback -  unable to transfer to RPH -    \nwas OB and using five9 and had mbr and mdo on the same call \n \n  Causality:  Unknown  ADE Resolved:  No   \n \nRelevant Medical History: \n \nAde related macular \n   \n \nCurrent Medications: \n \n \n   \n   \n   \n \nLot #    Expiration:     \n \nPhysician Information: \n \n  Name:  ABDALLAH JEROUDI  Phone:  3862585777   \n \n  Address:  564 HEALTH BLVD DAYTONA BEACH FL 32114   \n   \n \nBy submitting this form, I certify that this Adverse Event Report was initiated by the individual stated above and it was not solicited by me in any manner. ']
apiLogger::2021-10-25 17:05:36,525::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 17:05:36,525::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-25 17:05:36,905::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-25 17:05:36,906::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-25 17:05:36,906::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp4mpagjll 
apiLogger::2021-10-25 17:05:36,907::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-25 17:05:36,907::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-25 17:05:36,913::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-25 17:05:36,914::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp4mpagjll
apiLogger::2021-10-25 17:05:36,951::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-25 17:05:36,951::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-25 17:05:36,951::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-25 17:05:36,952::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-25 17:05:36,955::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-25 17:05:36,955::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-25 17:05:36,955::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-25 17:05:36,955::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Katarzyna Przezdziecki <katarzy.przezdziecki@regeneron.com>\nReceived Date : 25-Oct-2021 13:04:42 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 13 - Katie Przezdziecki\nScenario 13 25-Oct-2021 \n \nKind regards, \n \nKatie Przezdziecki, RN \nAssociate Manager - GPS- Case Evaluation and Reporting Management  \nRegeneron Pharmaceuticals Inc. \n777 Old Saw Mill River Rd, Tarrytown, NY 10591 \nTel: 914-479-8571 \nEmail: katarzy.przezdziecki@regeneron.com    \nUpcoming Out-Of-Office Dates: 15-Oct-2021, 18-Oct-2021 \nUpcoming Regeneron Holidays: 05Jul2021, 06Sep2021, 25-26Nov2021, 27-31Dec2021 \n \n \n ']
apiLogger::2021-10-25 17:05:36,956::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-25 17:05:36,956::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
